<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Exercise therapy for chronic low back pain - Hayden, JA - 2021 | Cochrane Library</title> <meta content="Exercise therapy for chronic low back pain - Hayden, JA - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009790.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Exercise therapy for chronic low back pain - Hayden, JA - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009790.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009790.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Exercise therapy for chronic low back pain" name="citation_title"/> <meta content="Jill A Hayden" name="citation_author"/> <meta content="Dalhousie University" name="citation_author_institution"/> <meta content="jhayden@dal.ca" name="citation_author_email"/> <meta content="Jenna Ellis" name="citation_author"/> <meta content="Dalhousie University" name="citation_author_institution"/> <meta content="Rachel Ogilvie" name="citation_author"/> <meta content="Dalhousie University" name="citation_author_institution"/> <meta content="Antti Malmivaara" name="citation_author"/> <meta content="National Institute for Health and Welfare (THL)" name="citation_author_institution"/> <meta content="Maurits W van Tulder" name="citation_author"/> <meta content="VU University Amsterdam" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD009790.pub2" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/09/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009790.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009790.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009790.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Exercise; Exercise Therapy; *Low Back Pain [therapy]; Mind-Body Therapies; *Musculoskeletal Manipulations" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009790.pub2&amp;doi=10.1002/14651858.CD009790.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009790\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009790\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","pt","th","ms","ja","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009790.pub2",title:"Exercise therapy for chronic low back pain",firstPublishedDate:"Sep 28, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Back and Neck Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009790.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009790.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009790.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009790.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009790.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009790.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009790.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009790.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009790.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009790.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>65847 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009790.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-sec-0091"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-sec-0042"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-sec-0085"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/appendices#CD009790-sec-0097"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/supinfo/CD009790StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/supinfo/CD009790StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Exercise therapy for chronic low back pain</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information#CD009790-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Jill A Hayden</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information#CD009790-cr-0005">Jenna Ellis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information#CD009790-cr-0006">Rachel Ogilvie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information#CD009790-cr-0007">Antti Malmivaara</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information#CD009790-cr-0008">Maurits W van Tulder</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information/en#CD009790-sec-0113">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 September 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009790.pub2">https://doi.org/10.1002/14651858.CD009790.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009790-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009790-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009790-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009790-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009790-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009790-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD009790-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009790-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009790-abs-0001" lang="en"> <section id="CD009790-sec-0001"> <h3 class="title" id="CD009790-sec-0001">Background</h3> <p>Low back pain has been the leading cause of disability globally for at least the past three decades and results in enormous direct healthcare and lost productivity costs. </p> </section> <section id="CD009790-sec-0002"> <h3 class="title" id="CD009790-sec-0002">Objectives</h3> <p>The primary objective of this systematic review is to assess the impact of exercise treatment on pain and functional limitations in adults with chronic non‐specific low back pain compared to no treatment, usual care, placebo and other conservative treatments. </p> </section> <section id="CD009790-sec-0003"> <h3 class="title" id="CD009790-sec-0003">Search methods</h3> <p>We searched CENTRAL (which includes the Cochrane Back and Neck trials register), MEDLINE, Embase, CINAHL, PsycINFO, PEDro, SPORTDiscus, and trials registries (<a href="https://clinicaltrials.gov/ct2/search/advanced" target="_blank">ClinicalTrials.gov</a> and World Health Organization International Clinical Trials Registry Platform), and conducted citation searching of relevant systematic reviews to identify additional studies. The review includes data for trials identified in searches up to 27 April 2018. All eligible trials have been identified through searches to 7 December 2020, but have not yet been extracted; these trials will be integrated in the next update. </p> </section> <section id="CD009790-sec-0004"> <h3 class="title" id="CD009790-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials that assessed exercise treatment compared to no treatment, usual care, placebo or other conservative treatment on the outcomes of pain or functional limitations for a population of adult participants with chronic non‐specific low back pain of more than 12 weeks’ duration. </p> </section> <section id="CD009790-sec-0005"> <h3 class="title" id="CD009790-sec-0005">Data collection and analysis</h3> <p>Two authors screened and assessed studies independently, with consensus. We extracted outcome data using electronic databases; pain and functional limitations outcomes were re‐scaled to 0 to 100 points for meta‐analyses where 0 is no pain or functional limitations. We assessed risk of bias using the Cochrane risk of bias (RoB) tool and used GRADE to evaluate the overall certainty of the evidence. When required, we contacted study authors to obtain missing data. To interpret meta‐analysis results, we considered a 15‐point difference in pain and a 10‐point difference in functional limitations outcomes to be clinically important for the primary comparison of exercise versus no treatment, usual care or placebo. </p> </section> <section id="CD009790-sec-0006"> <h3 class="title" id="CD009790-sec-0006">Main results</h3> <p>We included 249 trials of exercise treatment, including studies conducted in Europe (122 studies), Asia (38 studies), North America (33 studies), and the Middle East (24 studies). Sixty‐one per cent of studies (151 trials) examined the effectiveness of two or more different types of exercise treatment, and 57% (142 trials) compared exercise treatment to a non‐exercise comparison treatment. Study participants had a mean age of 43.7 years and, on average, 59% of study populations were female. Most of the trials were judged to be at risk of bias, including 79% at risk of performance bias due to difficulty blinding exercise treatments. </p> <p>We found moderate‐certainty evidence that exercise treatment is more effective for treatment of chronic low back pain compared to no treatment, usual care or placebo comparisons for pain outcomes at earliest follow‐up (MD ‐15.2, 95% CI ‐18.3 to ‐12.2), a clinically important difference. Certainty of evidence was downgraded mainly due to heterogeneity. For the same comparison, there was moderate‐certainty evidence for functional limitations outcomes (MD ‐6.8 (95% CI ‐8.3 to ‐5.3); this finding did not meet our prespecified threshold for minimal clinically important difference. Certainty of evidence was downgraded mainly due to some evidence of publication bias.  </p> <p>Compared to all other investigated conservative treatments, exercise treatment was found to have improved pain (MD ‐9.1, 95% CI ‐12.6 to ‐5.6) and functional limitations outcomes (MD ‐4.1, 95% CI ‐6.0 to ‐2.2). These effects did not meet our prespecified threshold for clinically important difference. Subgroup analysis of pain outcomes suggested that exercise treatment is probably more effective than education alone (MD ‐12.2, 95% CI ‐19.4 to ‐5.0) or non‐exercise physical therapy (MD ‐10.4, 95% CI ‐15.2 to ‐5.6), but with no differences observed for manual therapy (MD 1.0, 95% CI ‐3.1 to 5.1). </p> <p>In studies that reported adverse effects (86 studies), one or more adverse effects were reported in 37 of 112 exercise groups (33%) and 12 of 42 comparison groups (29%). Twelve included studies reported measuring adverse effects in a systematic way, with a median of 0.14 (IQR 0.01 to 0.57) per participant in the exercise groups (mostly minor harms, e.g. muscle soreness), and 0.12 (IQR 0.02 to 0.32) in comparison groups. </p> </section> <section id="CD009790-sec-0007"> <h3 class="title" id="CD009790-sec-0007">Authors' conclusions</h3> <p>We found moderate‐certainty evidence that exercise is probably effective for treatment of chronic low back pain compared to no treatment, usual care or placebo for pain. The observed treatment effect for the exercise compared to no treatment, usual care or placebo comparisons is small for functional limitations, not meeting our threshold for minimal clinically important difference. We also found exercise to have improved pain (low‐certainty evidence) and functional limitations outcomes (moderate‐certainty evidence) compared to other conservative treatments; however, these effects were small and not clinically important when considering all comparisons together. Subgroup analysis suggested that exercise treatment is probably more effective than advice or education alone, or electrotherapy, but with no differences observed for manual therapy treatments. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009790-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009790-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009790-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009790-abs-0019">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009790-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009790-abs-0017">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009790-abs-0012">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009790-abs-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009790-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009790-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD009790-abs-0010">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009790-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009790-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009790-abs-0002" lang="en"> <h3>Exercise for treatment of chronic low back pain</h3> <p><b>Is exercise an effective therapy to treat long‐lasting low back pain?</b> </p> <p><b><i>Key messages</i> </b> </p> <p>‐ Exercise probably reduces pain compared to no treatment, usual care or placebo in people with long‐lasting (chronic) low back pain. </p> <p>‐ Exercise may reduce pain and improve disability compared to common treatments such as electrotherapy or education. </p> <p>‐ There is a lot of research in this field but we need bigger and better designed studies to allow us to draw firm conclusions. </p> <p><b><i>How might exercise help people with long‐lasting low back pain?</i> </b> </p> <p>Long‐lasting (chronic) low back pain is a common cause of disability across the world and is expensive in terms of healthcare costs and lost working hours. Exercise therapy aims to increase muscle and joint strength, and improve muscle function and range of motion. This should reduce pain and disability, and speed recovery and return to usual activities. Exercise therapies are designed or prescribed by health professionals and cover a range of exercise types, durations, and delivery methods. Examples of exercise therapies include general physical fitness programmes delivered in a group setting, aerobic exercise in the form of walking programmes, and strengthening of specific muscles or groups of muscles to increase core stability. </p> <p><b><i>What did we want to find out?</i> </b> </p> <p>We wanted to know whether exercise improves pain and disability for people with chronic low back pain more than no treatment, usual care, placebo or other common treatments. In our review, chronic low back pain is pain that lasts three months or longer or that goes away but returns more than twice in one year. It does not have a specific cause such as a tumour or injury. Examples of common treatments are spinal manipulation, or psychological therapy. ‘Usual care’ is care provided by a family physician. </p> <p><b><i>What did we do?</i> </b> <br/>We searched for studies that assessed the effects of exercise therapy on pain or disability compared to no treatment, usual care, placebo or other common treatments. People in the studies had to be adults with chronic low back pain. </p> <p>We compared and summarised the results of the studies and rated our confidence in the evidence, based on factors such as study methods and sizes. </p> <p><b><i>What did we find?</i> </b> </p> <p>We found 249 studies with a total of 24,486 people. Most studies took place in Europe (122 studies); other common study locations were Asia, North America, and the Middle East. Study participants’ average age was 43.7 years; 59% were women. Participants’ average pain intensity at the start of the studies was 51 points on a 100‐point scale, where 100 is the most pain. They had back pain for 12 weeks to 3 years (78 studies) or longer than 3 years (72 studies); 99 studies did not report how long their participants had low back pain. </p> <p>Sixty‐one per cent of studies (151 studies) examined the effectiveness of two or more different types of exercise, and 57% (142 studies) compared exercise therapy to a non‐exercise treatment. The most common types of exercises were core strengthening (127 study groups), mixed exercises (&gt;2 types) (109 study groups), Pilates (29 study groups), general strengthening exercises (52 study groups), and aerobic exercise (30 study groups). Exercise sessions were one‐on‐one with a healthcare provider (163 study groups) or in a group exercise class (162 study groups). More than half of studies included another treatment alongside exercise (247 study groups), including education or advice (137 study groups), electrotherapy (46 study groups), or manual therapy (21 study groups). </p> <p>Most studies measured pain (223 studies) and disability (223 studies). Only 12 studies reported data that we could use on unwanted effects of treatments. Studies followed people in the short term (6 to 12 weeks; 184 studies); medium term (13 to 47 weeks; 121 studies) and long‐term (48 weeks or more, 69 studies). </p> <p>We also identified 172 more recent studies that we will add to the next version of our review. </p> <p><b><i>Main results</i> </b> </p> <p>People receiving exercise therapy rated their pain on average 15 points better and their disability 7 points better, on a scale of 0 to 100, three months after the start of treatment compared to people who had no treatment, usual care or placebo. Exercise is probably more effective for pain (35 studies, 2746 people) and probably slightly more effective for disability (38 studies, 2942 people) than no treatment, usual care or placebo at all follow‐up periods. </p> <p>Exercise may be more effective for pain (64 studies, 6295 people) and is probably more effective for disability (52 studies, 6004 people) than common treatments in the short and medium term. </p> <p>Few studies reported mostly minor unwanted effects of exercise, most commonly increased low back pain and muscle soreness. However, the non‐exercise groups reported similar types and numbers of unwanted effects. </p> <p><b><i>What are the limitations of the evidence?</i> </b> </p> <p>Our confidence in the evidence is limited. The studies used exercise therapy in different ways and so reported different results from each other. Some studies were very small – the average number of participants was just 98. It is possible that the design of some studies may have made the benefits of exercise seem larger than they are. </p> <p><b><i>How up to date is this evidence?</i> </b> </p> <p>The evidence is up to date to 28 April 2018.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009790-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009790-sec-0091"></div> <h3 class="title" id="CD009790-sec-0092">Implications for practice</h3> <section id="CD009790-sec-0092"> <p>Clinicians often turn to systematic reviews and the resulting guideline recommendations to inform their treatment of patients. This review fills an identified gap, the need for updated, high‐quality review of general exercise (<a href="./references#CD009790-bbs2-0498" title="AlmeidaMO , YamatoTP , ParreiraP , CostaLO , KamperS , SaragiottoBT . Overall confidence in the results of systematic reviews on exercise therapy for chronic low back pain: a cross-sectional analysis using the Assessing the Methodological Quality of Systematic Reviews (AMSTAR) 2 tool. Brazilian Journal of Physical Therapy2020;24(2):103-17.">Almeida 2020</a>). We found moderate evidence that exercise probably provides a small benefit for pain outcomes in treatment of chronic low pain compared to no treatment comparisons (including  usual care and placebo). The observed treatment effect for functional limitations outcomes was small and was not considered clinically important. Exercise treatment was found to have improved pain and functional limitations outcomes compared to other conservative treatments, however, these effects are small and not considered clinically important. We are not able to make recommendations about specific exercise types based on the results of this review, nor on the work of others to date; however, a related publication by this team will address this topic. </p> <p>Due to insufficient reporting of adverse events in included trials, we are not able to confirm the safety or harms related to exercise treatment for chronic low back pain; however, the trials that did measure adverse events report few and mostly minor adverse effects, such as muscle pain. Based on available evidence, exercise is likely a good option to manage chronic low back pain. However, when determining if exercise is right for their patient, clinicians can take into consideration a wide range of factors including patient preference, suitability, access, and costs. </p> </section> <h3 class="title" id="CD009790-sec-0093">Implications for research</h3> <section id="CD009790-sec-0093"> <p>We have identified 451 RCTs on exercise treatment for chronic low back pain (279 assessed, 172 awaiting assessment). Low back pain researchers need to avoid further research waste by ensuring future trials contribute to the evidence base by thoughtful planning, robust conduct, large sample size, complete protocol and manuscript reporting, sharing trial data for validation and future meta‐syntheses, and publication to properly archive results. </p> <p>One of the primary benefits of systematic review and meta‐analysis is combining studies of small sample sizes. However, the field is now saturated with small exercise trials many of which suffer from poor planning, conduct, and reporting due to limited resources. Efforts and research funding may be better spent on the co‐ordination of multi‐site studies, and the development of supports for good conduct and reporting. </p> <p>It is our position that there needs to be more co‐ordinated and thoughtful planning of trials in the field. This includes the identification of existing gaps and the planning of exercise treatments and assessment of outcomes based on the proposed mechanisms of effect (<a href="./references#CD009790-bbs2-0500" title="BirdML , MortensonWB , EngJJ . Evaluation and facilitation of intervention fidelity in community exercise programs through an adaptation of the TIDier framework. BMC Health Services Research2020;20(1):68-75.">Bird 2020</a>; <a href="./references#CD009790-bbs2-0583" title="WoodL , OgilvieR , HaydenJA . Specifying the treatment targets of exercise interventions: do we?British Journal of Sports Medicine2020;54:1235-36.">Wood 2020a</a>). </p> <p>Future trials should assess the recommended core outcome set (<a href="./references#CD009790-bbs2-0502" title="ChiarottoA , BoersM , DeyoRA , BuchbinderR , CorbinTP , CostaLO , et al. Core outcome measurement instruments for clinical trials in nonspecific low back pain. Pain2018;159(3):481-95.">Chiarotto 2018</a>), including health‐related quality of life and perceived effect; we found these important outcomes were only available for a small subset of studies. Trials should include the systematic measurement of harms, such as adverse events. There is also a need for careful selection of comparison groups to best contribute to evidence about the effective management of low back pain. </p> <p>In addition, a more comprehensive measurement of baseline participant characteristics will allow for future investigation of treatment effect modifiers and mediating characteristics (even when single trials are insufficiently powered for such analyses). Currently, inconsistent availability and measurement of patient baseline characteristics limit the ability to assess the generalisability of the trials and the overall body of evidence. Furthermore, this limits the usefulness of the trial to contribute to future important IPD meta‐analyses. IPD meta‐analyses are the most feasible way to investigate potential treatment effect modifiers. Identifying potential treatment effect modifiers and the phenotypes of patients who are likely to benefit more from a specific treatment is an important goal and a long‐term back pain research priority (Costa 2009b; <a href="./references#CD009790-bbs2-0532" title="HenschkeN , MaherCG , RefshaugeKM , DasA , McAuleyJH . Low back pain research priorities: a survey of primary care practitioners. BMC Family Practice2007;8:40-5.">Henschke 2007</a>). </p> <p>We support and encourage initiatives to make research data accessible for testing and further analyses. There are several benefits of this, including opportunities to double‐check data (before, during or after publication), which provides a collegial way to ensure the best quality of evidence is disseminated. Data sharing has the additional benefit of enabling analyses of IPD data to identify treatment effect modifiers in a more robust way, without the limitations of ecological bias from study level data. </p> <p>Finally, we believe there needs to be an increased emphasis on publishing trials in reputable journals with peer review and editorial processes to confirm the robustness of methods, assure complete reporting, and to require the proper archive of results to be included in future evidence reviews. If authors choose to publish their work in predatory journals, there does need to be a transparent system to determine if their trials should be eligible for inclusion in systematic reviews. </p> <section id="CD009790-sec-0094"> <h5 class="title">Future systematic review methods recommendations </h5> <p>One of the key benefits of a large overarching review, such as this one, is the ability to identify relationships that are not able to be investigated in smaller focussed reviews (e.g. characteristics of delivery, populations). Overarching reviews also have the potential to decrease the duplication of effort that often happens when multiple authors groups extract the same data for the same studies for inclusion in slightly different reviews. Overarching reviews enable the inclusion of trials that do not otherwise meet inclusion criteria for focussed reviews such as mixed exercise treatments (which represented 23% of all exercise groups in this review). However, feasibility of such large reviews is a barrier – they require tremendous time and resources for one team to complete and funding opportunities for systematic reviews are very limited. This presents an opportunity for more co‐ordination of efforts within the limits of the current flawed academic credit and funding system. </p> <p>This review has highlighted additional methods considerations for future systematic reviews, including attention to issues of research integrity in RCTs. We need further study to understand how to appropriately define and measure problematic characteristics, and to understand the relationships between study integrity characteristics and the reported outcomes. Issues of poor conduct, incomplete reporting, insecure archiving, and outright fabrication or fraud cannot be ignored and may be more problematic in some fields. These issues are important for systematic review authors and warrant investigation and consideration in the selection of studies and in the analyses conducted to summarise a body of evidence. </p> <p>We particularly draw attention to the issue of outlying and improbable results presented in RCTs. We defined a high threshold to consider results improbable or outlying and conducted sensitivity analyses to exclude these study data. In this review, the results and conclusions did not change in direction with the exclusion of improbable or outlying effects, adding robustness to the conclusions. However, the exclusion of these studies from analyses did impact the interpretation of the clinical importance of results; with a smaller number of studies, individual study results could have more weight in analyses and provide incorrect results and conclusions. </p> <p>We posit that we should stop doing the same type of trials about exercise treatment. Additional trials are unlikely to add anything to our knowledge, unless they are based on a new and plausible hypothesis for the cause of low back pain and a potential working mechanism of the intervention. Future studies should evaluate whether exercise treatment is cost‐effective compared to other interventions with similar effects. This will help patients, clinicians and policy‐makers to decide which intervention to choose. Implementation studies that evaluate how to best introduce exercise treatment in healthcare settings, and how to increase compliance seem important as well. Additionally, using modern technologies to support exercise treatments, monitor compliance, give positive feedback, and monitor outcomes may be the best way forward. </p> <p>Finally, progress in the field is unlikely to be feasible with small individual studies, so it will need to be facilitated by increased international collaboration, prospective planning of multi‐site and multi‐country trials, standardising measurement of baseline characteristics, and potentially by sharing of data through accessible repositories. Future prospective co‐ordination and collaboration for more consistent data collection will help researchers identify treatment effect modifiers. This will further advance a personalised management approach for chronic low back pain. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009790-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009790-sec-0008"></div> <div class="table" id="CD009790-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: Exercise treatment compared with no treatment, usual care or placebo for chronic low back pain</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects*</b><br/>  </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants<br/>(studies; study groups)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)<sup>a</sup> </b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Without exercise (no treatment, usual care or placebo<sup>b</sup>)</b><br/>  </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Difference with exercise</b><br/>  </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain intensity (0‐100; 0</b> = <b>no pain): Earliest follow‐up (time point closest to 3 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity outcome at follow‐up ranged across the no treatment, usual care or placebo comparison groups from 21 to 81. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity in the exercise treatment groups was 15 points better than the no treatment, usual care or placebo comparison groups at follow‐up (12 to 18 points better). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants = 2746; studies = 35; study groups = 47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate<sup>c</sup> </b> </p> <p>due to risk of inconsistency</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Functional limitations (0‐100; 0 = no functional limitations): Earliest follow‐up (time point closest to 3 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional limitations outcome at follow‐up ranged across the no treatment, usual care or placebo comparison groups from 7 to 58. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional limitations in the exercise treatment groups was 7 points better than the no treatment, usual care or placebo comparison groups at follow‐up (5 to 8 points better). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants = 2942; studies = 38; study groups = 50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate<sup>d</sup> </b> </p> <p>due to potential publication bias</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*The anticipated absolute effects without exercise come from the range of outcomes at follow‐up in the no treatment, usual care or comparison groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup> For all comparisons and outcomes ‐ certainty may be raised to high given that further similar research is very unlikely to change our confidence in the estimate of effect. </p> <p><sup>b</sup> Observed effects were consistent when we performed a post hoc sensitivity analysis restricting to only placebo‐controlled trials.  </p> <p><sup>c</sup>Seven studies (10 groups; 526 participants) were judged to have high risk of bias (19% of participant data). Exclusion of these studies in sensitivity analysis did not change conclusions. Serious unexplained inconsistency (substantial heterogeneity I<sup>2</sup> = 75%, point estimates and confidence intervals varied considerably). No concerns about indirectness or imprecision. No evidence of publication bias (Egger's test, P = 0.30). </p> <p><sup>d</sup> Nine studies (13 groups; 495 participants) were judged to have high risk of bias (17% of participant data). Exclusion of these studies in sensitivity analysis did not change conclusions. Some unexplained inconsistency (moderate heterogeneity I<sup>2</sup> = 38%, point estimates and confidence intervals varied). No concerns about indirectness or imprecision. Some evidence of publication bias (Egger's test, P = 0.005). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009790-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: Exercise treatment compared with other conservative treatments for chronic low back pain</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects*</b><br/>  </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants<br/>(studies; study groups)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)<sup>a</sup> </b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Without exercise (other conservative treatment comparison)</b><br/>  </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Difference with exercise</b><br/>  </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p><b>Pain intensity (0‐100 points; 0 = no pain): Earliest follow‐up (time point closest to 3 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="5" valign=""> <p>The mean pain intensity outcome at follow‐up ranged across the other conservative treatment comparison groups from 8 to 73 points.<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="5" valign=""> <p>The mean pain intensity in the exercise treatment groups was 9 points better than the other conservative treatment comparison groups at follow‐up (6 to 13 points better). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Participants = 6295; studies = 64; study groups = 85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>low<sup>b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>due to risk of inconsistency and publication bias</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p><b>Functional limitations (0‐100 points; 0 = no functional limitations): Earliest follow‐up (time point closest to 3 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="5" valign=""> <p>The mean functional limitations outcome at follow‐up ranged across the other conservative treatment comparison groups from 8 to 60 points. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="5" valign=""> <p>The mean functional limitations in the exercise treatment groups was 4 points better than the other conservative treatment comparison groups at follow‐up (2 to 6 points better). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Participants = 6004; studies = 52; study groups = 69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>moderate<sup>c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>due to risk of inconsistency</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The anticipated absolute effects without exercise come from the range of outcomes at follow‐up in the other conservative treatment comparison groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup> For all comparisons and outcomes ‐ certainty may be raised one level given that further similar research is very unlikely to change our confidence in the estimate of effect. </p> <p><sup>b</sup> Eleven studies (14 groups; 835 participants) were judged to have high risk of bias (13% of participant data). Exclusion of these studies in sensitivity analysis did not change conclusions. Serious inconsistency (considerable heterogeneity I<sup>2</sup> = 81%, point estimates and confidence intervals varied considerably), partially explained by exploration of effect in specific comparison subgroups (I<sup>2</sup> &lt; 75% for five of eight comparisons). No concerns about indirectness or imprecision. Some evidence of potential publication bias (Egger's test, P = 0.001). </p> <p><sup>c</sup> Seven studies (9 groups; 571 participants) were judged to have high risk of bias (10% of participant data). Exclusion of these studies in sensitivity analysis did not change conclusions. Serious inconsistency (considerable heterogeneity I<sup>2</sup> = 82%, point estimates and confidence intervals varied considerably), partially explained by exploration of effect in specific comparison subgroups (I<sup>2</sup> &lt; 75% for five of eight comparisons). No concerns about indirectness or imprecision. No evidence of publication bias (Egger's test, P = 0.40). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009790-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009790-sec-0009"></div> <p>Low back pain has been the leading cause of disability globally for at least the past three decades (<a href="./references#CD009790-bbs2-0519" title="GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet2018;392(10159):1789-1858.">GBD Collaborators 2018</a>) and results in enormous direct healthcare and lost productivity costs (<a href="./references#CD009790-bbs2-0507" title="DagenaisS , CaroJ , HaldemanS . A systematic review of low back pain cost of illness studies in the United States and internationally. Spine Journal2008;8(1):8-20.">Dagenais 2008</a>; <a href="./references#CD009790-bbs2-0519" title="GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet2018;392(10159):1789-1858.">GBD Collaborators 2018</a>; <a href="./references#CD009790-bbs2-0526" title="HaydenJA , ChouR , Hogg-JohnsonS , BombardierC . Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. Journal of Clinical Epidemiology2009;62(8):781-96.">Hayden 2009</a>; <a href="./references#CD009790-bbs2-0544" title="LimSS , VosT , FlaxmanAD , DanaeiG , ShibuyaK , Adair-RohaniH , et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease study 2010. Lancet2012;380(9859):2224-60.">Lim 2012</a>; <a href="./references#CD009790-bbs2-0550" title="MartinBI , DeyoRA , MirzaSK , TurnerJA , ComstockBA , HollingworthW , et al. Expenditures and health status among adults with back and neck problems. Journal of the American Medical Association2008;299(6):656-64.">Martin 2008</a>). The majority of the social and economic costs associated with low back pain are attributable to people who have prolonged disability – experiencing chronic and/or recurrent low back pain (<a href="./references#CD009790-bbs2-0524" title="HartvigsenJ , HancockMJ , KongstedA , LouwQ , FerreiraML , GenevayS , et al. What low back pain is and why we need to pay attention. Lancet2018;391(10137):2356-67.">Hartvigsen 2018</a>). Despite a large amount of research in the field, there remains uncertainty about the best treatment approach for this population. </p> <p>Back pain is managed across every level of healthcare systems – from emergent care to community care. Pooled prevalence rates indicate that healthcare utilisation for low back pain varies internationally (<a href="./references#CD009790-bbs2-0499" title="BeyeraGK , O'BrienJ , CampbellS . Health-care utilisation for low back pain: a systematic review and meta-analysis of population-based observational studies. Rheumatology International2019;39(10):1663-79.">Beyera 2019</a>). Recent work suggests that management of low back pain with exercise is associated with lower healthcare system costs and improvements in quality adjusted life years when compared to usual care for acute and chronic patients (<a href="./references#CD009790-bbs2-0553" title="MiyamotoGC , LinCC , CabralCMN , Van DongenJM , Van TulderMW . Cost-effectiveness of exercise therapy in the treatment of non-specific neck pain and low back pain: a systematic review with meta-analysis. British Journal of Sports Medicine2019;53(3):172-81.">Miyamoto 2019</a>). </p> <section id="CD009790-sec-0010"> <h3 class="title" id="CD009790-sec-0010">Description of the condition</h3> <p>Low back pain is defined as pain, muscle tension, or stiffness localised below the costal margin and above the inferior gluteal folds, with or without pain referred to the leg(s). Most patients who experience low back pain are labelled as having ‘non‐specific low back pain’, which is defined as symptoms not attributable to a recognisable, known, specific pathology (for example, fracture, ankylosing spondylitis, spondyloarthritis, infection, neoplasm, or metastasis). Several different structures of the back have been implicated in symptoms of non‐specific low back pain, including the musculature, joints, and discs; but also psychosocial factors including maladaptive pain coping behaviours, high baseline functional impairment, presence of psychiatric comorbidities, and low general health status (<a href="./references#CD009790-bbs2-0504" title="ChouR , ShekelleP . Will this patient develop persistent disabling low back pain?Journal of the American Medical Association2010;303(13):1295-302.">Chou 2010</a>). These psychosocial factors have been associated with persistent, disabling low back pain. </p> <p>Most patients with a new episode of acute low back pain have a favourable prognosis, with 75% to 90% recovering in terms of pain and disability (<a href="./references#CD009790-bbs2-0506" title="CosteJ , LefrancoisG , GuilleminF , PouchotJ . Prognosis and quality of life in patients with acute low back pain: insights from a comprehensive inception cohort study. Arthritis and Rheumatism2004;51(2):168-76.">Coste 2004</a>; <a href="./references#CD009790-bbs2-0521" title="GrotleM , BroxJI , VeierodMB , GlomsrodB , LonnJH , VollestadNK . Clinical course and prognostic factors in acute low back pain: patients consulting primary care for the first time. Spine2005;30(8):976-82.">Grotle 2005</a>), or returning to work within three to four weeks (<a href="./references#CD009790-bbs2-0533" title="HenschkeN , MaherCG , RefshaugeKM , HerbertRD , CummingRG , BleaselJ , et al. Characteristics of patients with acute low back pain presenting to primary care in Australia. Clinical Journal of Pain2009;25(1):5-11.">Henschke 2009</a>). In this review, we consider the effectiveness of exercise treatment for individuals whose symptoms persist beyond the acute stage. Previously, research studies and practice guidelines have defined individuals with low back pain episodes persisting beyond the acute stage as subacute and chronic. In this review, we focus on chronic low back pain which we have defined as pain, muscle tension, or stiffness lasting longer than 12 weeks or recurrent low back pain defined as two episodes in a year, lasting more than 24 hours, with more than 30 days pain‐free between. The two back pain populations included in our study (chronic and recurrent) are often described as 'persistent', but for the purpose of this review, they will be referred to as chronic. </p> <p>Individuals who progress to chronic low back pain often continue to experience long‐standing pain. A systematic review of cohort studies found that 33% of patients with low back pain recover in the first three months, but 65% still report pain after one year (<a href="./references#CD009790-bbs2-0541" title="ItzCJ , GeurtsJW , Van KleefM , NelemansP . Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care. European Journal of Pain2013;17(1):5-15.">Itz 2013</a>). Many factors including biophysical, psychological, social and genetic factors, and comorbidities can contribute to disabling, chronic low back pain. Factors associated with delayed recovery of chronic low back pain include previous sick leave due to low back pain, high disability or pain levels at the onset of chronicity, low levels of education, perceived risk of persistent pain, and psychological factors such as depression, anxiety, catastrophising and self‐efficacy (Costa 2009b; <a href="./references#CD009790-bbs2-0524" title="HartvigsenJ , HancockMJ , KongstedA , LouwQ , FerreiraML , GenevayS , et al. What low back pain is and why we need to pay attention. Lancet2018;391(10137):2356-67.">Hartvigsen 2018</a>). Specific predictors of poor outcome in patients with chronic low back pain have been inconsistent across prognosis studies. Chronic low back pain appears to be the result of nociceptive input combined with multiple complex factors. (<a href="./references#CD009790-bbs2-0526" title="HaydenJA , ChouR , Hogg-JohnsonS , BombardierC . Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. Journal of Clinical Epidemiology2009;62(8):781-96.">Hayden 2009</a>; <a href="./references#CD009790-bbs2-0531" title="HeitzCA , HilfikerR , BachmannLM , JoronenH , LorenzT , UebelhartD , et al. Comparison of risk factors predicting return to work between patients with subacute and chronic non-specific low back pain: systematic review. European Spine Journal2009;18(12):1829-35.">Heitz 2009</a>). </p> </section> <section id="CD009790-sec-0011"> <h3 class="title" id="CD009790-sec-0011">Description of the intervention</h3> <p>Exercise treatment is a management strategy that is widely used in low back pain. Exercise treatment encompasses a diverse set of treatments prescribed or planned by a health professional that include conducting specific activities, postures, or movements (or all). Exercise treatments are characterised by several interacting components. They are heterogeneous in treatment design (e.g. standard, individualised), dose (duration, frequency, intensity), delivery format (e.g. clinician supervised, group), specific exercise types (e.g. strengthening, stretching), and may be combined with other conservative treatments. Examples of exercise treatments include general physical fitness programmes delivered in a group setting, aerobic exercise in the form of walking programmes, and strengthening of specific muscles or groups of muscles to increase core stability. </p> </section> <section id="CD009790-sec-0012"> <h3 class="title" id="CD009790-sec-0012">How the intervention might work</h3> <p>Various types of exercise treatment are expected to be associated with different hypothesised mechanisms of effect. Exercise treatment may provide benefits to patients with chronic low back pain through the voluntary contraction of specific muscle groups, movement of the whole body, activities that improve postural musculature, stabilisation, and neuro‐co‐ordination, or a combination (<a href="./references#CD009790-bbs2-0559" title="PowellKE , PaluchAE , BlairSN . Physical activity for health: What kind? How much? How intense? On top of what?Annual Review of Public Health2011;32:349-65.">Powell 2011</a>). These physical therapies aim to increase muscle and joint strength, and improve muscle function and range of motion, with the goals to reduce pain, improve function, and speed patient recovery and return to usual activities. However, recent work has called on the back pain trialist community to prespecify their treatment target to improve the match between intervention and desired outcome (<a href="./references#CD009790-bbs2-0582" title="WoodL , FosterN , HaydenJA . Workshop WB8: Agreeing on treatment targets for future trials of exercise for back pain. In: International Back and Neck Forum; 2019 July 4; Quebec City, Canada. 2019.">Wood 2019</a>; <a href="./references#CD009790-bbs2-0583" title="WoodL , OgilvieR , HaydenJA . Specifying the treatment targets of exercise interventions: do we?British Journal of Sports Medicine2020;54:1235-36.">Wood 2020a</a>). In addition to the physical benefits of exercise treatment, there may be emotional and psychological benefits, which may lead to decreased pain and improved function. </p> </section> <section id="CD009790-sec-0013"> <h3 class="title" id="CD009790-sec-0013">Why it is important to do this review</h3> <p>Exercise is a common approach to the treatment of chronic low back pain. Clinical practice guidelines, including the American College of Physicians (ACP) (<a href="./references#CD009790-bbs2-0560" title="QaseemA , WiltTJ , McLeanRM , ForcieaMA . Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine2017;166(7):514-30.">Qaseem 2017</a>) and the UK National Institute for Health and Care Excellence (NICE) (<a href="./references#CD009790-bbs2-0556" title="National Guideline Centre. National Institute for Health and Care Excellence: Clinical Guidelines. In: Low Back Pain and Sciatica in Over 16s: Assessment and Management. London: National Institute for Health and Care Excellence (UK), 2016.">National Guideline Centre 2016</a>), recommend exercise as the first line of care for chronic low back pain and recommend exercise programmes that take individual needs, preferences, and capabilities into account. However, the most effective components of exercise interventions for patients with chronic low back pain have yet to be identified. In 2005, our team published the broad Cochrane review investigating the effectiveness of exercise for treating low back pain amongst acute, subacute and chronic populations; we included 43 randomised controlled trials (RCTs) on chronic low back pain in the review (<a href="./references#CD009790-bbs2-0587" title="HaydenJA , Van TulderMW , MalmivaaraA , KoesBW . Exercise therapy for treatment of non-specific low back pain. Cochrane Database of Systematic Reviews2005, Issue 3. Art. No: CD000335. [DOI: 10.1002/14651858.CD000335.pub2]">Hayden 2005a</a>; <a href="./references#CD009790-bbs2-0588" title="HaydenJA , Van TulderMW , MalmivaaraAV , KoesBW . Meta-analysis: exercise therapy for nonspecific low back pain. Annals of Internal Medicine2005;142(9):765-75.">Hayden 2005b</a>; <a href="./references#CD009790-bbs2-0525" title="HaydenJA , Van TulderMW , TomlinsonG . Systematic review: strategies for using exercise therapy to improve outcomes in chronic low back pain. Annals of Internal Medicine2005;142(9):776-85.">Hayden 2005c</a>). We found evidence of effectiveness in chronic populations relative to comparisons at all follow‐up periods; pooled mean improvement was 7.3 points (95% CI 3.7 to 10.9) for pain (out of 100), 2.5 points (1.0 to 3.9) for functional limitations (out of 100) at earliest follow‐up. Analyses related to the 2005 Cochrane review found that exercise design and delivery characteristics were statistically associated with improved effectiveness for pain and functional limitations outcomes, more so than specific exercise types (<a href="./references#CD009790-bbs2-0525" title="HaydenJA , Van TulderMW , TomlinsonG . Systematic review: strategies for using exercise therapy to improve outcomes in chronic low back pain. Annals of Internal Medicine2005;142(9):776-85.">Hayden 2005c</a>). These analyses and results, however, were limited by the small number of trials available at the time. </p> <p>In 2012, we split the 2005 Cochrane review into two separate Cochrane protocols, one of which that focusses on the chronic low back pain population (<a href="./references#CD009790-bbs2-0589" title="HaydenJA , CartwrightJ , Van TulderMW , MalmivaaraA . Exercise therapy for chronic low back pain. Cochrane Database of Systematic Reviews2012, Issue 4. Art. No: CD009790. [DOI: 10.1002/14651858.CD009790]">Hayden 2012</a>) (presented here), and the other that focusses on the acute low back pain population (<a href="./references#CD009790-bbs2-0542" title="JzelenbergW , RubinsteinSM , HaydenJ , KoesBW , Van TulderMW . Exercise therapy for acute non-specific low-back pain. Cochrane Database of Systematic Reviews2011, Issue 10. Art. No: CD009365. [DOI: 10.1002/14651858.CD009365]">Jzelenberg 2011</a>). </p> <p>Over the past 15 years, many new RCTs have been published investigating the effectiveness of exercise treatment for chronic low back pain. The methodology for conducting and interpreting systematic reviews of interventions is also constantly evolving and several methodologies have been updated since the 2005 review was published (<a href="./references#CD009790-bbs2-0538" title="HigginsJ , LassersonT , ChandlerJ , ToveyD , ThomasJ , FlemyngE , et al. Methodological Expectations of Cochrane Intervention Reviews (MECIR): Standards for the conduct and reporting of new Cochrane Intervention Reviews, reporting of protocols and the planning, conduct and reporting of updates. Cochrane, London, 2019. community.cochrane.org/mecir-manual (accessed prior to 5 Sept 2021);(1.07).">Higgins 2019</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009790-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009790-sec-0014"></div> <p>The primary objective of this systematic review is to assess the impact of exercise treatment on pain and functional limitations in adults with chronic non‐specific low back pain compared to no treatment, usual care, placebo and other conservative treatments. Related investigations will explore exercise intervention characteristics that decrease pain and improve functional limitations and compare the effectiveness of different types of exercise treatment in adults with chronic non‐specific low back pain. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009790-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009790-sec-0015"></div> <section id="CD009790-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009790-sec-0017"> <h4 class="title">Types of studies</h4> <p>We have included published reports of completed RCTs, with no language restrictions. We included only RCTs as they are the gold standard to assess the effectiveness of health‐related interventions and there is a considerable volume of trials for synthesis. </p> </section> <section id="CD009790-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included studies involving adult participants with chronic nonspecific low back pain of more than 12 weeks’ duration (defined as meaning back pain duration of the study group was greater than or equal to 12 weeks). We excluded studies that involved individuals with low back pain caused by specific pathologies (including fracture, ankylosing spondylitis, spondyloarthritis, infection, neoplasm, or metastasis) or conditions (for example, pregnancy), and studies that focussed exclusively on acute exacerbations of chronic low back pain. Studies of non‐specific low back pain often include participants with a mixture of individual and symptom characteristics. Patients with leg pain, symptoms or signs consistent with radiculopathy (irritation of the nerve root) were included if back pain was their main complaint. For syntheses, we separately considered the effectiveness of exercise treatment for study populations that allowed study participants with leg pain or neurological symptoms to be included, and populations with moderate (12 weeks to three years) and long (greater than three years) symptom durations of chronic low back pain at baseline (<a href="./references#CD009790-bbs2-0510" title="DunnKM , CroftPR . The importance of symptom duration in determining prognosis. Pain2006;121(1-2):126-32.">Dunn 2006</a>). </p> <p>We included participants who were recruited from any setting, including healthcare, occupational, general and mixed populations. </p> </section> <section id="CD009790-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Exercise is defined as "a series of specific movements with the aim of training or developing the body by a routine practice or as physical training to promote good physical health" (<a href="./references#CD009790-bbs2-0496" title="AbenhaimL , RossignolM , ValatJP , NordinM , AvouacB , BlotmanF , et al. The role of activity in the therapeutic management of back pain. Report of the International Paris Task Force on Back Pain. Spine2000;25(4 Suppl):1S-33S.">Abenhaim 2000</a>). This encompasses a heterogeneous set of treatments prescribed or planned by a health professional that include conducting specific activities, postures and/or movements with a goal to reduce pain and functional limitations. </p> <p>Eligible exercise treatment types included muscle strengthening, stretching, core strengthening, flexibility and mobilising exercises, aerobic exercises, functional restoration, McKenzie therapy, and yoga (<a href="#CD009790-tbl-0003">Table 1</a>). Exercise treatments including mixed types of exercises were included, as were those exercises that fell into an 'other' category (e.g. Tai Chi, rock climbing). Exercise treatments were assigned to one or two main types, or designated as 'mixed' (exercise treatments incorporating three or more types of exercise in which one did not clearly predominate). </p> <div class="table" id="CD009790-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study population and exercise treatment characteristic definitions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Characteristic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definitions</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Population LBP duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Acute</b> = Low back pain episode less than 6 weeks in duration<br/><b>Subacute</b> = Low back pain episode between 6 weeks and 3 months in duration<br/><b>Chronic</b> = Low back pain episode 3 months or more in duration </p> <p><b>Chronic recurrent</b> = Two episodes in a year, lasting more than 24 hours, with more than 30 days pain‐free between<br/><b>Mixed</b> = If population was mixed, we recorded the proportion of the population that had chronic low back pain </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Population source</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Healthcare</b> = Primary care, secondary/tertiary (referred), physiotherapy, occupational therapy, etc.<br/><b>Occupational</b> = Population selected by workplace, workers' compensation claims, etc.<br/><b>General</b> = Population selected to represent all residents living in a geographic area (non‐clinical)<br/><b>Mixed</b> = Two or more of the above categories </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise type</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Strengthening</b> = Strengthening exercises were those that were designed to increase an individual's ability to exert or resist force using load‐bearing or resistance exercises including weights, weight machines, or elastic cords. Strengthening exercises were categorised as whole‐body where they involved a broad set of exercises that were not specific only to the low back region (i.e. directed at muscles connecting to the lumbar spine and/or pelvis). </p> <p><b>Stretching</b> = Stretching exercises were those that intended to elongate soft tissues and poses held for varying periods of time. For the purpose of this review, stretching exercises were self‐administered (but could use aids). Depending on the location and types of stretches, stretches could be classified as whole‐body or back‐specific or both.<br/><b>Core strengthening</b> = Core strengthening exercises were those that were designed to improve the control, co‐ordination, and strength of the core, lumbar, and pelvic region muscles. These included motor control exercises, core stability or sling exercises, and Pilates, but excluded those that were generalised (whole‐body) stability exercises. We categorised core strengthening exercises as back‐specific.<br/><b>Flexibility/mobilising</b> = Neuromuscular techniques involved repeated movements within the patient’s range of motion and within the patient’s control. Typically, such exercises were geared toward improving the range of motion of joints related to low back pain and thereby were classified as low back‐specific.<br/><b>Aerobic</b> = Aerobic exercises were those that were designed to improve cardiorespiratory fitness and used large muscle groups, as such, we categorised it as a whole‐body exercise.<br/><b>Functional restoration</b> = Functional restoration treats chronic pain and is focussed on improving/maximizing patient function and activities through a multi‐pronged strategy of psychosocial support and physical activities. We categorised it as whole‐body. </p> <p><b>McKenzie</b> = McKenzie involves individualised assessment, specific loading exercises, and postural training and education including managing pain through self‐management. Because McKenzie was developed for and focusses on managing low back pain, we categorised it as low back‐specific.<br/><b>Yoga</b> = Yoga is a practice with many branches and styles, but which may involve physical poses designed for strengthening and stretching (asanas), controlled breathing (pranayama), and often medication (dhyana). Given the generalised physical nature of yoga practices, we categorised yoga as a whole‐body exercise. </p> <p><b>Mixed</b> (3 or more types) = Mixed exercises incorporated three or more types of exercise in which one did not clearly predominate/form most of the exercise intervention. Mixed exercises could be whole‐body, low back‐specific, or both, depending on the types and combination of exercises involved. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise specificity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Whole‐body</b> = Exercises involved many muscle groups from around the body, generally seeking to improve overall fitness.<br/><b>Back‐specific</b> = Exercises were concentrated around muscle groups that support the back (core, trunk, abdominal, back, pelvic, upper leg, etc.).<br/><b>Both</b> = Aspects of the intervention were focussed on both overall fitness and on the back specifically.<br/><b>Unclear</b> = Not enough description of the exercise(s) was provided to determine what part of the body it was working on.<br/><b>Other</b> = Exercises were not working on the body overall, nor focussed on the back, but a different specific part of the body. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Programme individualisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Individually designed</b> = Treating therapist completed a clinical history and physical examination and delivered an exercise treatment specifically designed for the individual participant.<br/><b>Partially individually designed</b> = Exercise treatment included the same type of exercises for all participants, but varied in intensity, duration or both.<br/><b>Standard design</b> = A fixed exercise treatment was delivered to all participants. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Delivery mode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Independent</b> = Home exercises only, in which the participants met initially with therapists, then participated in the exercise treatment with no supervision or follow‐up<br/><b>Independent with follow‐up</b> = Supervised home exercises in which the participants met initially with therapists, participated in the exercise treatment, and had follow‐up with their therapist at least every six weeks<br/><b>Group</b> = Group supervision, in which participants attended exercise treatment sessions with two or more participants<br/><b>Individual</b> = Individual supervision, in which participants received one‐on‐one intervention or supervision </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐exercise comparisons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Usual care/no treatment</b> = Participants received no intervention and received the same standard medical care they would have without being recruited to the study or participants who received a placebo or sham treatment. </p> <p><b>Education</b> = Verbal or written guidance, online or in person, related to their back pain (a formal intervention – not just advice) </p> <p><b>Electrotherapy</b> = e.g. TENS, laser, ultrasound, PENS </p> <p><b>Manual therapy</b> = Manual therapist, physiotherapist, or other professional delivers manual therapy; these can be passive techniques, mobilisation. </p> <p><b>Physical therapy</b> = Mixed physical therapy interventions, including more than one non‐modality (e.g. heat + mobilisation; manual therapy + TENS + heat); does not include exercise as a main treatment component of intervention. </p> <p><b>Psychological therapy</b> = A psychological intervention, delivered by a healthcare professional, including Cognitive Behavioural Therapy (psychologist, psychological therapist, psychiatrist, counsellor, etc.) </p> <p><b>Back school</b> = A programme containing both educational and active training components, delivered by a therapist or other professional. Topics cover a range, including spinal anatomy, causes of LBP, ergonomic advice, exercises to deal with LBP, causes of LBP, posture, relaxation, LBP prevention. </p> <p><b>Anti‐inflammatory/analgesics</b> = Participants in this group were given analgesics or nonsteroidal anti‐inflammatory drugs to deal with LBP symptoms. </p> <p><b>Relaxation</b> = Relaxation programme/intervention delivered by a healthcare professional </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>LBP: low back pain</sup><br/><sup>PENS: Percutaneous electrical nerve stimulation</sup><br/><sup>TENS: Transcutaneous electrical nerve stimulation</sup> </p> </div> </div> <p>We characterised exercise treatment groups by the type of exercise delivered (listed above), exercise treatment design (individually‐designed, partially individually‐designed, standard), delivery type (independent, independent with follow‐up, group‐supervised, individually‐supervised), dose (low dose, high dose; considering intensity and duration), and inclusion of additional treatments. We defined the design of the exercise treatment as “individually‐designed,” when the treating therapist completed a clinical history and physical examination and delivered an exercise treatment specifically designed for the individual participant; “partially individually‐designed”, when the exercise treatment included the same type of exercises for all participants but varied in intensity, duration, or “standard design”, when a fixed exercise treatment was delivered to all participants (<a href="./references#CD009790-bbs2-0525" title="HaydenJA , Van TulderMW , TomlinsonG . Systematic review: strategies for using exercise therapy to improve outcomes in chronic low back pain. Annals of Internal Medicine2005;142(9):776-85.">Hayden 2005c</a>). We categorised delivery type as: "independent" when the participant met with the treating therapist once and then participated in the treatment at home without supervision; "independent with follow‐up" when the participant met with the treating therapist initially, participated in the treatment at home, then received follow‐up with the therapist at least every six weeks; "group‐supervised" if the participant attended supervised group therapy sessions with two or more participants; and "individual" when the participant attended one‐on‐one sessions with the treating therapist. We categorised dose as "low dose" when the participants received fewer than 20 hours of intervention and "high dose" when the participant received 20 or more hours of intervention. Dose was calculated by multiplying the number of hours per session by the number of sessions. Finally, we indicated all non‐exercise co‐interventions that were included in the exercise treatment. </p> <p>We included studies that compared exercise treatment to a) no treatment, usual care or placebo, b) other conservative therapy, or c) another exercise group. We categorised, and hereafter refer to, a comparison group as “no treatment” when participants received placebo, no or minimal treatment or the same standard medical care they would have without being recruited to the study. We assumed a similar effect of placebo treatments (detuned electrotherapy in included trials) to the most common treatment type in this category, guideline recommended ‘usual care’, due to few available studies and difficulty of identifying an adequate placebo that blinds providers and participants. We categorised a comparison as “other conservative therapy” when participants received any non‐exercise interventions (categorised as education, manual therapy, electrotherapy, psychological therapy, non‐exercise physical therapy (multi‐modal), back school, relaxation, anti‐inflammatories); and "another exercise group" when the comparison included another eligible exercise intervention. We excluded studies that compared exercise treatment with spinal surgery. </p> </section> <section id="CD009790-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>Proposed outcome measures for this study were fully described in our published protocol (<a href="./references#CD009790-bbs2-0589" title="HaydenJA , CartwrightJ , Van TulderMW , MalmivaaraA . Exercise therapy for chronic low back pain. Cochrane Database of Systematic Reviews2012, Issue 4. Art. No: CD009790. [DOI: 10.1002/14651858.CD009790]">Hayden 2012</a>). Global improvement was shifted from a primary outcome to a secondary outcome, and satisfaction with treatment and reduction in frequency of analgesic use were removed as secondary outcomes due to limited and inconsistent reporting in early data extraction. </p> <section id="CD009790-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>We fully reported the following primary outcomes:</p> <p> <ul id="CD009790-list-0001"> <li> <p>Pain intensity, measured by a pain scale (for example, visual analogue scale (VAS), numerical rating scale (NRS), or McGill pain score (<a href="./references#CD009790-bbs2-0551" title="MelzackR . The McGill Pain Questionnaire: major properties and scoring methods. Pain1975;1:277-99.">Melzack 1975</a>)) </p> </li> <li> <p>Functional limitations, measured by a back pain‐specific scale (for example, the Roland‐Morris Disability Questionnaire (RMDQ) (<a href="./references#CD009790-bbs2-0565" title="RolandM , FairbankJ . The Roland Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine2000;25:3115-24.">Roland 2000</a>), or the Oswestry Disability Index (ODI) (<a href="./references#CD009790-bbs2-0514" title="FairbankJ , CouperJ , DaviesJ , O'BrienJP . The Oswestry Low Back Pain Questionnaire. Physiotherapy1980;66:271-3.">Fairbank 1980</a>)) </p> </li> </ul> </p> </section> <section id="CD009790-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p>We have also described measurement for the following secondary outcomes (secondary outcomes were not synthesised): </p> <p> <ul id="CD009790-list-0002"> <li> <p>Return to work/absenteeism</p> </li> <li> <p>Health‐related quality of life (for example, SF‐36 (<a href="./references#CD009790-bbs2-0578" title="WareJE , SherbourneCD . The MOS 36 item short-form health survey (SF-36). 1: conceptual framework and item selection. Medical Care1992;30:473-80.">Ware 1992</a>) (as measured by the general health subscale), EuroQol (<a href="./references#CD009790-bbs2-0513" title="EuroQol Research Foundation. Q-5D-5L User Guide. euroqol.org/publications/user-guides 2019 (accessed prior to 5 Sept 2021).">Euroquol Research Foundation 2019</a>), general health (for example, as measured on a VAS scale) or similarly validated index) </p> </li> <li> <p>Global improvement or perceived recovery</p> </li> <li> <p>Adverse events</p> </li> </ul> </p> <p>Outcome assessment data for primary outcomes were extracted for all reported time periods and were grouped into three follow‐up periods for the purposes of analyses: short‐term (post‐treatment assessment closest to three months after randomisation (6‐12 weeks)), moderate‐term (post‐treatment assessment closest to six months after randomisation (13‐47 weeks)), and long‐term follow‐up (post‐treatment assessment closest to 12 months after randomisation (48 weeks or more)). For primary analyses, we used the post‐treatment time period closest to short‐term, omitting studies that only reported time periods less than four weeks as this immediate follow‐up was judged to be not meaningful. </p> </section> </section> </section> <section id="CD009790-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>Electronic and reference searches for this systematic review were conducted periodically (approximately annually) between 2012 and 2020. In August 2019, we re‐ran the full electronic search strategy to reconcile the previous, overlapping search returns and to facilitate reporting, then updated the electronic search in December 2020. </p> <section id="CD009790-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases with no language restrictions to 7 December 2020:</p> <p> <ul id="CD009790-list-0003"> <li> <p>Cochrane Back and Neck Trials Register (Cochrane Central Register of Controlled Trials (CENTRAL) and the Cochrane Register of Studies (CRS)), searched using CRS Web (7 August 2019) and Wiley CENTRAL (7 December 2020) </p> </li> <li> <p>MEDLINE (Epub Ahead of Print, In‐Process &amp; Other Non‐indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE) (OvidSP, 1946 to 7 December 2020) </p> </li> <li> <p>Embase (OvidSP, 1980 to 6 August 2019; Embase.com to 7 December 2020)</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO, 1981 to 7 December 2020) </p> </li> <li> <p>PsycINFO (OvidSP, 2002 to July Week 5 2019; EBSCO to 7 December 2020)</p> </li> <li> <p>Physiotherapy Evidence Database (<a href="http://www.pedro.org.au/" target="_blank">PEDro</a>) (6 August 2019) </p> </li> <li> <p>SPORTDiscus (EBSCO to 7 December 2020)</p> </li> <li> <p>Trial registry web sites: <a href="https://clinicaltrials.gov/ct2/search/advanced" target="_blank">ClinicalTrials.gov</a> and World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (6 August 2019) </p> </li> </ul> </p> <p>Citations were managed using <a href="./references#CD009790-bbs2-0512" title="EndNote X8. Clarivate Analytics, 2018.">EndNote X8</a> software. Search methods are consistent with the Cochrane Back and Neck methods guidelines (<a href="./references#CD009790-bbs2-0518" title="FurlanAD , MalmivaaraA , ChouR , MaherCG , DeyoRA , SchoeneM , et al. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine2015;40(21):1660-73.">Furlan 2015</a>) and the Cochrane Handbook (<a href="./references#CD009790-bbs2-0536" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>). See <a href="./appendices#CD009790-sec-0098">Appendix 1</a> for the current strategy. A similar search strategy was used for the Cochrane Back and Neck's acute, chronic and older adult exercise reviews. </p> <p>We have included studies up to 27 April 2018 in the analyses in this review and have identified all additional eligible studies up to 7 December 2020. Updated inclusion of studies will be conducted as part of a Network Systematic Review pilot project. </p> </section> <section id="CD009790-sec-0025"> <h4 class="title">Searching other resources</h4> <p>A large number of systematic reviews on the effectiveness of exercise treatment for low back pain have been published. We screened cited references of all identified previously published systematic reviews and conducted citation searches of the previous version of this Cochrane review (<a href="./references#CD009790-bbs2-0587" title="HaydenJA , Van TulderMW , MalmivaaraA , KoesBW . Exercise therapy for treatment of non-specific low back pain. Cochrane Database of Systematic Reviews2005, Issue 3. Art. No: CD000335. [DOI: 10.1002/14651858.CD000335.pub2]">Hayden 2005a</a>) (searches conducted in August 2019). </p> </section> </section> <section id="CD009790-sec-0026"> <h3 class="title" id="CD009790-sec-0026">Data collection and analysis</h3> <p>We followed a standard protocol for study selection and data extraction as recommended by the Cochrane Back and Neck methods guidelines (<a href="./references#CD009790-bbs2-0518" title="FurlanAD , MalmivaaraA , ChouR , MaherCG , DeyoRA , SchoeneM , et al. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine2015;40(21):1660-73.">Furlan 2015</a>). </p> <section id="CD009790-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two independent reviewers screened citations identified in the literature search based on the title, title and abstract, and subsequently full text, for inclusion in the review. Consensus and, if necessary, a third reviewer were used to resolve disagreements. Conference proceedings, theses, opinion pieces, correspondence and stand‐alone abstracts were excluded. Studies published in languages other than English were assessed for inclusion and included in the review whenever feasible using English language abstracts, translation tools and/or review by co‐authors and colleagues familiar with the language of publication. </p> </section> <section id="CD009790-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We extracted population characteristics (patient population source and setting, study inclusion criteria, mean duration of pain episode, symptom characteristics, mean age and sex of patient populations), intervention characteristics (description and types of exercise treatment, duration and number of treatment sessions, intervention delivery type, and any additional interventions), comparison group characteristics (category and main type for the other conservative treatments), and outcome data. Detailed description of the exercise characteristics extracted is provided in <a href="#CD009790-tbl-0003">Table 1</a>. Results for primary outcomes pain and functional limitations were extracted as final value scores for inclusion in meta‐analyses. </p> <p>Extracted data were recorded on pre‐developed and tested forms using web‐based electronic systematic review software (<a href="./references#CD009790-bbs2-0509" title="Distiller SR. Ottawa, ON: Evidence Partners, 2020.">Distiller SR</a>), Evidence Partners Incorporated, Ottawa, Canada) (2017 search updates, onward), and a specially designed Microsoft Access database (2012‐2016 search updates). A single reviewer extracted study information and at least one other author checked data extractions from the original study publications. Reviewers were not blinded to authors, institution, or journal of publication as this was not feasible and because they were familiar with the literature. Trial authors were contacted to request any missing study characteristics, data points or risk of bias information, when required. For the sets of studies included prior to 2017, corresponding authors were sent an email with the clarifying questions indicated in the body of the email and sent their responses back via email. For the set of studies identified in the 2017‐2018 updates, authors were sent an email with a link to a REDCap (<a href="./references#CD009790-bbs2-0523" title="HarrisPA , TaylorR , MinorBL , ElliottV , FernandezM , O’NealL , et al. The REDCap consortium: building an international community of software partners. Journal of Biomedical Informatics2019;95:1-10.">Harris 2019</a>) data capture form, where both extracted data and missing fields were clearly displayed. Authors completed the missing fields, and had the opportunity to correct any incorrect extracted data, then submitted the survey through REDCap. </p> </section> <section id="CD009790-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The risk of bias assessment for RCTs was conducted using the criteria recommended by Cochrane (<a href="./references#CD009790-bbs2-0536" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>) and Cochrane Back and Neck (<a href="./references#CD009790-bbs2-0518" title="FurlanAD , MalmivaaraA , ChouR , MaherCG , DeyoRA , SchoeneM , et al. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine2015;40(21):1660-73.">Furlan 2015</a>). Risk of bias assessments were carried out independently by two authors, with consensus. Any disagreements that could not be resolved through discussion were referred to a third author. Inter‐author reliability related to risk of bias was calculated as overall agreement and Kappa scores based on assessments before consensus judgements were reached. </p> <p>We assessed potential bias related to: selection bias (randomisation, treatment allocation concealment, similarity at baseline), performance bias (blinding of participants and care provider, intention‐to‐treat), detection bias (blinding of outcome assessors, similar timing of outcome assessment), attrition (missing outcome data), reporting bias (selective outcome reporting), and other biases to assess adherence (avoidance of co‐interventions, compliance) (see <a href="#CD009790-tbl-0004">Table 2</a> and <a href="#CD009790-tbl-0005">Table 3</a>). Individual criteria were scored as "high risk", "low risk" or "unclear risk" and reported in a Risk of Bias table. A study with an overall low risk of bias was defined as fulfilling six or more of the twelve criteria items, and with no other fatal flaws; otherwise, a study was considered to have high potential risk. We used sensitivity analyses to assess the robustness of our findings by excluding from the syntheses studies considered to be at high risk of bias. For the most recent set of 64 studies extracted (2017‐2018 search updates), we assessed items of the new Cochrane RoB 2 tool (<a href="./references#CD009790-bbs2-0574" title="SterneJA , SavovićJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. British Medical Journal2019;366:1-8.">Sterne 2019</a>), which we used to recreate the Cochrane Back and Neck Group criteria (subsequently referred to as RoB 1 tool) presented here for consistency. </p> <div class="table" id="CD009790-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sources of risk of bias</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Bias domain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Source of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Possible answers</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Was the method of randomisation adequate?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(2) Was the treatment allocation concealed?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(3) Was the patient blinded to the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(4) Was the care provider blinded to the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(5) Was the outcome assessor blinded to the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(6) Was there missing outcome data (dropout rate described and acceptable)?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(7) Were all randomised participants analysed in the group to which they were allocated?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(8) Are reports of the study free of suggestion of selective outcome reporting?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(9) Were the groups similar at baseline regarding the most important prognostic indicators?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other (adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(10) Were co‐interventions avoided or similar?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other (adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(11) Was the compliance acceptable in all groups?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(12) Was the timing of the outcome assessment similar in all groups?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(13) Are other sources of potential bias unlikely?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>See <a href="./references#CD009790-bbs2-0518" title="FurlanAD , MalmivaaraA , ChouR , MaherCG , DeyoRA , SchoeneM , et al. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine2015;40(21):1660-73.">Furlan 2015</a> </p> </div> </div> <div class="table" id="CD009790-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Criteria for a judgement of ‘‘yes’’ for the sources of risk of bias</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A random (unpredictable) assignment sequence. Examples of adequate methods are coin toss (for studies with two groups), rolling a dice (for studies with two or more groups), drawing of balls of different colours, drawing of ballots with the study group labels from a dark bag, computer‐generated random sequence, pre‐ordered sealed envelopes, sequentially‐ordered vials, telephone call to a central office, and preordered list of treatment assignments. Examples of inadequate methods are: alternation, birth date, social insurance/security number, date in which they are invited to participate in the study, and hospital registration number. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assignment generated by an independent person not responsible for determining the eligibility of the patients. This person has no information about the persons included in the trial and has no influence on the assignment sequence or on the decision about eligibility of the patient. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Index and control groups are indistinguishable for the patients or if the success of blinding was tested among the patients and it was successful </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Index and control groups are indistinguishable for the care providers or if the success of blinding was tested among the care providers and it was successful </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adequacy of blinding should be assessed for each primary outcome separately. This item should be scored ‘‘yes’’ if the success of blinding was tested among the outcome assessors and it was successful or: </p> <p>‐ for patient‐reported outcomes in which the patient is the outcome assessor (e.g. pain, functional limitations): the blinding procedure is adequate for outcome assessors if participant blinding is scored ‘‘yes’’<br/>‐ for outcome criteria assessed during scheduled visit and that supposes a contact between participants and outcome assessors (e.g. clinical examination): the blinding procedure is adequate if patients are blinded, and the treatment or adverse effects of the treatment cannot be noticed during clinical examination<br/>‐ for outcome criteria that do not suppose a contact with participants (e.g. radiography, magnetic resonance imaging): the blinding procedure is adequate if the treatment or adverse effects of the treatment cannot be noticed when assessing the main outcome<br/>‐ for outcome criteria that are clinical or therapeutic events that will be determined by the interaction between patients and care providers (e.g. co‐interventions, hospitalisation length, treatment failure), in which the care provider is the outcome assessor: the blinding procedure is adequate for outcome assessors if item ‘‘4’’ (caregivers) is scored ‘‘yes’’<br/>‐ for outcome criteria that are assessed from data of the medical forms: the blinding procedure is adequate if the treatment or adverse effects of the treatment cannot be noticed from the extracted data </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The number of participants who were included in the study but did not complete the observation period or were not included in the analysis must be described and reasons given. If the percentage of withdrawals and dropouts does not exceed 20% for short‐term follow‐up and 30% for long‐term follow‐up and does not lead to substantial bias, a ‘‘yes’’ is scored. (N.B. these percentages are arbitrary, not supported by literature) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All randomised patients are reported/analysed in the group they were allocated to by randomisation for the most important moments of effect measurement (minus missing values) irrespective of noncompliance and co‐interventions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All the results from all prespecified outcomes have been adequately reported in the published report of the trial. This information is either obtained by comparing the protocol and the report, or in the absence of the protocol, assessing that the published report includes enough information to make this judgement. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Groups have to be similar at baseline regarding demographic factors, duration and severity of complaints, percentage of patients with radicular symptoms, and value of main outcome measure(s). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If there were no co‐interventions or they were similar between the index and control groups </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The reviewer determines if the compliance with the interventions is acceptable, based on the reported intensity, duration, number and frequency of sessions for both the index intervention and control intervention(s). For example, physiotherapy treatment is usually administered for several sessions; therefore it is necessary to assess how many sessions each patient attended. For single‐session interventions (e.g. surgery), this item is irrelevant. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timing of outcome assessment should be identical for all intervention groups and for all primary outcome measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other types of biases. For example:<br/>‐ When the outcome measures were not valid. There should be evidence from a previous or present scientific study that the primary outcome can be considered valid in the context of the present.<br/>‐ Industry‐sponsored trials. The conflict of interest (COI) statement should explicitly state that the researchers have had full possession of the trial process from planning to reporting without funders with potential COI having any possibility of interfering in the process. If, for example, the statistical analyses have been done by a funder with a potential COI, usually ‘‘unsure’’ is scored. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>See <a href="./references#CD009790-bbs2-0518" title="FurlanAD , MalmivaaraA , ChouR , MaherCG , DeyoRA , SchoeneM , et al. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine2015;40(21):1660-73.">Furlan 2015</a> </p> <p>COI: Conflict of interest</p> </div> </div> <p>In addition to risk of bias, we also comprehensively assessed several characteristics of research integrity for the included studies. Research integrity was assessed using four criteria: publication in a predatory journal, presence of significant plagiarism, high risk of bias, and inadequate reporting of minimal basic CONSORT items. Publication in a predatory journal was assessed by two reviewers with consensus. A study was judged to be published in a predatory journal if they were not on the list of reputable publishers or organisations (e.g. Elsevier, Wiley‐Blackwell, Springer, Taylor &amp; Francis, Sage, BMJ, Informa, IOS Press, Oxford University Press, PLOS, ACP, American Medical Association, Canadian Medical Association, World Health Organization), were not on Cabell's white list, and were not listed on the Directory of Open Access Journals but were listed on either Beall's List or on www.PredatoryJournals.com. </p> <p>Plagiarism was assessed by two independent reviewers with consensus using <a href="./references#CD009790-bbs2-0540" title="iThenticate Plagiarism Detection Software. Turnitin LLC, 2020.">iThenticate 2020</a> plagiarism detection software. Our assessment was limited to the introduction, results, and discussion sections. We defined a case of plagiarism using a two‐stage process. If a publication failed both stages of the assessment, they were deemed to include plagiarism. In the first stage, we assessed publications to determine if 3% or more of the publication was duplicated from a single source (other than the authors own publications). For those studies with 3% or more duplication from a single source, in the second stage, we assessed if the publication included more than 80% duplication of at least two full sentences (we ignored common phrases or expressions). For both stages, we excluded the text from abstracts, methods, and references lists from assessment. This manual approach, supported by algorithmic plagiarism software, was informed by methods of <a href="./references#CD009790-bbs2-0546" title="LykkesfeldtJ . Strategies for using plagiarism software in the screening of incoming journal manuscripts: recommendations based on a recent literature survey. Basic &amp; Clinical Pharmacology and Toxicology2016;119(2):161-4.">Lykkesfeldt 2016</a> and <a href="./references#CD009790-bbs2-0537" title="HigginsJR , LinFC , EvansJP . Plagiarism in submitted manuscripts: incidence, characteristics and optimization of screening-case study in a major specialty medical journal. Research Integrity and Peer Review2016;1:13-21.">Higgins 2016</a>, and supported by a recent commentary (<a href="./references#CD009790-bbs2-0579" title="Weber-WulffD . Plagiarism detectors are a crutch, and a problem. Nature2019;567(7749):435.">Weber‐Wulff 2019</a>). We chose a liberal approach to cautiously classify a publication as including plagiarism. Given the lack of evidence and clear guidance in the plagiarism field, we feel this approach was appropriate. Twelve studies could not be assessed using iThenticate due to incompatibility issues with the study file format (<a href="./references#CD009790-bbs2-0022" title="BentsenH , LindgärdeF , ManthorpeR . The effect of dynamic strength back exercise and/or a home training program in 57-year old women with chronic low back pain: results of a prospective randomized study with a 3-year follow-up period. Spine1997;22(13):1494-500. ">Bentsen 1997</a>; <a href="./references#CD009790-bbs2-0028" title="BronfortG , GoldsmithCH , NelsonC , BolinePD , AndersonAV . Trunk exercise combined with spinal manipulative or NSAID therapy for chronic low back pain: a randomized, observer-blinded clinical trial. Journal of Manipulative &amp; Physiological Therapeutics1996;19(9):570-82. ">Bronfort 1996</a>; <a href="./references#CD009790-bbs2-0053" title="DalichauS , ScheeleK . Effects of elastic lumbar belts on the effect of a muscle training program for patients with chronic back pain. Zeitschrift fur Orthopadie und Ihre Grenzgebiete2000;138(1):8-16. ">Dalichau 2000</a>; <a href="./references#CD009790-bbs2-0269" title="GaoMX , LiuXY , ZhenP , WangP , WangXM , XueY . Evaluation of the efficacy of exercise program in the remission of low back pain in manage tank soldiers. Chinese Journal of Clinical Rehabilitation2006;10(8):32-4. ">Gao 2006</a>; <a href="./references#CD009790-bbs2-0095" title="HildebrandtVH , ProperKI , Van den BergR , DouwesM , Van den HeuvelSG , Van BuurenS . Cesar therapy is temporarily more effective in patients with chronic low back pain than the standard treatment by family practitioner: randomized, controlled and blinded clinical trial with 1 year follow-up. Nederlands Tijdschrift voor Geneeskunde2000;144:2258-64. ">Hildebrandt 2000</a>; <a href="./references#CD009790-bbs2-0106" title="KankaanpaaM , TaimelaS , AiraksinenO , HanninenO . The efficacy of active rehabilitation in chronic low back pain. Effect on pain intensity, self-experienced disability, and lumbar fatigability. Spine1999;24(10):1034-42. ">Kankaanpaa 1999</a>; <a href="./references#CD009790-bbs2-0109" title="KendallPH , JenkinsJM . Exercises for backache: a double-blind controlled trial. Physiotherapy1968;54:154-7. ">Kendall 1968</a>; <a href="./references#CD009790-bbs2-0127" title="LiY , WangY , ZhangY . Rehabilitation nursing effect of carrying out backbone deep muscles stability training for patients with chronic low back pain. Chinese Nursing Research2008;22(5A):1166-7. ">Li 2008</a>; <a href="./references#CD009790-bbs2-0128" title="LieH , FreyS . Mobilizing or stabilizing exercise in degenerative disk disease in the lumbar region?Tidsskrift for Den Norske Laegeforening1999;119:2051-3. ">Lie 1999</a>; <a href="./references#CD009790-bbs2-0164" title="MuharramA , LiuW , WangZ , SunL , WuW . Shadow boxing for relief of chronic low back pain. International Journal of Athletic Therapy &amp; Training2011;16(6):29-33. ">Muharram 2011</a>; <a href="./references#CD009790-bbs2-0182" title="PetersenT , KrygerP , EkdahlC , OlsenS , JacobsenS . The effect of McKenzie therapy as compared with that of intensive strengthening training for the treatment of patients with subacute or chronic low back pain: a randomized controlled trial. Spine2002;27(16):1702-9. PetersenT , LarsenK , JacobsenS . One-year follow-up comparison of the effectiveness of McKenzie treatment and strengthening training for patients with chronic low back pain: outcome and prognostic factors. Spine2007;32(26):2948-56. ">Petersen 2002</a>; <a href="./references#CD009790-bbs2-0210" title="ShenYC , ShenYX . Effect of eperisone hydrochloride on the paraspinal muscle blood flow in patients with chronic low back pain: a randomized controlled observation. Journal of Clinical Rehabilitative Tissue Engineering Research2009;13(7):1293-6. ">Shen 2009</a>). </p> <p>A study was judged to be inadequately reported if the study failed to report one or more minimal baseline study population characteristics (age, sex, pain intensity, duration of low back pain) and also failed to include or describe one or more key reporting components (study flow chart, study eligibility criteria, method of randomisation, study population description). </p> <p>A study was judged to be at high risk of bias by two independent reviewers using the RoB 1 tool, as described above. </p> <p>Studies were excluded from the review due to potential research integrity concerns if they were judged to be either plagiarised or published in a predatory journal in addition to at least one other research integrity concern (high risk of bias, inadequate reporting). For more information regarding the process for developing the research integrity criteria, further description of integrity characteristics and their relationship to other trial methods and reporting characteristics, please see our articles on this topic (<a href="./references#CD009790-bbs2-0527" title="HaydenJA . Predatory publishing dilutes and distorts evidence in systematic reviews. Journal of Clinical Epidemiology2020;121:117-9.">Hayden 2020a</a>; <a href="./references#CD009790-bbs2-0529" title="HaydenJA , EllisJ , OgilvieR , BoulosL , StanojevicS . Meta-epidemiological study of publication integrity, and quality of conduct and reporting of randomized trials included in a systematic review of low back pain. Journal of Clinical Epidemiology2021;134:65-78.">Hayden 2021a</a>). </p> </section> <section id="CD009790-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>In the low back pain literature, several outcome measures are used to assess the constructs of pain intensity (for example, 10 mm or 100 mm visual analogue scales (VAS), or 0 to 10 numerical rating scales (NRS)) (see reviews by <a href="./references#CD009790-bbs2-0503" title="ChiarottoA , MaxwellLJ , OsteloRW , BoersM , TugwellP , TerweeCB . Measurement properties of visual analogue scale, numeric rating scale, and pain severity subscale of the brief pain inventory in patients with low back pain: a systematic review. Journal of Pain2019;20(3):245-63.">Chiarotto 2019</a>; <a href="./references#CD009790-bbs2-0577" title="Von KorffM , JensenMP , KarolyP . Assessing global pain severity by self-report in clinical and health services research. Spine2000;25(24):3140-51.">Von Korff 2000</a>) and back‐related functioning (for example, the 24‐point Roland‐Morris Disability Questionnaire, or the Oswestry Disability Index scored out of 100) (see reviews by <a href="./references#CD009790-bbs2-0501" title="ChiarottoA , MaxwellLJ , TerweeCB , WellsGA , TugwellP , OsteloRW . Roland-Morris Disability Questionnaire and Oswestry Disability Index: which has better measurement properties for measuring physical functioning in nonspecific low back pain? systematic review and meta-analysis. Physical Therapy2016;96(10):1620-37.">Chiarotto 2016</a>; <a href="./references#CD009790-bbs2-0543" title="KopecJA . Measuring functional outcomes in persons with back pain: a review of back-specific questionnaires. Spine2000;25(24):3110-4.">Kopec 2000</a>). Our primary meta‐analyses assessed pain (measured as VAS or NRS) and back‐related functioning (measured as Roland‐Morris Disability Questionnaire or Oswestry Disability Index, preferentially selecting the Roland‐Morris Disability Questionnaire) treatment effects (core outcomes reliably reported in eligible RCTs). Research has established agreement of the VAS and NRS pain scales and this same research established that either can be used interchangeably to assess back pain intensity (<a href="./references#CD009790-bbs2-0569" title="ShafshakTS , ElnemrR . The visual analogue scale versus numerical rating scale in measuring pain severity and predicting disability in low back pain. Journal of Clinical Rheumatology 2020 [Epub ahead of print]. [DOI: 10.1097/RHU.0000000000001320]">Shafshak 2020</a>). With respect to functional limitations, there is evidence that the Roland‐Morris Disability Questionnaire and the Oswestry Disability Index are highly correlated and similarly responsive enough for meta‐analysis (<a href="./references#CD009790-bbs2-0501" title="ChiarottoA , MaxwellLJ , TerweeCB , WellsGA , TugwellP , OsteloRW . Roland-Morris Disability Questionnaire and Oswestry Disability Index: which has better measurement properties for measuring physical functioning in nonspecific low back pain? systematic review and meta-analysis. Physical Therapy2016;96(10):1620-37.">Chiarotto 2016</a>). The individual trial outcomes for pain and functioning were re‐scaled to 0 to 100 points for meta‐analyses (for example, a VAS pain score (standard deviation) of 5.1 (2.3) out of 10 would be re‐scaled to 51 (23) out of 100), where positive mean effect sizes indicates improvement (i.e. decreased pain and decreased functional limitations). Re‐scaling is accepted and common in the back pain field (<a href="./references#CD009790-bbs2-0543" title="KopecJA . Measuring functional outcomes in persons with back pain: a review of back-specific questionnaires. Spine2000;25(24):3110-4.">Kopec 2000</a>) and facilitates comparison and interpretability of the syntheses. </p> <p>We interpreted a clinically important difference in results for exercise treatment compared to no treatment as a difference in pain of 15 points out of 100, and difference in function of 10 points, calculated as the smallest worthwhile effects based on a 30% reduction, the estimated upper interquartile range for patient‐reported smallest worthwhile effect with physiotherapy treatment compared to without (<a href="./references#CD009790-bbs2-0516" title="FerreiraML , HerbertRD , FerreiraPH , LatimerJ . The smallest worthwhile effect of nonsteroidal anti-inflammatory drugs and physiotherapy for chronic low back pain: a benefit-harm trade-off study. Journal of Clinical Epidemiology2013;66(12):1397-404.">Ferreira 2013</a>), from the average baseline pain (50.9, 95% CI 49.1 to 52.8), and average baseline functional limitations (38.9, 95% CI 35.8 to 42.0), respectively, for included studies. We interpreted smaller differences in effectiveness of exercise treatment compared to other conservative treatments as 'probably meaningful' when the 95% confidence interval was entirely on one side of the no effect line. This is relevant given similar inconveniences and adverse effects for comparison treatments considered in this review (<a href="./references#CD009790-bbs2-0560" title="QaseemA , WiltTJ , McLeanRM , ForcieaMA . Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine2017;166(7):514-30.">Qaseem 2017</a>). Differences were considered statistically significant at the 5% level. </p> </section> <section id="CD009790-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>Opportunities for unit of analysis issues in this systematic review were due to: 1. repeated observations on participants, 2. studies with more than two intervention groups, 3. non‐parallel study designs (cross‐over and cluster‐randomised trials). </p> <section id="CD009790-sec-0032"> <h5 class="title">Repeated observations on participants</h5> <p>We assessed available data from multiple follow‐up periods of the same treatment groups by defining different outcomes based on different periods of follow‐up: short‐term (post‐treatment assessment closest to three months after randomisation (6‐12 weeks)), moderate‐term (post‐treatment assessment closest to six months after randomisation (13‐47 weeks)), and long‐term follow‐up (post‐treatment assessment closest to 12 months after randomisation (48 weeks or more)). </p> </section> <section id="CD009790-sec-0033"> <h5 class="title">Studies with more than two relevant intervention groups</h5> <p>Exercise treatment groups from included trials were included in the meta‐analyses if they had an independent no treatment or other conservative treatment comparison group. This requirement meant that studies with no comparison group (i.e. trials that contrasted multiple exercise treatment groups only) were not included in the primary meta‐analyses, and comparison groups were not "double counted" in the meta‐analyses. This latter criterion was necessary to avoid correlation in effect sizes resulting from the use of repeated comparison data. We selected groups to include in analyses based on relevance to the review selection criteria. If multiple relevant comparison groups existed in a trial, we split the ‘shared’ group into two or more groups with smaller sample sizes to allow inclusion in meta‐analyses; this allowed investigation of heterogeneity across treatment arms (<a href="./references#CD009790-bbs2-0536" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>). </p> <p>Our additional network meta‐analysis and meta‐regression analyses have been reported in a related peer‐reviewed publication (<a href="./references#CD009790-bbs2-0530" title="HaydenJA , EllisJ , OgilvieR , StewartS , BaggMK , StanojevicS , YamatoTP , SaragiottoBT . Some types of exercise are more effective than others in people with chronic low back pain: a network meta-analysis. Journal of Physiotherapy2021;67(4):252-62.">Hayden 2021b</a>). These analyses use available data from all treatment groups including indirect and direct comparisons and allow inclusion of data from studies with only multiple exercise group comparisons. We briefly reported these related study results and referred to them in the discussion. </p> </section> <section id="CD009790-sec-0034"> <h5 class="title">Non‐parallel study designs</h5> <p>For any eligible cross‐over trials, we conservatively extracted data from the pre‐cross‐over and post‐cross‐over periods as if the trial was a parallel trial. For cluster‐randomised trials, we assessed the appropriateness of analyses to control for correlation of individuals within clusters. If clustering was not accounted for in a trial, we would reduce the sample size to an estimate of the effective sample size for continuous outcome data in this review.   </p> </section> </section> <section id="CD009790-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>Any missing data were first requested from individual study authors. In the event that the original authors could not be contacted, or were unable to supply missing data, missing variance scores were imputed using the mean variance from studies with similar populations of low back pain. Where data in study papers were reported as a median and interquartile range (IQR), for studies with moderate to large sample sizes (n &gt; 25), we used the median to estimate the mean; for studies with small sample sizes, we planned to use the formula proposed by Hozo and colleagues (<a href="./references#CD009790-bbs2-0539" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13.">Hozo 2005</a>). The standard deviation was calculated with the width of the IQR equivalent to 1.35 times the standard deviation (<a href="./references#CD009790-bbs2-0535" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine2002;21(11):1539-58.">Higgins 2002</a>). In studies where a range was presented along with the median instead of an IQR, the standard deviation was estimated to be one‐quarter of the range (<a href="./references#CD009790-bbs2-0536" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>). We conducted sensitivity analyses to explore the impact of assumptions about missing or incomplete data. </p> </section> <section id="CD009790-sec-0036"> <h4 class="title">Assessment of heterogeneity</h4> <p>We pooled data if studies were clinically homogeneous with regard to study population, intervention, and outcomes. Statistical heterogeneity was assessed using I<sup>2</sup> statistics and confidence intervals (<a href="./references#CD009790-bbs2-0536" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>). The I<sup>2</sup> statistic describes how much of the total variation across included studies can be attributed to heterogeneity rather than to chance. We interpreted the I<sup>2</sup> statistic according to rough guidance provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009790-bbs2-0536" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1.">Higgins 2011</a>): </p> <p> <ul id="CD009790-list-0004"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> <p>These overlapping intervals reflect that the interpretation of the I<sup>2</sup> statistic depends on the value as well as the size and direction of the treatment effect and variance of the I<sup>2</sup> estimate. The assessment of heterogeneity informed our appraisal of the certainty of evidence available using the GRADE framework. </p> </section> <section id="CD009790-sec-0037"> <h4 class="title">Assessment of reporting biases</h4> <p>We evaluated between‐study publication bias with Egger's test and funnel plots (<a href="./references#CD009790-bbs2-0511" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. British Medical Journal1997;315(7109):629-34.">Egger 1997</a>). We also assessed within‐study publication bias by considering whether all expected outcomes were reported for each follow‐up period of interest. If we were suspicious of reporting bias for a particular study, we would have contacted study authors for additional information and attempted to locate the study protocol to determine if there were differences between the protocol and publication; this was not required. </p> </section> <section id="CD009790-sec-0038"> <h4 class="title">Data synthesis</h4> <p>Forest plots were constructed in Review Manager 5.4 (<a href="./references#CD009790-bbs2-0562" title="Review Manager (RevMan). Version 5.4. Copenhagen: Nordic Cochrane Centre: The Cochrane Collaboration, 2020.">Review Manager 2020</a>) in order to give a pictorial overview of all study results. We used quantitative meta‐analyses, which were conducted for continuous outcome measures by pooling weighted mean differences with random‐effects models and data from at least three studies (<a href="./references#CD009790-bbs2-0508" title="DerSimonianR , LairdN . Meta-analysis in clinical trials. Controlled Clinical Trials1986;7(3):177-88.">DerSimonian 1986</a>). Prediction intervals were calculated (<a href="./references#CD009790-bbs2-0564" title="RileyRD , HigginsJP , DeeksJJ . Interpretation of random effects meta-analyses. British Medical Journal2011;342:d549. [PMID: 21310794]">Riley 2011</a>) to estimate the likely effect of exercise treatment in individual study settings. Stata 14 (<a href="./references#CD009790-bbs2-0573" title="Stata Statistical Software. StataCorp, Version 14. College Station, TX: StataCorp LP, 2015.">StataCorp 2015</a>) (for descriptive analyses and data checking), Review Manager 5.4 (<a href="./references#CD009790-bbs2-0562" title="Review Manager (RevMan). Version 5.4. Copenhagen: Nordic Cochrane Centre: The Cochrane Collaboration, 2020.">Review Manager 2020</a>), and R packages (<a href="./references#CD009790-bbs2-0561" title="R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013.">R Core Team 2013</a>) (for meta‐analyses) were used. </p> </section> <section id="CD009790-sec-0039"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We used subgroup analyses to explore heterogeneity due to study‐level variables, such as population source and characteristics. We characterised the population sources as healthcare (primary, secondary or tertiary care centres), occupational (patients presenting to occupational healthcare facilities or personnel in compensatory situations), or from a general or mixed population (e.g. including individuals recruited by newspaper advertisements) to differentiate the studies of patients in typical treatment settings (healthcare and occupational) from those including individuals with low back pain who may not normally present for treatment. We separately considered the effect of exercise treatment for populations with moderate (12 weeks to three years) and long (greater than three years) duration of chronic low back pain at baseline (<a href="./references#CD009790-bbs2-0510" title="DunnKM , CroftPR . The importance of symptom duration in determining prognosis. Pain2006;121(1-2):126-32.">Dunn 2006</a>). We also considered subgroup analyses of study populations with radicular symptoms (leg pain and/or neurological symptoms); no participants with radicular symptoms, including participants with leg pain and/or neurological symptoms; or radicular symptoms not specified. An additional subgroup analysis, not described in the original protocol, explored specific types of conservative treatment comparisons, including advice or education alone, manual therapy, electrotherapy, psychological therapy, back school, relaxation, anti‐inflammatory agents or analgesics, or non‐exercise physical therapy interventions. We compared primary outcomes for subgroups of studies (<a href="./references#CD009790-bbs2-0572" title="SongF , AltmanDG , GlennyAM , DeeksJJ . Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. British Medical Journal2003;326(7387):472.">Song 2003</a>). </p> </section> <section id="CD009790-sec-0040"> <h4 class="title">Sensitivity analysis</h4> <p>‐We conducted sensitivity analyses in order to explain possible sources of heterogeneity between studies and to determine the robustness of our original analyses. We conducted sensitivity analyses excluding studies with high risk of bias (and exploring the impact of RoB 1 and RoB 2 assessment), to test assumptions about imputing data for studies that did not adequately present variance scores, or where median values were presented, and including only studies with the most homogeneous outcome measures for functional limitations (Roland‐Morris Disability Questionnaire only). </p> <p>We conducted sensitivity analyses that omitted study outcome data from meta‐analyses that were judged to be outliers to explore the impact of extreme study results on review conclusions. A study was judged to have an improbable or outlying mean outcome if the absolute difference between any exercise group and any comparison group over all available follow‐ups was greater than a predetermined threshold of 30/100 for pain and 20/100 for functional limitations, selected based on clinical judgement. </p> </section> <section id="CD009790-sec-0041"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We have presented results for our primary outcomes of pain and functional limitations in the summary of findings tables, produced using the GRADE framework (<a href="./references#CD009790-bbs2-0520" title="GRADEpro Guideline Development Tool. Evidence Prime, Incorporated, Version accessed prior to 5 Sept 2021. Hamilton (ON): GRADE Working Group, McMaster University, 2015. www.gradepro.org.">GRADEpro</a>). These tables include a summary of the number of studies included in the review, continuous outcome measure results reflecting absolute treatment effects, and a statement regarding the overall quality of the evidence available (see <a href="./appendices#CD009790-sec-0109">Appendix 2</a> for description). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009790-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009790-sec-0042"></div> <section id="CD009790-sec-0043"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD009790-sec-0119" title="">Characteristics of included studies</a>; <a href="./references#CD009790-sec-0120" title="">Characteristics of excluded studies</a>. </p> <p><a href="#CD009790-fig-0001">Figure 1</a> provides detail about the flow of citations and studies through our search and selection process. </p> <div class="figure" id="CD009790-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009790-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <section id="CD009790-sec-0044"> <h4 class="title">Results of the search</h4> <p>Our electronic database searches identified 12,883 unique citations up to December 2020. We screened 1103 full‐text publications, identified 279 as potentially eligible, and included 249 RCTs of exercise treatment for chronic low back pain in this review. A further 172 RCTs have been identified as likely to be eligible and are listed in <a href="./references#CD009790-sec-0121" title="">Characteristics of studies awaiting classification</a>. </p> </section> <section id="CD009790-sec-0045"> <h4 class="title">Included studies</h4> <p>A descriptive summary of the characteristics of the 249 studies (24,486 included participants) is in <a href="#CD009790-fig-0002">Figure 2</a>. A complete description of each included study is presented in the <a href="./references#CD009790-sec-0119" title="">Characteristics of included studies</a> and citations are available: References: <a href="./references#CD009790-bbs1-0001" title="">Included studies</a>. </p> <div class="figure" id="CD009790-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Summary characteristics of included studies." data-id="CD009790-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary characteristics of included studies.</p> </div> </div> </div> <section id="CD009790-sec-0046"> <h5 class="title">Study design and setting</h5> <p>Studies included in this review were conducted in geographically diverse settings. The trials were conducted in Europe (49%, 122 studies), Asia (15%, 38 studies), North America (13%, 33 studies), the Middle East (10%, 24 studies), South America (6%, 15 studies), Oceania (5%, 12 studies), and Africa (2%, 4 studies); there was also one multi‐regional trial. Most of the trials included in this review have been published since 2011 (56%, 139) with an increasing trend since the earliest included trial, published in 1968. Over half (58%) of included studies were conducted in healthcare settings, with 29% and 9% of studies conducted in general/mixed population settings, or in occupational settings, respectively (4% of studies did not describe their population source). Sixty‐one per cent of studies (151 trials) examined the effectiveness of two or more different types of exercise treatment, and 57% (142 trials) compared exercise to a non‐exercise comparison treatment (no treatment, or other conservative therapy). Each study included a median of two groups with a range of two to eight. <a href="#CD009790-fig-0002">Figure 2</a> describes the distribution of exercise and comparison treatment groups across the included studies. </p> <p>The distribution of the number of subjects participating in the included studies was skewed to the right, with mean of 98 (95% CI: 87 to 109), a median of 70 participants (IQR: 42 to 125), and a range of 10 to 722 study participants. The average number of subjects per treatment group was 42 (95% CI: 38 to 46). Only 19% of included trials (39 of 203 studies that adequately reported data) had sufficient sample size to estimate a statistically significant realistic effect size. Trial registration or prior protocol publication was reported for only 29% of included trials (69 trials). Most study publications included an ethics statement (76%, 185 of 242 studies assessed) and a conflict of interest statement (81%, 195 of 242 assessed). Work status, health‐related quality of life, and global perceived recovery were measured in 14%, 29%, and 19% of studies, respectively. Only 44 included studies (18% of studies) included a measure of each of the recommended core outcomes for low back pain trials: pain intensity, functional limitations and health‐related quality of life. </p> </section> <section id="CD009790-sec-0047"> <h5 class="title">Participant characteristics</h5> <p>The study participants in the 249 included trials had a mean age of 43.7 years (95% CI: 42.5 to 44.8); on average, 59% of study populations were female. The participants reported a mean pain intensity at baseline of 51 points on a 100‐point scale (95% CI: 49.1 to 52.8), a mean functional limitations score at baseline of 38.0 (35.9 to 40.1), and 100 included studies (40%) had some participants with leg pain or neurologic symptoms in addition to their main complaint of chronic low back pain. The study samples in 78 trials (31%) included participants with chronic low back pain of moderate symptom duration (mean duration 12 weeks to three years) and 72 trials (29%) included participants with longer symptom duration of greater than three years; 99 trials did not specify the mean duration of chronic low back pain of participants. Nineteen trials (8%) included participants with chronic recurrent low back pain symptoms. </p> </section> <section id="CD009790-sec-0048"> <h5 class="title">Interventions</h5> <p>The 249 included studies had a total of 585 treatment groups: 426 exercise groups and 159 comparison groups. Most exercise treatment groups included mixed types of exercises (i.e. greater than two types) (23%, 110 study groups). The most common specific types of exercises investigated were core strengthening (27%, 131 study groups) and Pilates (6%, 29 study groups), general strengthening exercises (12%, 57 study groups), stretching (11%, 51 study groups), and aerobic exercise (8%, 41 study groups). Other specific types of exercises were investigated in 3% of study groups (16 study groups). We classified 46% of exercise treatments as back‐specific (196 study groups), and 29% as whole body exercises (125 study groups). The exercise treatments were classified as standardised for 46% of exercise groups (195 study groups), and were most commonly delivered in an individually‐supervised (38%, 163 study groups), or group‐supervised setting (38%, 162 study groups), and were of low dose/intensity (&lt; 20 hours) (68%, 288 study groups). More than half of studies included additional treatment with the primary exercise intervention (58%, 247 study groups), including education or advice (32%, 137 study groups), electrotherapy (11%, 46 study groups), or manual therapy (5%, 21 study groups). Psychological interventions (e.g. cognitive behaviour therapy, behavioural support, or psychiatry sessions) were included with the exercise intervention for 14% (58 study groups) of exercise treatment groups. </p> <p>Non‐exercise treatment comparison interventions in the included studies were: no treatment (39%, 62 study groups, including four studies with placebo groups), and other conservative treatments (61%, 97 study groups). Other conservative treatment comparison groups included education (32%, 31 study groups), physical therapy (multi‐modal non‐exercise) (30%, 29 study groups), manual therapy (15%, 15 study groups), electrotherapy (6%, 6 study groups), or psychological therapy (6%, 6 study groups). </p> </section> <section id="CD009790-sec-0049"> <h5 class="title">Outcomes</h5> <p>Pain intensity outcomes were reported in 90% of included studies (223 studies). Measurement scales used were most commonly the Visual Analogue Scale (60%, 133 studies) or the Numeric Rating Scale (22%, 50 studies). No other pain outcome measures were reported in 10 or more studies. Our meta‐analyses of pain intensity considered only studies that measured with this outcome with the Visual Analogue Scale or the Numeric Rating Scale and adequately reported outcome data (178 studies). </p> <p>Functional limitations were reported in 90% of included studies (223 studies). The Roland‐Morris Disability Questionnaire and the Oswestry Disability Index were the most commonly reported outcome measures, reported in 42% (93 studies), and 37% (83 studies), respectively. No other functional limitations outcome measures were reported in 10 or more studies. Our meta‐analyses of functional limitations considered only studies that measured this outcome with the Roland‐Morris Disability Questionnaire or the Oswestry Disability Index and adequately reported outcome data (161 studies). </p> <p>Other outcomes were not consistently reported in the included studies. Global perceived recovery was reported in 19% of included studies (47 studies), with the Global Perceived Effect measure reported by 15 included studies. Health‐related quality of life was reported in 29% of included studies (71 studies). The SF‐36 was the most common health‐related quality of life scale used, reported in 63% (45 of 71 studies). The EuroQol‐5D and SF‐12 were reported in 17% (12 of 71) and 14% of included studies (10 of 71), respectively. Work status after treatment, for example, return to work for people off work due to a workers' compensation claim, was reported in 14% of included studies (36 studies). We excluded one study that did not report any patient‐reported outcomes, according to our protocol (described in the <a href="./references#CD009790-sec-0120" title="">Characteristics of excluded studies</a>). </p> <p>Adverse effects were measured in 86 studies reporting on 120 exercise groups and 58 comparison groups. There was no mention of measurement of adverse effects in 150 studies (60%) (13 were non‐English publications ‐ 5%). Measurement was variable in the 86 studies that mentioned adverse effects; only presence or absence was reported for 74 studies with 112 exercise groups and 42 comparison groups. In these studies, one or more adverse events was reported for 33% of exercise groups (none = 71; one or more = 37), and 29% of comparison groups (none = 30; one or more = 12). Only 12 included studies appeared to measure adverse effects in a systematic way (for all participants at regular time points as part of the study protocol rather than ‘as reported’). The twelve studies (19 exercise groups; 7 comparison groups) that systematically measured adverse events reported a range of between zero and an average of 3.2 adverse events (350 reported for 111 participants) per participant in the exercise groups (median 0.14; IQR: 0.01 to 0.57), and an average of 0.02 (1 reported for 64 participants) to 0.6 per person (25 reported for 43 participants) in comparison groups (median 0.12; IQR: 0.02 to 0.32). In the 15 exercise groups reporting adverse events, 11 reported minor only (most commonly increased low back pain and muscle soreness), and four reported minor and major (including disc herniation). </p> <p>The available follow‐up time periods reported in the included studies ranged from immediate to two years. Twelve studies reported only time periods less than four weeks so were not included in any syntheses. One hundred and eighty‐four studies reported short‐term follow‐up. Moderate follow‐up outcomes were available for 49% of included studies (121 studies), and long‐term follow‐up was available for 28% of included studies (69 studies). The median follow‐up duration for studies included in the earliest follow‐up time period for our review primary analyses was 12 weeks (IQR: 8 to 12 weeks), including 18 studies that reported follow‐up time periods between four‐ and six‐weeks post‐treatment.  </p> </section> <section id="CD009790-sec-0050"> <h5 class="title">Study data available for analyses</h5> <p>In total, 261 trial authors of the 279 potentially eligible trials were contacted to request missing information. We received responses that resulted in changes to study data from 80 authors (45/186 using email data request ‐ 24% response rate; and 35/75 using REDCap data request ‐ 47% response rate). Study mean outcome data for meta‐analyses and related network meta‐analyses remained incomplete for 23 studies following author contact (9% of studies available for quantitative analyses). Standard deviations were missing or considered to be improbable for 39 (26%) of the studies available for meta‐analyses (22 studies with SD missing before imputation; 10 studies with low outlying or improbable SD values); these studies were included in our primary analyses with data imputed from studies similar on two characteristics (population and chronicity), and subsequently excluded in sensitivity analyses. </p> <p>Sufficient data for quantitative analyses were available from 203 included studies (19,633 participants) for pain or functional limitations outcomes. The characteristics of these studies were not substantially different from the 46 studies that did not adequately report outcome data (i.e. studies missing data for analyses or pre‐defined homogeneous measures of pain and functional limitations), except that they were less likely to report pain (92% versus 79%) and functional limitations outcome measures (91% versus 81%) (<a href="#CD009790-fig-0002">Figure 2</a>). We included data from 117 studies (12,872 participants) that had a non‐exercise comparison treatment group in at least one of our primary meta‐analyses. We also described the characteristics of this subset of studies in <a href="#CD009790-fig-0002">Figure 2</a>. </p> </section> </section> <section id="CD009790-sec-0051"> <h4 class="title">Excluded studies</h4> <p>In total, 491 studies were excluded at the full‐text level; a further 74 studies were excluded at the data extraction stage. Of the studies excluded at the full‐text stage, 117 studies were not RCTs, 141 studies did not have a majority chronic population, 82 studies were not full‐text publications, 76 studies were exact duplicates of previously assessed studies (i.e. publications that inappropriately passed through the duplicate citation screen and were identified as a duplicate at the full‐text or data extraction stage), 72 studies did not have an eligible comparison group, and three studies did not include a relevant outcome. Of the 74 studies excluded at the data extraction stage, 29 studies did not have a majority chronic population, 14 studies did not have an eligible comparison group, one study did not include a relevant outcome and 30 studies were excluded due to research integrity concerns. </p> <p>Of the 30 studies excluded from the review for integrity reasons (1218 participants), 20 studies were excluded as they were judged to be published in a predatory journal in addition to at least one other integrity concern (high risk of bias = 10; inadequate reporting = 19). Eight studies were excluded as they were judged to have substantial plagiarism in addition to at least one other integrity concern (high risk of bias = 3; inadequate reporting = 8). Two studies were excluded as they were judged to be both published in a predatory journal and to have substantial plagiarism; both included an additional research integrity concern (inadequate reporting = 2). Two unrelated trials (different author groups, different countries of conduct) were excluded for research integrity reasons as they presented identical data which could not be explained, despite attempts to contact both author groups, their institutions, and the publishing journals. </p> <p>The exclusion of studies due to multiple research integrity concerns resulted in 0 to 13% of studies (0 to 6% of participants) being excluded from the primary review meta‐analysis comparisons of pain outcomes, and 0 to 11% of studies (0 to 3% of participants) being excluded from primary meta‐analysis comparisons of functional limitations outcomes. This is lower than the overall numbers excluded because these studies often did not report data that was usable. There was no substantial impact on the primary meta‐analysis effect sizes for any outcomes or follow‐up periods with these exclusions. </p> <p>A complete description of reasons for exclusion for the 74 studies excluded at the data extraction stage can be found in the <a href="./references#CD009790-sec-0120" title="">Characteristics of excluded studies</a> table. </p> <section id="CD009790-sec-0052"> <h5 class="title">Studies awaiting classification</h5> <p>In total, 172 studies likely to be eligible for inclusion in this review are awaiting classification. These studies were identified in the most recent search update (152 studies), or are subject to translation to English language (20 studies). They have been screened through title abstract and full‐text screening and are awaiting data extraction. </p> </section> <section id="CD009790-sec-0053"> <h5 class="title">Ongoing studies</h5> <p>At each search update, we screened trial registries to identify published versions of completed trials. We did not identify additional ongoing trials due to the high volume of completed trials to include in the review at each update. </p> </section> </section> </section> <section id="CD009790-sec-0054"> <h3 class="title">Risk of bias in included studies</h3> <p>Of the 249 included trials, 129 (52%) were at risk of selection bias, 195 (78%) were at risk of performance bias, 182 (73%) were at risk of detection bias, 49 (20%) were at risk of attrition bias, 22 (9%) were at risk of reporting bias, and 173 (59%) were susceptible to other potential sources of bias. Although the majority of trials were susceptible to some level of bias, three studies had low risk of bias in all domains assessed (<a href="./references#CD009790-bbs2-0060" title="DoughertyPE , KaruzaJ , SavinoD , KatzP . Evaluation of a modified clinical prediction rule for use with spinal manipulative therapy in patients with chronic low back pain: a randomized clinical trial. Chiropractic &amp; Manual Therapies2014;22(1):41-53. ">Dougherty 2014</a>; <a href="./references#CD009790-bbs2-0072" title="GarciaAN , CostaL , HancockMJ , SouzaFS , GomesG , AlmeidaMO , et al. McKenzie method of mechanical diagnosis and therapy was slightly more effective than placebo for pain, but not for disability, in patients with chronic non-specific low back pain: a randomised placebo controlled trial with short and longer term follow-up. British Journal of Sports Medicine2017;52(9):594-600. ">Garcia 2017</a>; <a href="./references#CD009790-bbs2-0141" title="MannionAF , MuntenerM , TaimelaS , DvorakJ . A randomized clinical trial of three active therapies for chronic low back pain. Spine1999;24(23):2435-48. MannionAF , MuntenerM , TaimelaS , DvorakJ . Comparison of three active therapies for chronic low back pain: results of a randomized clinical trial with one-year follow-up. Rheumatology2001;40(7):772-8. MannionAF , TaimelaS , MuntenerM , DvorakJ . Active therapy for chronic low back pain part 1. Effects on back muscle activation, fatigability, and strength. Spine2001;26(8):897-908. ">Mannion 1999</a>). </p> <section id="CD009790-sec-0055"> <h4 class="title">Allocation</h4> <p>In total, 120 trials (48%) were deemed to have an appropriate method of randomisation, sufficient allocation concealment, and balanced baseline variables, and thus were at a low risk of selection bias. Sixty‐three trials had unclear reporting of the method of sequence generation and 59 had unclear reporting of the method of allocation concealment while 19 did not present any baseline characteristics. Generic statements such as “participants were randomised” without any further information were considered to be of unclear risk of bias. </p> </section> <section id="CD009790-sec-0056"> <h4 class="title">Blinding</h4> <p>While blinding is often unfeasible due to the nature of the interventions in question, a trial could still be considered at a low risk for performance bias if the risks of biasing effects were adequately mitigated. For example, equally plausible treatment options would lead participants to believe that treatments were comparable in effectiveness, reducing the risk of bias due to lack of blinding of participants. Further, if distinct personnel provided care for a group in their area of expertise, the risk of non‐blinded personnel may also be reduced. </p> <section id="CD009790-sec-0057"> <h5 class="title">Performance bias</h5> <p>Eighty‐two trials were considered to have adequately blinded patients, 65 trials had adequately blinded personnel with 59 studies being at a low risk of bias in both domains. Inadequate information was provided to make a decision about participant blinding in 12 studies and personnel blinding in 10 studies; these studies were deemed to have an unclear risk of bias. Sixty‐eight trials did not conduct an intent‐to‐treat analysis and a further 21 did not clearly state whether they did or not. </p> <p>Of the 185 studies assessed using RoB 1, 183 (99%) were deemed to be at high risk of performance bias. Conversely, within the 64 studies assessed using RoB 2, only 12 (19%) were classified as high risk. None of these 64 trials attempted to blind both patients and personnel.  </p> </section> <section id="CD009790-sec-0058"> <h5 class="title">Detection bias</h5> <p>Our primary outcomes, pain and functional limitations, are patient‐reported subjective outcomes. In total, 68 trials were found to have low risk of bias due to outcome assessor blinding. Forty‐one studies had inadequate information to make a decision and were deemed to have an unclear risk of bias. Three trials did not have similar timing of assessments across groups and five were missing adequate information to make a judgement. </p> </section> </section> <section id="CD009790-sec-0059"> <h4 class="title">Incomplete outcome data</h4> <p>Two hundred trials had losses to follow‐up that were minimal or that were unlikely to bias the outcome. Dropouts that were unlikely to bias results included those that were balanced between groups or were caused by reasons deemed unrelated to outcomes. Studies could also be rated as low risk for attrition bias if they had evidence of a lack of biasing effect like the results of a sensitivity analysis. Fifteen studies had insufficient information on missing data and were classified as having unclear risk. </p> </section> <section id="CD009790-sec-0060"> <h4 class="title">Selective reporting</h4> <p>In total, 227 trials were judged to have a low risk of selective reporting bias. When protocols, statistical analysis plans, or trial registrations were not available, a study could still be rated as low risk if there were no omissions of results based on the within‐paper’s methods section and no obvious omissions such as a lack of pain outcomes or if outcomes were missing from certain follow‐up. Seventeen trials did not have adequate reporting and were deemed to have unclear risk. </p> </section> <section id="CD009790-sec-0061"> <h4 class="title">Other potential sources of bias</h4> <p>In total, 173 trials were deemed to have at least one other potential source of bias, either via a lack of compliance or unbalanced co‐interventions. Fifty‐seven trials reported poor study adherence rates and a further 75 did not report on compliance. Thirty‐nine trials had an imbalance in the external co‐interventions sought by patients and a further 82 did not collect any information or attempt to restrict participants’ external activities. A study could be rated at low risk for bias if, despite not collecting co‐intervention information, patients were instructed to refrain from certain non‐exercise treatments. </p> <section id="CD009790-sec-0062"> <h5 class="title">Intra‐rater agreement</h5> <p>Out of 2528 total items, reviewers agreed on 2270 for an overall agreement of 90% and a Kappa value of 0.84 (95% CI 0.82 to 0.85), indicating a high level of agreement. Trials that were assessed using the Cochrane RoB 1 tool had higher agreement (96%, Kappa 0.93, 95% CI 0.92 to 0.94) than those that were assessed using the Cochrane RoB 2 tool (75%, Kappa 0.45, 95% CI 0.42 to 0.46). </p> </section> <section id="CD009790-sec-0063"> <h5 class="title">Comparisons of RoB 1 and RoB 2</h5> <p>For the most recent set of 64 studies included in this review (included and extracted since the publication of the RoB 2 tool), we used the RoB 2 items to recreate a RoB 1 assessment for consistency across the review. This assessment often included incorporating clarifying questions included in RoB 2 to prompt a more fulsome response. In these domains – blinding of patients, blinding of personnel, missing data, and selective reporting – there were fewer trials classified as having an unclear risk of bias when using RoB 2 (7% of items vs 2% of items classified as unclear). This was not true, however, for the domain of outcome assessor blinding which had a much higher proportion of studies judged to be of unclear risk when using RoB 2. </p> <p>The domains looking at the blinding of patients and personnel were also more frequently deemed to be low risk of bias when using RoB 2 – 94% of studies were low risk in these domains in RoB 2 vs 7% for RoB 1. Although this could, in part, be due to systematic differences between the sets of trials assessed, in exercise trials blinding is often unfeasible and RoB 2 allowed for a more in‐depth assessment of the risk of bias that resulted in trials not being classified as high risk in blinding domains. </p> <p>Post hoc analysis comparing RoB 1 and RoB 2 assessment tools for trials with specific comparison groups found the differences between the tool judgements (i.e. RoB 2 with fewer trials judged as ‘unclear’ risk of bias) were greater in trials with no treatment than those with other comparisons. Similar to other comparison types, no treatment comparisons were more likely to be judged low risk of bias for blinding of patients and personnel with RoB 2 than with RoB 1. </p> </section> </section> </section> <section id="CD009790-sec-0064"> <h3 class="title" id="CD009790-sec-0064">Effects of interventions</h3> <p>See: <a href="./full#CD009790-tbl-0001"><b>Summary of findings 1</b> Summary of findings: Exercise treatment compared with no treatment, usual care or placebo for chronic low back pain</a>; <a href="./full#CD009790-tbl-0002"><b>Summary of findings 2</b> Summary of findings: Exercise treatment compared with other conservative treatments for chronic low back pain</a> </p> <p>Complete meta‐analysis data, including forest plots and full results are provided in the ’<a href="./references#CD009790-sec-0096" title="">Data and analyses</a>’ section. Overall, there is moderate‐certainty evidence of effectiveness of exercise treatment for improving pain and functional limitations outcomes (<a href="./full#CD009790-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD009790-tbl-0002">summary of findings Table 2</a>). </p> <section id="CD009790-sec-0065"> <h4 class="title">Pain intensity outcomes</h4> <p>Ninety‐nine studies (132 study groups) provided data on 9041 participants for earliest pain outcomes comparing exercise treatment to other comparisons (40% of all included studies, 37% of all included participants) (<a href="./references#CD009790-fig-0004" title="">Analysis 1.1</a>). </p> <section id="CD009790-sec-0066"> <h5 class="title">Exercise treatment versus no treatment, usual care or placebo</h5> <p>Thirty‐five studies (47 study groups) provided data on 2746 participants comparing exercise treatment to no treatment comparisons (including usual care and placebo) on pain outcomes. The pooled mean difference in pain for exercise treatment compared to no treatment comparisons at the earliest follow‐up point was ‐15.2 (95% CI ‐18.3 to ‐12.2; I<sup>2</sup> = 75%). This effect is compatible with a clinically important improvement in pain outcomes for exercise compared to no treatment. The prediction interval describing the expected range of true effect in similar studies is ‐33.0 to 2.5.  </p> <p>This evidence was judged to be moderate certainty for the comparison of exercise treatment to no treatment. The certainty of the evidence was downgraded due to inconsistency (substantial heterogeneity). There were no serious concerns due to indirectness, imprecision, or publication bias. Seven studies (10 groups; 526 participants) were judged to have high risk of bias (19% of participant data), however, exclusion of these studies in sensitivity analysis did not change conclusions so the certainty of evidence was not downgraded further (<a href="./full#CD009790-tbl-0001">summary of findings Table 1</a>; <a href="#CD009790-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD009790-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Funnel plots for primary analyses (x axis = mean difference). Earliest follow‐up study results for: 1. Pain outcome: a. exercise compared to placebo, no treatment or usual care, b. exercise compared to other conservative treatments; and 2. Functional limitations: c. exercise compared to no treatment, usual care or placebo, d. exercise compared to other conservative treatments." data-id="CD009790-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plots for primary analyses (x axis = mean difference). Earliest follow‐up study results for: 1. Pain outcome: a. exercise compared to placebo, no treatment or usual care, b. exercise compared to other conservative treatments; and 2. Functional limitations: c. exercise compared to no treatment, usual care or placebo, d. exercise compared to other conservative treatments. </p> </div> </div> </div> <p>Separate post hoc analysis of placebo treatments compared to exercise treatments in studies providing pain outcome data (2 studies; 300 participants) found a pooled mean difference of ‐8.9 (95% CI ‐15.1 to ‐2.6; I<sup>2</sup> = 0%) (<a href="./references#CD009790-fig-0033" title="">Analysis 9.1</a>). </p> </section> <section id="CD009790-sec-0067"> <h5 class="title">Exercise treatment versus other conservative treatments</h5> <p>Sixty‐four studies (85 study groups) provided data on 6295 participants comparing exercise treatment to other conservative treatment comparisons. The pooled mean difference in pain for exercise treatment compared to all other conservative treatments investigated at the earliest follow‐up point was ‐9.1 (95% CI ‐12.6 to ‐5.6; I<sup>2</sup> = 93%). This improvement did not meet our prespecified threshold for clinically important difference in pain outcomes, but is probably meaningful. The prediction interval describing the expected range of true effect in similar studies is ‐40.1 to 21.9. </p> <p>This evidence was judged to be low certainty for the comparison of exercise treatment to other conservative treatments. The certainty of the evidence was downgraded due to inconsistency (considerable heterogeneity), and some evidence of publication bias, however, heterogeneity  was partially explained by exploration of effect in specific comparison subgroups. There were no serious concerns due to indirectness or imprecision. Eleven studies (14 groups; 835 participants) were judged to have high risk of bias (13% of participant data), however, exclusion of these studies in sensitivity analysis did not change conclusions so the certainty of evidence was not downgraded further (<a href="./full#CD009790-tbl-0002">summary of findings Table 2</a>; <a href="#CD009790-fig-0003">Figure 3</a>). </p> </section> <section id="CD009790-sec-0068"> <h5 class="title">Short, medium and long‐term follow‐up periods</h5> <p>Data about pain outcomes for the short‐term follow‐up period (approximately three months) were available for exercise treatment compared to no treatment comparisons (MD ‐16.4, 95% CI ‐20.3 to ‐12.4; participants = 2247; studies = 26; study groups = 37; I<sup>2</sup> = 78%) (<a href="./references#CD009790-fig-0005" title="">Analysis 1.2</a>). This mean effect of exercise treatment is most compatible with a clinically important difference. The observed mean effect differences did not meet this threshold of clinically important difference at medium‐term (approximately six months) (MD ‐10.6, 95% CI ‐15.0 to ‐6.1; participants = 1491; studies = 17; study groups = 20; I<sup>2</sup> = 79%) (<a href="./references#CD009790-fig-0006" title="">Analysis 1.3</a>) or long‐term follow‐up (approximately 12 months) (MD ‐11.8, 95% CI ‐22.0 to ‐1.6; participants = 498; studies = 5; study groups = 5; I<sup>2</sup> = 88%) (<a href="./references#CD009790-fig-0007" title="">Analysis 1.4</a>). </p> <p>For exercise treatment compared to all other conservative treatments investigated at specific follow‐up periods, data at short‐term (MD ‐8.6, 95% CI ‐13.1 to ‐4.1; participants = 4874; studies = 47; study groups = 60; I<sup>2</sup> = 95%) (<a href="./references#CD009790-fig-0005" title="">Analysis 1.2</a>) and medium‐term follow‐up periods (MD ‐8.1, 95% CI ‐12.3 to ‐3.9; participants = 4078; studies = 38; study groups = 52; I<sup>2</sup> = 90%) (<a href="./references#CD009790-fig-0006" title="">Analysis 1.3</a>) were similar and probably meaningful. For the long‐term follow‐up period, smaller non‐significant differences were observed (MD ‐5.2, 95% CI ‐11.3 to 0.8; participants = 2490; studies = 19; study groups = 28; I<sup>2</sup> = 92%) (<a href="./references#CD009790-fig-0007" title="">Analysis 1.4</a>). </p> </section> <section id="CD009790-sec-0069"> <h5 class="title">Subgroup analyses</h5> <p>Subgroup analyses explored the impact of population source, symptom duration, study participants with leg pain or neurologic symptoms, and specific type of conservative treatment comparison. </p> <section id="CD009790-sec-0070"> <h6 class="title">Population source</h6> <p>Exploring population source, the pooled mean difference in pain at the earliest follow‐up period for exercise treatments compared to no treatment groups were: healthcare study populations (MD ‐16.9, 95% CI ‐20.9 to ‐13.0; participants = 1454; studies = 18; study groups = 23; I<sup>2</sup> = 68%), occupational populations (MD ‐22.9, 95% CI ‐39.7 to ‐6.1; participants = 252; studies = 3; study groups = 3; I<sup>2</sup> = 90%), and general or mixed populations (MD ‐12.2, 95% CI ‐17.1 to ‐7.3; participants = 1010; studies = 13; study groups = 20; I<sup>2</sup> = 76%) (<a href="./references#CD009790-fig-0012" title="">Analysis 2.1</a>). </p> <p>For exercise treatment compared to other conservative treatments, the pooled mean difference in pain at the earliest follow‐up period were: healthcare study populations (MD ‐8.0, 95% CI ‐12.2 to ‐3.9; participants = 2602; studies = 33; study groups = 46; I<sup>2</sup> = 88%), occupational study populations (MD ‐14.6, 95% CI ‐28.4 to ‐0.8; participants = 935; studies = 9; study groups = 11; I<sup>2</sup> = 97%), and general or mixed populations (MD ‐8.4, 95% CI ‐12.8 to ‐3.9; participants = 2698; studies = 21; study groups = 27; I<sup>2</sup> = 87%) (<a href="./references#CD009790-fig-0013" title="">Analysis 2.2</a>). </p> </section> <section id="CD009790-sec-0071"> <h6 class="title">Symptom duration</h6> <p>Exploring pain outcome results at the earliest follow‐up period according to the symptom duration of the study population, the pooled mean difference for exercise treatments compared to no treatment groups were: moderate symptom duration studies of 12 weeks to three years (MD ‐16.4, 95% CI ‐22.6 to ‐10.3; participants = 523; studies = 8; study groups = 12; I<sup>2</sup> = 77%), long symptom duration &gt; three years (MD ‐8.5, 95% CI ‐11.1 to ‐6.0; participants = 1318; studies = 13; study groups = 17; I<sup>2</sup> = 0%), and for studies that did not specify symptom duration (MD ‐21.6, 95% CI ‐26.6 to ‐16.5; participants = 905; studies = 14; study groups = 18; I<sup>2</sup> = 71%) (<a href="./references#CD009790-fig-0016" title="">Analysis 3.1</a>). </p> <p>The pooled mean difference for exercise treatments compared to other conservative treatment groups were: moderate symptom duration studies of 12 weeks to three years (MD ‐10.6, 95% CI ‐18.1 to ‐3.0; participants = 1555; studies = 17; study groups = 25; I<sup>2</sup> = 95%), long symptom duration &gt; three years (MD ‐6.8, 95% CI ‐11.7 to ‐1.8; participants = 2094; studies = 17; study groups = 22; I<sup>2</sup> = 83%) and for studies that did not specify symptom duration (MD ‐9.5, 95% CI ‐14.2 to ‐4.7; participants = 2646; studies = 30; study groups = 38; I<sup>2</sup> = 91%) (<a href="./references#CD009790-fig-0017" title="">Analysis 3.2</a>). </p> </section> <section id="CD009790-sec-0072"> <h6 class="title">Study participants with leg pain or neurologic symptoms</h6> <p>Exploring pain outcome results at earliest follow‐up period according to the inclusion of study participants with leg pain or neurologic symptoms, the pooled mean difference for exercise treatments compared to no treatment groups were: studies that excluded participants with leg pain or neurologic symptoms (MD ‐17.0, 95% CI ‐22.6 to ‐11.3; participants = 816; studies = 14; study groups = 20; I<sup>2</sup> = 83%), studies that included participants with leg pain or neurologic symptoms (MD ‐15.9, 95% CI ‐20.9 to ‐10.9; participants = 1382; studies = 13; study groups = 15; I<sup>2</sup> = 74%), and studies that did not specify (MD ‐11.2, 95% CI ‐14.7 to ‐7.8; participants = 548; studies = 8; study groups = 12; I<sup>2</sup> = 15%) (<a href="./references#CD009790-fig-0020" title="">Analysis 4.1</a>). </p> <p>The pooled mean difference in pain outcomes at earliest follow‐up for exercise treatment interventions compared to other conservative treatment groups were: studies that excluded participants with leg pain or neurologic symptoms (MD ‐9.5, 95% CI ‐14.6 to ‐4.4; participants = 1657; studies = 19; study groups = 23; I<sup>2</sup> = 88%), studies that included participants with leg pain or neurologic symptoms (MD ‐4.9, 95% CI ‐9.1 to ‐0.7; participants = 2766; studies = 27; study groups = 35; I<sup>2</sup> = 85%), and studies that did not specify (MD ‐13.7, 95% CI ‐20.0 to ‐7.4; participants = 1872; studies = 18; study groups = 27; I<sup>2</sup> = 93%) (<a href="./references#CD009790-fig-0021" title="">Analysis 4.2</a>). </p> </section> <section id="CD009790-sec-0073"> <h6 class="title">Type of conservative treatment comparison</h6> <p>The pooled mean difference in pain at earliest follow‐up period for exercise treatments compared to other conservative treatments were: education comparisons (MD ‐12.2, 95% CI ‐19.4 to ‐5.0; participants = 2039; studies = 20; study groups = 26, I<sup>2</sup> = 94%), manual therapy comparisons (MD 1.0, 95% CI ‐3.1 to 5.1; participants = 1632; studies = 12; study groups = 18; I<sup>2</sup> = 74%), electrotherapy comparisons (MD ‐10.3, 95% CI ‐23.9 to 3.2; participants = 200; studies = 3; study groups = 6; I<sup>2</sup> = 91%), non‐exercise physical therapy comparisons (MD ‐10.4, 95% CI ‐15.2 to ‐5.6; participants = 1869; studies = 21; study groups = 26; I<sup>2</sup> = 89%) and back school (MD ‐14.0, 95% CI ‐22.7 to ‐5.6; participants = 241; studies = 3; study groups = 3; I<sup>2</sup> = 66%). Fewer than three studies were available for each of the other comparison treatments: psychological therapy, relaxation, anti‐inflammatories (<a href="./references#CD009790-fig-0024" title="">Analysis 5.1</a>). </p> </section> </section> </section> <section id="CD009790-sec-0074"> <h4 class="title">Functional limitations outcomes</h4> <p>Eighty‐eight studies provided data on 8946 participants for earliest functional limitations outcomes comparing exercise treatment to other comparisons (35% of studies, 37% of participants) (<a href="./references#CD009790-fig-0008" title="">Analysis 1.5</a>). </p> <section id="CD009790-sec-0075"> <h5 class="title">Exercise treatment versus no treatment, usual care or placebo</h5> <p>Thirty‐eight studies (50 study groups) provided data on 2942 participants comparing exercise treatment to no treatment comparisons (including usual care and placebo) on functional limitations outcomes. The pooled mean difference in functional limitations with exercise treatment compared to no treatment comparisons at the earliest follow‐up point was ‐6.8 (95% CI ‐8.3 to ‐5.3; I<sup>2</sup> = 38%). This effect did not meet our prespecified threshold for minimal clinically important difference in functional limitations outcomes. The prediction interval describing the expected range of true effect in similar studies is ‐13.2 to ‐0.4. </p> <p>This evidence was judged to be moderate certainty for the comparison of exercise treatment to no treatment comparisons. The certainty of the evidence was downgraded due to potential publication bias. There were no serious concerns due to inconsistency, indirectness, or imprecision. Nine studies (13 groups; 495 participants) were judged to have high risk of bias (17% of participant data), however, exclusion of these studies in sensitivity analysis did not change conclusions so the certainty of evidence was not downgraded further (<a href="./full#CD009790-tbl-0001">summary of findings Table 1</a>; <a href="#CD009790-fig-0003">Figure 3</a>). </p> <p>Separate post hoc analysis of placebo treatments compared to exercise treatments in studies providing functional limitations outcome data (3 studies; 400 participants) found a pooled mean difference of ‐5.6 (95% CI ‐11.2 to ‐0.01; I<sup>2</sup> = 33%) (<a href="./references#CD009790-fig-0034" title="">Analysis 9.2</a>). </p> </section> <section id="CD009790-sec-0076"> <h5 class="title">Exercise treatment versus other conservative treatments</h5> <p>Fifty‐two studies (69 study groups) provided data on 6004 participants comparing exercise treatment to other conservative treatment comparisons. The pooled mean difference in functional limitations with exercise treatment compared to other conservative treatments at the earliest follow‐up point was ‐4.1 (95% CI ‐6.0 to ‐2.2; I<sup>2</sup> = 82%). This improvement did not meet our prespecified threshold for clinically important difference in functional limitations outcomes, but is probably meaningful. The prediction interval describing the expected range of true effect in similar studies is ‐17.6 to 9.3. </p> <p>This evidence was judged to be moderate certainty for the comparison of exercise treatment to other conservative treatment. The certainty of the evidence was downgraded due to inconsistency (substantial heterogeneity), however, this  was partially explained by exploration of the effect in specific comparison subgroups. There were no serious concerns due to indirectness, imprecision, or publication bias. Seven studies (9 groups; 571 participants) were judged to have high risk of bias (10% of participant data), however, exclusion of these studies in sensitivity analysis did not change conclusions so the certainty of evidence was not downgraded further (<a href="./full#CD009790-tbl-0002">summary of findings Table 2</a>; <a href="#CD009790-fig-0003">Figure 3</a>). </p> </section> <section id="CD009790-sec-0077"> <h5 class="title">Short, medium and long‐term follow‐up periods</h5> <p>Data about functional limitations outcomes for the short‐term follow‐up period (approximately three months) were available for exercise treatment compared to no treatment comparisons (MD ‐7.4, 95% CI ‐9.2 to ‐5.6; participants = 2555; studies = 30; study groups = 41; I<sup>2</sup> = 43%) (<a href="./references#CD009790-fig-0009" title="">Analysis 1.6</a>). This mean effect did not meet our prespecified threshold for clinically important difference. Similar results were observed for medium‐term (approximately six months) (MD ‐6.6, 95% CI ‐8.3 to ‐4.8; participants = 1831; studies = 22; study groups = 25; I<sup>2</sup> = 21%) (<a href="./references#CD009790-fig-0010" title="">Analysis 1.7</a>) and for long‐term follow‐up periods (approximately 12 months) (MD ‐4.4, 95% CI ‐7.3 to ‐1.5; participants = 550; studies = 6; study groups = 6; I<sup>2</sup> = 0%) (<a href="./references#CD009790-fig-0011" title="">Analysis 1.8</a>). </p> <p>For exercise treatment compared to all other conservative treatments investigated at specific follow‐up periods, data at short‐term follow‐up is probably meaningful (MD ‐4.0, 95% CI ‐6.0 to ‐1.9; participants = 5541; studies = 44; study groups = 58; I<sup>2</sup> = 82%) (<a href="./references#CD009790-fig-0009" title="">Analysis 1.6</a>). For medium‐term follow‐up (MD ‐2.2, 95% CI ‐4.5 to 0.1; participants = 3531; studies = 29; study groups = 40; I<sup>2</sup> = 77%) (<a href="./references#CD009790-fig-0010" title="">Analysis 1.7</a>) and long‐term follow‐up periods (MD 0.3, 95% CI ‐2.2 to 2.7; participants = 2816; studies = 15; study groups = 21; I<sup>2</sup> = 71%), smaller non‐significant differences were observed (<a href="./references#CD009790-fig-0011" title="">Analysis 1.8</a>). </p> </section> <section id="CD009790-sec-0078"> <h5 class="title">Subgroup analyses</h5> <p>Subgroup analyses explored the impact of population source, symptom duration, study participants with leg pain or neurologic symptoms, and specific type of conservative treatment comparison. </p> <section id="CD009790-sec-0079"> <h6 class="title">Population source</h6> <p>Exploring population source, the pooled mean difference in functional limitations at the earliest follow‐up period for exercise treatments compared to no treatment groups were: healthcare study populations (MD ‐7.9, 95% CI ‐10.0 to ‐5.7; participants = 1900; studies = 22; study groups = 28; I<sup>2</sup> = 50%), occupational populations (MD ‐3.4, 95% CI ‐7.1 to 0.4; participants = 237; studies = 4; study groups = 5; I<sup>2</sup> = 11%), and general or mixed populations (MD ‐5.7, 95% CI ‐8.4 to ‐2.9; participants = 651; studies = 9; study groups = 13; I<sup>2</sup> = 14%) (<a href="./references#CD009790-fig-0014" title="">Analysis 2.3</a>). </p> <p>For exercise treatment compared to other conservative treatments, the pooled mean difference in functional limitations at the earliest follow‐up period were: healthcare study populations (MD ‐3.3, 95% CI ‐6.2 to ‐0.4; participants = 2488; studies = 28; study groups = 35; I<sup>2</sup> = 86%), occupational study populations (MD ‐2.1, 95% CI ‐7.0 to 2.9; participants = 583; studies = 4; study groups = 6; I<sup>2</sup> = 81%), and general or mixed populations (MD ‐5.4, 95% CI ‐8.1 to ‐2.7; participants = 2873; studies = 19; study groups = 27; I<sup>2</sup> = 72%) (<a href="./references#CD009790-fig-0015" title="">Analysis 2.4</a>). </p> </section> <section id="CD009790-sec-0080"> <h6 class="title">Symptom duration</h6> <p>Exploring functional limitations outcome results at the earliest follow‐up period according to the symptom duration of the study population, the pooled mean difference for exercise treatments compared to no treatment groups were: moderate symptom duration studies of 12 weeks to three years (MD ‐4.7, 95% CI ‐7.1 to ‐2.4; participants = 543; studies = 8; study groups = 11; I<sup>2</sup> = 3%), long symptom duration &gt; three years (MD ‐5.6, 95% CI ‐7.4 to ‐3.7; participants = 1295; studies = 13; study groups = 17; I<sup>2</sup> = 0%), and for studies that did not specify symptom duration (MD ‐8.5, 95% CI ‐11.4 to ‐5.6; participants = 1104; studies = 17; study groups = 22; I<sup>2</sup> = 62%) (<a href="./references#CD009790-fig-0018" title="">Analysis 3.3</a>). </p> <p>The pooled mean difference for exercise treatments compared to other conservative treatment groups were: moderate symptom duration studies of 12 weeks to three years (MD ‐4.8, 95% CI ‐7.8 to ‐1.8; participants = 1736; studies = 15; study groups = 21; I<sup>2</sup> = 77%), long symptom duration &gt; three years (MD ‐4.9, 95% CI ‐8.5 to ‐1.2; participants = 2076; studies = 15; study groups = 21; I<sup>2</sup> = 82%) and for studies that did not specify symptom duration (MD ‐3.0, 95% CI ‐6.2 to 0.2; participants = 2192; studies = 22; study groups = 27; I<sup>2</sup> = 85%) (<a href="./references#CD009790-fig-0019" title="">Analysis 3.4</a>). </p> </section> <section id="CD009790-sec-0081"> <h6 class="title">Study participants with leg pain or neurologic symptoms</h6> <p>Exploring functional limitations outcome results at the earliest follow‐up period according to the inclusion of study participants with leg pain or neurologic symptoms, the pooled mean difference for exercise treatments compared to no treatment groups were: studies that excluded participants with leg pain or neurologic symptoms (MD ‐6.0, 95% CI ‐8.1 to ‐3.9; participants = 983; studies = 15; study groups = 21; I<sup>2</sup> = 24%), studies that included participants with leg pain or neurologic symptoms (MD ‐6.6, 95% CI ‐8.4 to ‐4.9; participants = 1676; studies = 17; study groups = 20; I<sup>2</sup> = 7%), and studies that did not specify (MD ‐7.3, 95% CI ‐13.5 to ‐1.2; participants = 283; studies = 6; study groups = 9; I<sup>2</sup> = 73%) (<a href="./references#CD009790-fig-0022" title="">Analysis 4.3</a>). </p> <p>The pooled mean difference in functional limitations outcomes at the earliest follow‐up for exercise treatment interventions compared to other conservative treatment groups were: studies that excluded participants with leg pain or neurologic symptoms (MD ‐5.9, 95% CI ‐8.9 to ‐2.9; participants = 2022; studies = 19; study groups = 25; I<sup>2</sup> = 83%), studies that included participants with leg pain or neurologic symptoms (MD ‐0.9, 95% CI ‐3.50 to 1.71; participants = 2789; studies = 20; study groups = 27; I<sup>2</sup> = 77%), and studies that did not specify (MD ‐6.7, 95% CI ‐10.5 to ‐2.9; participants = 1193; studies = 13; study groups = 17; I<sup>2</sup> = 73%) (<a href="./references#CD009790-fig-0023" title="">Analysis 4.4</a>). </p> </section> <section id="CD009790-sec-0082"> <h6 class="title">Type of conservative treatment comparison</h6> <p>The pooled mean difference in functional limitations at the earliest follow‐up period for exercise treatments compared to other conservative treatments were: education comparisons (MD ‐8.0, 95% CI ‐10.8 to ‐5.3; participants = 2598; studies = 19; study groups = 26; I<sup>2</sup> = 78%), manual therapy comparisons (MD 1.5, 95% CI ‐1.5 to 4.4; participants = 1637; studies = 12; study groups = 18; I<sup>2</sup> = 64%), non‐exercise physical therapy comparisons (MD ‐4.3, 95% CI ‐9.0 to 0.4; participants = 1074; studies = 12; study groups = 13; I<sup>2</sup> = 89%), and electrotherapy comparisons (MD ‐3.8, 95% CI ‐10.1 to 2.4; participants = 248; studies = 4; study groups = 6; I<sup>2</sup> = 71%). Fewer than three studies were available for each of the other comparison treatments: psychological therapy, back school, relaxation, and anti‐inflammatories (<a href="./references#CD009790-fig-0025" title="">Analysis 5.2</a>). </p> </section> </section> </section> <section id="CD009790-sec-0083"> <h4 class="title">Sensitivity analyses</h4> <p>The results were robust to assumptions about data, functional limitations outcome measures, risk of bias, and excluding trial mean difference data that were judged to be improbable or outlying. To test assumptions about data, we omitted studies that required imputation of data to represent the follow‐up outcomes standard deviations, or where assumptions about the normality of the data were questionable; this omitted 28 studies (28%; 43 groups; 2696 participants) from the primary pain outcome meta‐analysis, and 21 studies (23%; 30 groups; 2127 participants) from the primary functional limitations outcome meta‐analysis, however, interpretation of results did not change. This sensitivity analysis resulted in pooled estimates of mean differences for pain and functional limitations outcomes for exercise treatment compared to any other intervention at the earliest follow‐up of MD ‐12.1 (95% CI ‐15.5 to ‐8.7; I<sup>2</sup> = 93%) (<a href="./references#CD009790-fig-0026" title="">Analysis 6.1</a>) and MD ‐5.5 (95% CI ‐7.1 to ‐3.9; I<sup>2</sup> = 77%) (<a href="./references#CD009790-fig-0027" title="">Analysis 6.2</a>), respectively. </p> <p>We omitted 35 studies (39%; 45 groups; 2718 participants omitted) to synthesise outcome results for only studies that measured functional limitations using the Roland‐Morris Disability Questionnaire. This sensitivity analysis resulted in a pooled estimate of mean difference for functional limitations outcomes for exercise treatment compared to any other intervention at earliest follow‐up of MD ‐6.3 (95% CI ‐8.3 to ‐4.3; I<sup>2</sup> = 78%) with similar effect size and heterogeneity observed (<a href="./references#CD009790-fig-0028" title="">Analysis 6.3</a>). </p> <p>We omitted studies that were judged to have high risk of bias; this omitted 18 studies (18%; 24 groups; 1361 participants) from the primary pain outcome meta‐analysis, and 16 studies (18%; 22 groups; 1066 participants) from the primary functional limitations outcome meta‐analysis. This sensitivity analysis resulted in pooled estimates of mean differences for pain and functional limitations outcomes for exercise treatment compared to any other intervention at earliest follow‐up of MD ‐11.2 (95% CI ‐14.1 to ‐8.3; I<sup>2</sup> = 91%) (<a href="./references#CD009790-fig-0029" title="">Analysis 7.1</a>) and MD ‐5.6 (95% CI ‐7.1 to ‐4.1; I<sup>2</sup> = 77%) (<a href="./references#CD009790-fig-0030" title="">Analysis 7.2</a>), respectively. We conducted a post hoc sensitivity analysis to explore the impact of RoB 1 potentially underestimating bias due to blinding (performance bias and detection bias), and RoB 2 potentially overestimating bias due to outcome measure blinding. These results did not change our results or conclusions (results not presented). </p> <p>To test robustness of our results, we conducted primary analyses excluding trial data that were judged to be improbable or outlying typical results in the field. These sensitivity analyses resulted in exclusion of data from 12 studies in primary pain outcome meta‐analysis comparisons (12%; 17 groups; 1024 participants) (<a href="./references#CD009790-fig-0031" title="">Analysis 8.1</a>), and four studies were excluded in primary functional limitations outcome meta‐analysis comparisons (4%; 8 groups; 516 participants) (<a href="./references#CD009790-fig-0032" title="">Analysis 8.2</a>). These results did not change any conclusions, however average effect sizes and heterogeneity observed were smaller for pain and functional limitations outcomes when outliers were omitted. Results were less heterogeneous, and still showed strong effectiveness of exercise treatment, although not meeting our criteria for a clinically important difference compared to no treatment for pain outcome (MD ‐11.5, 95% CI ‐13.8 to ‐9.2; I<sup>2</sup> = 47%). </p> </section> <section id="CD009790-sec-0084"> <h4 class="title">Importance of population and exercise intervention characteristics</h4> <p>The effects of specific types of exercise treatments and delivery characteristics on pain and functional limitations outcomes were investigated in a companion publication. Detailed network meta‐analysis methods and results are presented in <a href="./references#CD009790-bbs2-0530" title="HaydenJA , EllisJ , OgilvieR , StewartS , BaggMK , StanojevicS , YamatoTP , SaragiottoBT . Some types of exercise are more effective than others in people with chronic low back pain: a network meta-analysis. Journal of Physiotherapy2021;67(4):252-62.">Hayden 2021b</a>. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009790-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009790-sec-0085"></div> <p>This review is an updated assessment of the effectiveness of exercise for treatment of chronic non‐specific low back pain. A tremendous number of RCTs have been published since the last publication of the Cochrane review (more than 200 additional studies included in this review). We identified potential research integrity concerns and excluded 30 trials that otherwise met selection criteria. We included 249 RCTs (24,486 participants), with 203 trials providing sufficient data for meta‐analyses (19,633 participants): 142 RCTs compared exercise to non‐exercise comparisons (117 with data for meta‐analyses), and 151 compared different types of exercise treatments. Despite considering study‐level sources of clinical heterogeneity, the studies within meta‐analyses were heterogeneous. However, we found consistent results across primary, subgroup and sensitivity analyses to draw conclusions about the effectiveness of exercise for treatment of chronic low back pain described below. </p> <section id="CD009790-sec-0086"> <h3 class="title" id="CD009790-sec-0086">Summary of main results</h3> <p>This systematic review provides useful information for primary care clinicians to help guide their patient management and referral practices. </p> <p>There is moderate‐certainty evidence that exercise treatment is probably more effective than no treatment, usual care or placebo for pain intensity and functional limitations outcomes. For pain intensity outcomes, our findings are most compatible with a clinically important difference of 15 points compared to no treatment; for functional limitations outcomes, the mean effect  did not meet our prespecified threshold for minimal clinically important difference. The observed effect sizes would likely be smaller for comparison to placebo only.  </p> <p>There is low to moderate‐certainty evidence that there is a small difference in pain and functional limitations for exercise treatment compared with other conservative treatments. The effect size did not meet our prespecified threshold of clinically important group‐level difference, but is larger than mean effects reported for other treatments for low back pain. For example, a recent systematic review of spinal manipulation for chronic low back pain found that a mean difference of spinal manipulation compared with non‐recommended therapies was ‐7.5 (95% CI ‐11.5 to ‐3.5) for short‐term pain relief (<a href="./references#CD009790-bbs2-0566" title="RubinsteinSM , De ZoeteA , Van MiddelkoopM , AssendelftWJJ , De BoerMR , Van TulderMW . Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials. British Medical Journal2019;364(1689):1-15.">Rubinstein 2019</a>); a systematic review of behavioural treatment reported an overall mean difference of ‐5.2 (95% CI ‐9.8 to ‐0.6) compared to usual care for short‐term pain relief (<a href="./references#CD009790-bbs2-0534" title="HenschkeN , OsteloRW , Van TulderMW , VlaeyenJW , MorleyS , AssendelftWJ , et al. Behavioural treatment for chronic low-back pain. Cochrane Database of Systematic Reviews2010, Issue 7. Art. No: CD002014. [DOI: 10.1002/14651858.CD002014.pub3]">Henschke 2010</a>); and another review found improvement in pain outcomes with back school compared to no treatment to be a mean difference of ‐6.1 (95% CI ‐10.2 to ‐2.0) (<a href="./references#CD009790-bbs2-0558" title="ParreiraP , HeymansMW , Van TulderMW , EsmailR , KoesBW , PoquetN , et al. Back Schools for chronic non-specific low back pain. Cochrane Database of Systematic Reviews2017, Issue 8. Art. No: CD011674. [DOI: 10.1002/14651858.CD011674.pub2]">Parreira 2017</a>). </p> <p>Data from 64 trials comparing exercise treatment to other conservative treatments found exercise to be more effective, although the effect size was small and not clinically important overall (9 points improvement in pain; 4 points improvement in functional limitations); comparisons with some specific other conservative treatments (e.g. electrotherapy, education alone) showed exercise treatments to have larger improvements compatible with a clinically important difference. </p> <p>Adverse effects of exercise treatment were rarely reported. When they were reported, those likely to be related to the intervention mainly included increased low back pain and muscle soreness. </p> </section> <section id="CD009790-sec-0087"> <h3 class="title" id="CD009790-sec-0087">Overall completeness and applicability of evidence</h3> <p>This review included numerous studies across geographic locations and settings. Most studies were conducted in healthcare settings where exercise treatments are often delivered, making this evidence applicable to clinical practice. However, fewer studies were available in community settings. Only nine studies conducted in occupational settings contributed data to primary meta‐analyses, limiting the strength of this evidence. Subgroup analyses suggested that the results are applicable to healthcare, occupational and general/mixed populations. </p> <p>A broad range of exercise treatments were investigated in the included studies. We classified treatment groups according to exercise types; the most common types included were core strengthening and mixed exercise types. We also classified exercises by design and delivery characteristics. The most common design was standardised (e.g. an aerobics class delivered to all participants), delivered in either a group or individually‐supervised format, with a median of 12 hours of exercise time delivered over a median of eight weeks. These most common exercise characteristics are in line with current clinical practice in most regions, suggesting applicability of our findings. We may have misclassified studies based on the (often) brief descriptions available in study reports. By design, we aimed to include studies that met a broad definition of exercise treatment. By using a broad definition, the evidence remains relevant to many stakeholders, and allows assessment of the impact of delivery and design characteristics, which our team found to be important in previous analyses. This broad inclusion likely contributed to the heterogeneity across studies. </p> <p>Comparison interventions for exercise treatment in the included studies were no treatment, usual care, placebo and various other conservative treatments. There are few studies comparing exercise treatment to several conservative treatments that are described as effective for treating chronic low back pain in the NICE (<a href="./references#CD009790-bbs2-0556" title="National Guideline Centre. National Institute for Health and Care Excellence: Clinical Guidelines. In: Low Back Pain and Sciatica in Over 16s: Assessment and Management. London: National Institute for Health and Care Excellence (UK), 2016.">National Guideline Centre 2016</a>) or ACP (<a href="./references#CD009790-bbs2-0560" title="QaseemA , WiltTJ , McLeanRM , ForcieaMA . Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine2017;166(7):514-30.">Qaseem 2017</a>) practice guidelines, including NSAIDS (NICE and ACP recommended), psychological therapies (NICE and ACP recommended), acupuncture (ACP recommended), and tramadol or duloxetine (described as second‐line treatment options in the ACP guidelines). If any, future trials on exercise treatment should evaluate effectiveness and cost‐effectiveness compared with other effective therapies, as this will guide clinicians in their choice for the best treatment. </p> <p>In a related investigation, we found a dearth of complete reporting of study methods, participant characteristics and results. Over 30% of studies did not report data comparable to a CONSORT flow chart, 25% of studies did not fully report their method of randomisation, and 33% of studies did not adequately report allocation concealment. Half of the included studies failed to report a set of minimal baseline characteristics (age, sex, baseline pain intensity, duration of low back pain). These reporting gaps raise questions about methods and potential biases. Additionally, a substantial proportion of the eligible studies, almost 20%, that measured our primary outcomes did not report data completely or in a form usable in our meta‐analyses. If we had not imputed missing values, 38% of studies would have been omitted from analysis as only 62% reported complete usable data. There is a dire need for better reporting of trials. We suggest trialists use the CONSORT tool when reporting trials. However, there is also a need for journal editors to more strictly check whether trial manuscripts meet the recommendations of these tools. </p> <p>Many of the included studies, particularly more recently published studies, had very small sample sizes (median = 70, IQR: 42 to 125 participants per study; median = 30 per group). Only 26% of included trials had sufficient sample sizes for greater than or equal to 80% power. Fewer than 20% had sufficient sample size to find a statistically significant difference in the treatment effect for a planned realistic observed effect. Exercise is by far the most studied intervention for low back pain. Additional small trials will not add anything to the current evidence. </p> <p>Despite these gaps in reporting, we think that it is unlikely that inclusion of data from excluded studies would change the conclusions reached in our review. </p> </section> <section id="CD009790-sec-0088"> <h3 class="title" id="CD009790-sec-0088">Quality of the evidence</h3> <p>Overall, there was moderate‐quality evidence for the effectiveness of exercise treatment compared to no treatment, usual care or placebo, and low to moderate compared to other conservative treatments for pain and functional limitations outcomes. Evidence was downgraded mainly due to heterogeneity across primary analyses, which could not be explained by study and population‐level characteristics assessed in subgroup and sensitivity analyses. Considerable heterogeneity in comparisons of exercise with other conservative treatments could be partially explained by specific comparison treatment subgroups. </p> <p>We recorded and explored the impact of several sources of heterogeneity, including setting, population, exercise and comparison interventions, outcomes and study design characteristics. Statistical heterogeneity as assessed with the I‐squared measure, was substantial in most primary analyses (I<sup>2</sup> = 60‐90%) and remained moderate to substantial in most subgroup and sensitivity analyses. </p> <p>There are several additional important sources of heterogeneity when considering the effectiveness of exercise treatment, including heterogeneity in the exercise treatments, comparison interventions, and individual patient level differences. Our primary analyses considered all types of exercise treatment together. We recognise that these represent a very heterogeneous set of interventions. However, there is limited evidence that one specific type of exercises is more effective than others (<a href="./references#CD009790-bbs2-0517" title="FosterNE , AnemaJR , CherkinD , ChouR , CohenSP , GrossDP , et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet2018;391(10137):2368-83.">Foster 2018</a>). Clinical guidelines recommend exercise programmes that take individual needs, preferences, and capabilities into account. We think that there is value to look broadly at exercise treatment as an intervention since there are likely to be common mechanisms of effect. Further research is needed to better define and assess the most effective components. Exploration of individual level patient characteristics and their relationship with the effectiveness of exercise was beyond the scope of this review, however, is important to consider in future research (<a href="./references#CD009790-bbs2-0549" title="MalmivaaraA . Generalizability of findings from randomized controlled trials is limited in the leading general medical journals. Journal of Clinical Epidemiology2019;107:36-41.">Malmivaara 2019</a>). </p> <p>The included studies broadly represented the heterogeneous chronic low back pain population, so we did not rate down the quality of evidence available for indirectness. Precision was high for the estimates of treatment effect for both pain and functional limitations outcomes due to the large number of trials, and thus participants, available for all primary analysis comparisons. There was evidence of potential publication bias in the analysis of exercise versus other conservative treatment for pain data, and for functional limitations outcomes for exercise versus no treatment, usual care or placebo; we downgraded the certainty of the evidence in these analyses due to this potential publication bias. No evidence of publication bias (Egger’s test for funnel plot asymmetry) was found for other analyses. </p> </section> <section id="CD009790-sec-0089"> <h3 class="title" id="CD009790-sec-0089">Potential biases in the review process</h3> <p>Our systematic review, and the evidence presented within, has numerous strengths afforded by our structured processes, comprehensive search, assessment, and the large number of studies available. Limitations in our review are mainly related to potential selection and publication biases. A further source of both the limitations and strengths of this review is the sheer volume of included studies and, as a result, the duration of time to complete the review. </p> <p>In the interest of completing this review, we were not able to extract data and incorporate results from 152 trials from our most recent electronic search update. We also identified 20 non‐English language publications, however, we were not able to translate these in time for submission. These 172 studies are ‘awaiting assessment’. Considering the limited change in the conclusions of this systematic review since the last publication in 2005, and the limited impact of multiple subgroup and sensitivity analyses on interpretation of results, we do not expect that the addition of more study data will result in a change of the overall conclusions. </p> <p>At least two reviewers independently assessed trials for inclusion, extracted and checked data, and assessed risk of bias, with a third reviewer adjudicating any discrepancies. Because of the long duration to complete this review, the personnel involved in the review changed. At each search update (generally yearly) all extracted data were cleaned and re‐checked to ensure consistency. This impacted the efficiency of review completion; however, we do not believe that this negatively impacted the reliability of the data. Indeed, it resulted in a very transparent and well documented process of electronic data capture and data validation as all data extraction was moved to <a href="./references#CD009790-bbs2-0509" title="Distiller SR. Ottawa, ON: Evidence Partners, 2020.">Distiller SR</a>. </p> <p>Additional limitations of our systematic review methods related to length of time to complete this review were due to changes in systematic review methods recommendations since approval of our protocol in 2012. Recommendations for risk of bias assessment changed over the course of our review. We used the Cochrane Back and Neck group operationalisation of the Cochrane RoB 1 tool with high risk of bias defined by a threshold cut‐point of the 12 tool items assessed based on the primary pain and functional limitations outcomes (both self‐report). This threshold may have misclassified studies as high or low risk of bias. We do not think that this introduced systematic bias; sensitivity analyses modifying the assessment of blinding did not change our conclusions. </p> <p>Despite feasibility limitations, there are benefits to our large systematic review and overarching review question. We were able to observe patterns in the study reports and data that may be missed with smaller focussed systematic reviews. A comprehensive investigation of research integrity characteristics was prompted by identification of exact duplication of data in two eligible studies (identified during a data checking stage prior to primary analyses). We defined integrity characteristics, planned and implemented additional data extraction without consideration of study results, and conducted analyses with studies blinded (identified by a study ID). This assessment was not described in our original protocol. </p> <p>We have adopted a conservative estimate of clinical importance based on the upper interquartile range estimate of smallest worthwhile effect from a study of physiotherapy treatment for chronic low back pain (<a href="./references#CD009790-bbs2-0516" title="FerreiraML , HerbertRD , FerreiraPH , LatimerJ . The smallest worthwhile effect of nonsteroidal anti-inflammatory drugs and physiotherapy for chronic low back pain: a benefit-harm trade-off study. Journal of Clinical Epidemiology2013;66(12):1397-404.">Ferreira 2013</a>), representing a difference that 75% of participants reported as being worthwhile compared to no treatment. Two recent systematic reviews of drug interventions for low back pain have used a lower smallest worthwhile effect of 10 points for pain and for function. With a higher threshold for important difference in pain outcome, we may have underestimated the clinical importance of the difference for exercise treatments. It is also important to consider that the smallest worthwhile effect estimates are specific for treatment and comparison interventions. The available research (<a href="./references#CD009790-bbs2-0505" title="ChristiansenDH ,   De Vos AndersonNB , PoulsenPH , Ostelo RW. The smallest worthwhile effect of primary care physiotherapy did not differ across musculoskeletal pain sites. Journal of Clinical Epidemiology2018;101:44-52.">Christiansen 2018</a>; <a href="./references#CD009790-bbs2-0516" title="FerreiraML , HerbertRD , FerreiraPH , LatimerJ . The smallest worthwhile effect of nonsteroidal anti-inflammatory drugs and physiotherapy for chronic low back pain: a benefit-harm trade-off study. Journal of Clinical Epidemiology2013;66(12):1397-404.">Ferreira 2013</a>) estimated the smallest worthwhile effect values for physiotherapy treatment compared to no treatment. One might expect different estimates compared to other conservative treatment comparisons, as we have included in this review.  </p> <p>Although we undertook a comprehensive electronic search strategy with no restrictions and searched the reference lists of included studies and other published reviews, we may have missed relevant studies in the search or screening process (our funnel plot analysis of exercise versus other conservative treatments suggests potential publication bias). However, we consider it highly unlikely that we have missed any important, large studies. </p> <p>We contacted authors for missing information but had responses from only 31% of those contacted. We did improve response rates (from 25% to 47%) by moving information requests from email to REDCap electronic survey. The overall low response may have introduced bias in our results if author response was selective. </p> <p>Our definition of research integrity concerns resulting in exclusion of studies from our review was based on a combination of multiple conduct or reporting issues, including serious plagiarism and/or predatory journal publication. We also excluded two trials where there was unexplained exact duplication of study data (unresolved after report to the author institutions and publishing journal editors). Similar criteria have not previously been used to exclude studies from Cochrane reviews. However, we feel strongly that such exclusions are necessary and justified to increase confidence in the evidence base. We may have misclassified and inappropriately excluded useful study data; however, these exclusions did not change our results or conclusions. </p> <p>Future updates of this review will assess evidence for health‐related quality of life and patient‐perceived recovery outcomes, as available. We also plan to use RoB 2 consistently across all studies; although there are challenges with the use of the tool, and lower agreement scores (<a href="./references#CD009790-bbs2-0552" title="MinozziS , CinquiniM , GianolaS , Gonzalez-LorenzoM , BanziR . The revised Cochrane risk-of-bias tool for randomised trials (RoB 2) showed low inter-rater reliability and challenges in its application. Journal of Clinical Epidemiology2020;126:37-44.">Minozzi 2020</a>), this approach has face validity for study/outcome level assessment of potential biases. </p> </section> <section id="CD009790-sec-0090"> <h3 class="title" id="CD009790-sec-0090">Agreements and disagreements with other studies or reviews</h3> <p>Effectiveness of exercise treatment for low back pain is a very active research field. Hundreds of systematic reviews on focussed populations or exercise types have been published in the past 10 years. While there has been an abundance of systematic reviews published on the effectiveness of exercise for low back pain, it is interesting to note that <a href="./references#CD009790-bbs2-0498" title="AlmeidaMO , YamatoTP , ParreiraP , CostaLO , KamperS , SaragiottoBT . Overall confidence in the results of systematic reviews on exercise therapy for chronic low back pain: a cross-sectional analysis using the Assessing the Methodological Quality of Systematic Reviews (AMSTAR) 2 tool. Brazilian Journal of Physical Therapy2020;24(2):103-17.">Almeida 2020</a> found that 74% of the 28 included reviews of “exercise for low back pain” interventions had an overall confidence rating of critically low. All four reviews rated as high (3) or moderate (1) were prospectively registered Cochrane reviews, including the first publication of this review in 2005. This review presents the most comprehensive identification and evaluation of the evidence about the effectiveness of exercise treatment, broadly defined, for treatment of chronic low back pain. In this systematic review, we have drawn similar conclusions to the previous publication of this Cochrane review (<a href="./references#CD009790-bbs2-0587" title="HaydenJA , Van TulderMW , MalmivaaraA , KoesBW . Exercise therapy for treatment of non-specific low back pain. Cochrane Database of Systematic Reviews2005, Issue 3. Art. No: CD000335. [DOI: 10.1002/14651858.CD000335.pub2]">Hayden 2005a</a>), with more confidence, supported by a much larger number of available trials and participants, more robust methods, and several additional analyses. Our observed effect sizes are larger than previously observed. Sensitivity analyses omitting study results that were outlying and considered improbable show smaller effects, however, similar interpretation of effectiveness of exercise treatment. We used this strategy in our primary analysis to present a more conservative and in our opinion more reliable assessment of the evidence. </p> <p>Large reviews of all treatments for low back pain have made similar conclusions about the effectiveness of exercise treatment. A recent update of an Agency for Healthcare Research and Quality (AHRQ) systematic review of non‐pharmacological interventions for chronic musculoskeletal conditions reported moderate‐quality evidence of effectiveness of exercise treatment for chronic low back pain at short‐term follow‐up for function, and low‐quality evidence for pain (all time points) and at medium and long‐term time points for function (<a href="./references#CD009790-bbs2-0571" title="SkellyAC , ChouR , DettoriJR , TurnerJA , FriedlyJL , RundellSD , et al, Agency for Healthcare Research and Quality (US). Noninvasive nonpharmacological treatment for chronic pain: a systematic review update. effectivehealthcare.ahrq.gov/products/nonpharma-treatment-pain/research-2018 (accessed prior to 5 Sept 2021).">Skelly 2020</a>). </p> <p>Overlapping focussed reviews of specific types of exercise therapies include published Cochrane reviews (<a href="./references#CD009790-bbs2-0567" title="SaragiottoBT , MaherCG , YamatoTP , CostaLO , Menezes CostaLC , OsteloR , et al. Motor control exercise for chronic non‐specific low‐back pain. Cochrane Database of Systematic Reviews2016, Issue 1. Art. No: CD012004. [DOI: 10.1002/14651858.CD012004]">Saragiotto 2016</a>; <a href="./references#CD009790-bbs2-0568" title="SchaafsmaFG , WhelanK , Van der BeekAJ , Van der Es‐LambeekLC , OjajärviA , VerbeekJH . Physical conditioning as part of a return to work strategy to reduce sickness absence for workers with back pain. Cochrane Database of Systematic Reviews2013, Issue 8. Art. No: CD001822. [DOI: 10.1002/14651858.CD001822.pub3]">Schaafsma 2013</a>; <a href="./references#CD009790-bbs2-0581" title="WielandLS , SkoetzN , PilkingtonK , VempatiR , D'AdamoCR , BermanBM . Yoga treatment for chronic non‐specific low back pain. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD010671. [DOI: 10.1002/14651858.CD010671]">Wieland 2017</a>; <a href="./references#CD009790-bbs2-0585" title="YamatoTP , MaherCG , SaragiottoBT , HancockMJ , OsteloR , CabralCMN , et al. Pilates for low back pain. Cochrane Database of Systematic Reviews2015, Issue 7. Art. No: CD010265. [DOI: 10.1002/14651858.CD010265]">Yamato 2015</a>), Cochrane protocols (<a href="./references#CD009790-bbs2-0545" title="LiuH , YaoK , ZhangJ , LiL , WuT , BroxJI , et al. Sling exercise therapy for chronic low‐back pain. Cochrane Database of Systematic Reviews2013, Issue 9. Art. No: CD010689. [DOI: 10.1002/14651858.CD010689]">Liu 2013</a>; <a href="./references#CD009790-bbs2-0547" title="MachadoL , LinCWC , ClareH , Van TulderMW . The McKenzie method for (sub)acute non‐specific low‐back pain. Cochrane Database of Systematic Reviews2012, Issue 3. Art. No: CD009711. [DOI: 10.1002/14651858.CD009711]">Machado 2012a</a>; <a href="./references#CD009790-bbs2-0548" title="MachadoL , Van TulderMW , LinCWC , ClareH , HaydenJA . The McKenzie method for chronic non‐specific low‐back pain. Cochrane Database of Systematic Reviews2012, Issue 3. Art. No: CD009712. [DOI: 10.1002/14651858.CD009712]">Machado 2012b</a>) and many recent systematic reviews that have been published outside of the Cochrane Library (<a href="./references#CD009790-bbs2-0497" title="AlhakamiAM , DavisS , QasheeshM , ShapheA , ChahalA . Effects of McKenzie and stabilization exercises in reducing pain intensity and functional disability in individuals with nonspecific chronic low back pain: a systematic review. Journal of Physical Therapy Science2019;31(7):590-7.">Alhakami 2019</a>; <a href="./references#CD009790-bbs2-0555" title="NamnaqaniFI , MashabiAS , YaseenKM , AlshehriMA . The effectiveness of McKenzie method compared to manual therapy for treating chronic low back pain: a systematic review. Journal of Musculoskeletal and Neuronal Interactions2019;19(4):492-9.">Namnaqani 2019</a>; <a href="./references#CD009790-bbs2-0557" title="NiedererD , MuellerJ . Sustainability effects of motor control stabilisation exercises on pain and function in chronic nonspecific low back pain patients: a systematic review with meta-analysis and meta-regression. PLOS One2020;15(1):e0227423.">Niederer 2020</a>; <a href="./references#CD009790-bbs2-0570" title="ShiZ , ZhouH , LuL , PanB , WeiZ , YaoX , et al. Aquatic exercises in the treatment of low back pain: a systematic review of the literature and meta-analysis of eight studies. American Journal of Physical Medicine &amp; Rehabilitation2018;97(2):116-22.">Shi 2018</a>; <a href="./references#CD009790-bbs2-0575" title="VantiC , AndreattaS , BorghiS , GuccioneAA , PillastriniP , BertozziL . The effectiveness of walking versus exercise on pain and function in chronic low back pain: a systematic review and meta-analysis of randomized trials. Disability &amp; Rehabilitation2019;41(6):622-32.">Vanti 2019</a>; <a href="./references#CD009790-bbs2-0580" title="WewegeMA , BoothJ , ParmenterBJ . Aerobic vs. resistance exercise for chronic non-specific low back pain: a systematic review and meta-analysis. Journal of Back and Musculoskeletal Rehabilitation2018;31(5):889-99.">Wewege 2018</a>; Zhang 2019a; <a href="./references#CD009790-bbs2-0586" title="ZouL , ZhangY , YangL , LoprinziPD , YeungAS , KongJ , et al. Are mindful exercises safe and beneficial for treating chronic lower back pain? A systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Medicine2019;8(5):628-54.">Zou 2019b</a>). These reviews have included five to 29 studies on treatments for chronic low back pain ‐ a small proportion of the studies included here with more focussed review questions and selection criteria, and some differences in methods. Similar to our findings, the Cochrane reviews reported low to moderate‐quality evidence that the specific exercise type investigated produced small to moderate improvements in outcome compared to minimal intervention; they similarly reported limited evidence of important differences compared to other types of conservative treatments. Non‐Cochrane reviews, often on focussed topics with a small number of included studies, usually reported significant favourable results, often not meeting minimal clinically important outcomes. </p> <p>We believe that the most effective components and approach of exercise treatments for low back pain patients have yet to be confirmed. Effectiveness studies have only recently raised the importance of considering likely mechanisms of effect and few available trials appear to have planned their interventions considering potentially effective mechanisms (<a href="./references#CD009790-bbs2-0582" title="WoodL , FosterN , HaydenJA . Workshop WB8: Agreeing on treatment targets for future trials of exercise for back pain. In: International Back and Neck Forum; 2019 July 4; Quebec City, Canada. 2019.">Wood 2019</a>; <a href="./references#CD009790-bbs2-0584" title="WoodL , FosterNE , LewisM , BishopA . Exercise interventions for persistent non-specific low back pain - does matching outcomes to treatment targets make a difference? A systematic review and meta-analysis. Journal of Pain2021;22(2):107-26.">Wood 2021</a>). Exercise treatments investigated have been heterogeneous in treatment design, dose, delivery format, specific exercise types, and are often combined with other conservative treatments (<a href="./references#CD009790-bbs2-0515" title="FerreiraML , SmeetsRJ , KamperSJ , FerreiraPH , MachadoLA . Can we explain heterogeneity among randomized clinical trials of exercise for chronic back pain? A meta-regression analysis of randomized controlled trials. Physical Therapy2010;90(10):1383-403.">Ferreira 2010</a>). Even with the large number of trials included in this review, remaining heterogeneity, incomplete descriptions and our potential misclassification makes this difficult to tease apart. Our prior work found that exercise design and delivery characteristics were statistically associated with improved effectiveness for pain and functional limitations outcomes, more so than specific exercise types (<a href="./references#CD009790-bbs2-0587" title="HaydenJA , Van TulderMW , MalmivaaraA , KoesBW . Exercise therapy for treatment of non-specific low back pain. Cochrane Database of Systematic Reviews2005, Issue 3. Art. No: CD000335. [DOI: 10.1002/14651858.CD000335.pub2]">Hayden 2005a</a>; <a href="./references#CD009790-bbs2-0588" title="HaydenJA , Van TulderMW , MalmivaaraAV , KoesBW . Meta-analysis: exercise therapy for nonspecific low back pain. Annals of Internal Medicine2005;142(9):765-75.">Hayden 2005b</a>; <a href="./references#CD009790-bbs2-0525" title="HaydenJA , Van TulderMW , TomlinsonG . Systematic review: strategies for using exercise therapy to improve outcomes in chronic low back pain. Annals of Internal Medicine2005;142(9):776-85.">Hayden 2005c</a>). Our related network meta‐analysis study (<a href="./references#CD009790-bbs2-0530" title="HaydenJA , EllisJ , OgilvieR , StewartS , BaggMK , StanojevicS , YamatoTP , SaragiottoBT . Some types of exercise are more effective than others in people with chronic low back pain: a network meta-analysis. Journal of Physiotherapy2021;67(4):252-62.">Hayden 2021b</a>) found Pilates, McKenzie therapy and functional restoration exercises were more effective than other exercise types for reducing pain and functional limitations. The results in this network meta‐analysis were consistent for the benefits of other conservative treatments added to an exercise treatment, and greater benefits of higher dose.  </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009790-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009790-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Summary characteristics of included studies." data-id="CD009790-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Summary characteristics of included studies.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Funnel plots for primary analyses (x axis = mean difference). Earliest follow‐up study results for: 1. Pain outcome: a. exercise compared to placebo, no treatment or usual care, b. exercise compared to other conservative treatments; and 2. Functional limitations: c. exercise compared to no treatment, usual care or placebo, d. exercise compared to other conservative treatments." data-id="CD009790-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Funnel plots for primary analyses (x axis = mean difference). Earliest follow‐up study results for: 1. Pain outcome: a. exercise compared to placebo, no treatment or usual care, b. exercise compared to other conservative treatments; and 2. Functional limitations: c. exercise compared to no treatment, usual care or placebo, d. exercise compared to other conservative treatments. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: PRIMARY ANALYSES, Outcome 1: Pain (/100): Earliest follow‐up" data-id="CD009790-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: PRIMARY ANALYSES, Outcome 1: Pain (/100): Earliest follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: PRIMARY ANALYSES, Outcome 2: Pain (/100): Short‐term follow‐up (6‐12 weeks)" data-id="CD009790-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: PRIMARY ANALYSES, Outcome 2: Pain (/100): Short‐term follow‐up (6‐12 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: PRIMARY ANALYSES, Outcome 3: Pain (/100): Medium‐term follow‐up (~6 months)" data-id="CD009790-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: PRIMARY ANALYSES, Outcome 3: Pain (/100): Medium‐term follow‐up (~6 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: PRIMARY ANALYSES, Outcome 4: Pain (/100): Long‐term follow‐up (&gt; 12 months)" data-id="CD009790-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: PRIMARY ANALYSES, Outcome 4: Pain (/100): Long‐term follow‐up (&gt; 12 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: PRIMARY ANALYSES, Outcome 5: Function (/100): Earliest follow‐up" data-id="CD009790-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: PRIMARY ANALYSES, Outcome 5: Function (/100): Earliest follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: PRIMARY ANALYSES, Outcome 6: Function (/100): Short‐term follow‐up (6‐12 weeks)" data-id="CD009790-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: PRIMARY ANALYSES, Outcome 6: Function (/100): Short‐term follow‐up (6‐12 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: PRIMARY ANALYSES, Outcome 7: Function (/100): Medium‐term follow‐up (~6 months)" data-id="CD009790-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: PRIMARY ANALYSES, Outcome 7: Function (/100): Medium‐term follow‐up (~6 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: PRIMARY ANALYSES, Outcome 8: Function (/100): Long‐term follow‐up (&gt; 12 months)" data-id="CD009790-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: PRIMARY ANALYSES, Outcome 8: Function (/100): Long‐term follow‐up (&gt; 12 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SUBGROUP ANALYSES (Population source), Outcome 1: Pain (/100); Earliest follow‐up; Exercise vs. no treatment or usual care" data-id="CD009790-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: SUBGROUP ANALYSES (Population source), Outcome 1: Pain (/100); Earliest follow‐up; Exercise vs. no treatment or usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SUBGROUP ANALYSES (Population source), Outcome 2: Pain (/100); Earliest follow‐up; Exercise vs. other conservative treatment" data-id="CD009790-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: SUBGROUP ANALYSES (Population source), Outcome 2: Pain (/100); Earliest follow‐up; Exercise vs. other conservative treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SUBGROUP ANALYSES (Population source), Outcome 3: Function (/100); Earliest follow‐up; Exercise vs. no treatment or usual care" data-id="CD009790-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: SUBGROUP ANALYSES (Population source), Outcome 3: Function (/100); Earliest follow‐up; Exercise vs. no treatment or usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SUBGROUP ANALYSES (Population source), Outcome 4: Function (/100); Earliest follow‐up; Exercise vs. other conservative treatment" data-id="CD009790-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: SUBGROUP ANALYSES (Population source), Outcome 4: Function (/100); Earliest follow‐up; Exercise vs. other conservative treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SUBGROUP ANALYSES (Symptom duration), Outcome 1: Pain (/100): Earliest follow‐up; Exercise vs. no treatment or usual care" data-id="CD009790-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: SUBGROUP ANALYSES (Symptom duration), Outcome 1: Pain (/100): Earliest follow‐up; Exercise vs. no treatment or usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SUBGROUP ANALYSES (Symptom duration), Outcome 2: Pain (/100): Earliest follow‐up; Exercise vs. other conservative treatment" data-id="CD009790-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: SUBGROUP ANALYSES (Symptom duration), Outcome 2: Pain (/100): Earliest follow‐up; Exercise vs. other conservative treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SUBGROUP ANALYSES (Symptom duration), Outcome 3: Function (/100): Earliest follow‐up; Exercise vs. no treatment or usual care" data-id="CD009790-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: SUBGROUP ANALYSES (Symptom duration), Outcome 3: Function (/100): Earliest follow‐up; Exercise vs. no treatment or usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SUBGROUP ANALYSES (Symptom duration), Outcome 4: Function (/100): Earliest follow‐up; Exercise vs. other conservative treatment" data-id="CD009790-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: SUBGROUP ANALYSES (Symptom duration), Outcome 4: Function (/100): Earliest follow‐up; Exercise vs. other conservative treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SUBGROUP ANALYSES (Radicular symptoms), Outcome 1: Pain (/100): Earliest follow‐up; Exercise vs. no treatment or usual care" data-id="CD009790-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: SUBGROUP ANALYSES (Radicular symptoms), Outcome 1: Pain (/100): Earliest follow‐up; Exercise vs. no treatment or usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SUBGROUP ANALYSES (Radicular symptoms), Outcome 2: Pain (/100): Earliest follow‐up; Exercise vs. other conservative treatment" data-id="CD009790-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: SUBGROUP ANALYSES (Radicular symptoms), Outcome 2: Pain (/100): Earliest follow‐up; Exercise vs. other conservative treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SUBGROUP ANALYSES (Radicular symptoms), Outcome 3: Function (/100): Earliest follow‐up; Exercise vs. no treatment or usual care" data-id="CD009790-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: SUBGROUP ANALYSES (Radicular symptoms), Outcome 3: Function (/100): Earliest follow‐up; Exercise vs. no treatment or usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SUBGROUP ANALYSES (Radicular symptoms), Outcome 4: Function (/100): Earliest follow‐up; Exercise vs. other conservative treatment" data-id="CD009790-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: SUBGROUP ANALYSES (Radicular symptoms), Outcome 4: Function (/100): Earliest follow‐up; Exercise vs. other conservative treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: SUBGROUP ANALYSES (Conservative comparisons), Outcome 1: Pain (/100): Earliest follow‐up, Exercise vs. other conservative treatments" data-id="CD009790-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: SUBGROUP ANALYSES (Conservative comparisons), Outcome 1: Pain (/100): Earliest follow‐up, Exercise vs. other conservative treatments </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: SUBGROUP ANALYSES (Conservative comparisons), Outcome 2: Function (/100): Earliest follow‐up, Exercise vs. other conservative treatments" data-id="CD009790-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: SUBGROUP ANALYSES (Conservative comparisons), Outcome 2: Function (/100): Earliest follow‐up, Exercise vs. other conservative treatments </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: SENSITIVITY ANALYSES (No assumptions about data), Outcome 1: Pain (/100): Earliest follow‐up, no imputation of SD" data-id="CD009790-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: SENSITIVITY ANALYSES (No assumptions about data), Outcome 1: Pain (/100): Earliest follow‐up, no imputation of SD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: SENSITIVITY ANALYSES (No assumptions about data), Outcome 2: Function (/100): Earliest follow‐up, no imputation of SD" data-id="CD009790-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: SENSITIVITY ANALYSES (No assumptions about data), Outcome 2: Function (/100): Earliest follow‐up, no imputation of SD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: SENSITIVITY ANALYSES (No assumptions about data), Outcome 3: Function (/100): Earliest follow‐up, RMDQ measurement only" data-id="CD009790-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: SENSITIVITY ANALYSES (No assumptions about data), Outcome 3: Function (/100): Earliest follow‐up, RMDQ measurement only </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: SENSITIVITY ANALYSES (Low risk of bias), Outcome 1: Pain (/100): Earliest follow‐up" data-id="CD009790-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: SENSITIVITY ANALYSES (Low risk of bias), Outcome 1: Pain (/100): Earliest follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: SENSITIVITY ANALYSES (Low risk of bias), Outcome 2: Function (/100): Earliest follow‐up" data-id="CD009790-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: SENSITIVITY ANALYSES (Low risk of bias), Outcome 2: Function (/100): Earliest follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: SENSITIVITY ANALYSES (Excluding outlying means), Outcome 1: Pain (/100): Earliest follow‐up" data-id="CD009790-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: SENSITIVITY ANALYSES (Excluding outlying means), Outcome 1: Pain (/100): Earliest follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: SENSITIVITY ANALYSES (Excluding outlying means), Outcome 2: Function (/100): Earliest follow‐up" data-id="CD009790-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: SENSITIVITY ANALYSES (Excluding outlying means), Outcome 2: Function (/100): Earliest follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: SENSITIVITY ANALYSES (Placebo only comparisons), Outcome 1: Pain (/100): Earliest follow‐up" data-id="CD009790-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: SENSITIVITY ANALYSES (Placebo only comparisons), Outcome 1: Pain (/100): Earliest follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009790-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/urn:x-wiley:14651858:media:CD009790:CD009790-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: SENSITIVITY ANALYSES (Placebo only comparisons), Outcome 2: Function (/100): Earliest follow‐up" data-id="CD009790-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_t/tCD009790-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: SENSITIVITY ANALYSES (Placebo only comparisons), Outcome 2: Function (/100): Earliest follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/media/CDSR/CD009790/image_n/nCD009790-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009790-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: Exercise treatment compared with no treatment, usual care or placebo for chronic low back pain</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects*</b><br/>  </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants<br/>(studies; study groups)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)<sup>a</sup> </b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Without exercise (no treatment, usual care or placebo<sup>b</sup>)</b><br/>  </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Difference with exercise</b><br/>  </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain intensity (0‐100; 0</b> = <b>no pain): Earliest follow‐up (time point closest to 3 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity outcome at follow‐up ranged across the no treatment, usual care or placebo comparison groups from 21 to 81. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain intensity in the exercise treatment groups was 15 points better than the no treatment, usual care or placebo comparison groups at follow‐up (12 to 18 points better). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants = 2746; studies = 35; study groups = 47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate<sup>c</sup> </b> </p> <p>due to risk of inconsistency</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Functional limitations (0‐100; 0 = no functional limitations): Earliest follow‐up (time point closest to 3 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional limitations outcome at follow‐up ranged across the no treatment, usual care or placebo comparison groups from 7 to 58. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean functional limitations in the exercise treatment groups was 7 points better than the no treatment, usual care or placebo comparison groups at follow‐up (5 to 8 points better). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants = 2942; studies = 38; study groups = 50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate<sup>d</sup> </b> </p> <p>due to potential publication bias</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*The anticipated absolute effects without exercise come from the range of outcomes at follow‐up in the no treatment, usual care or comparison groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup> For all comparisons and outcomes ‐ certainty may be raised to high given that further similar research is very unlikely to change our confidence in the estimate of effect. </p> <p><sup>b</sup> Observed effects were consistent when we performed a post hoc sensitivity analysis restricting to only placebo‐controlled trials.  </p> <p><sup>c</sup>Seven studies (10 groups; 526 participants) were judged to have high risk of bias (19% of participant data). Exclusion of these studies in sensitivity analysis did not change conclusions. Serious unexplained inconsistency (substantial heterogeneity I<sup>2</sup> = 75%, point estimates and confidence intervals varied considerably). No concerns about indirectness or imprecision. No evidence of publication bias (Egger's test, P = 0.30). </p> <p><sup>d</sup> Nine studies (13 groups; 495 participants) were judged to have high risk of bias (17% of participant data). Exclusion of these studies in sensitivity analysis did not change conclusions. Some unexplained inconsistency (moderate heterogeneity I<sup>2</sup> = 38%, point estimates and confidence intervals varied). No concerns about indirectness or imprecision. Some evidence of publication bias (Egger's test, P = 0.005). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: Exercise treatment compared with no treatment, usual care or placebo for chronic low back pain</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009790-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: Exercise treatment compared with other conservative treatments for chronic low back pain</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects*</b><br/>  </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants<br/>(studies; study groups)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)<sup>a</sup> </b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Without exercise (other conservative treatment comparison)</b><br/>  </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Difference with exercise</b><br/>  </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p><b>Pain intensity (0‐100 points; 0 = no pain): Earliest follow‐up (time point closest to 3 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="5" valign=""> <p>The mean pain intensity outcome at follow‐up ranged across the other conservative treatment comparison groups from 8 to 73 points.<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="5" valign=""> <p>The mean pain intensity in the exercise treatment groups was 9 points better than the other conservative treatment comparison groups at follow‐up (6 to 13 points better). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Participants = 6295; studies = 64; study groups = 85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>low<sup>b</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>due to risk of inconsistency and publication bias</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p><b>Functional limitations (0‐100 points; 0 = no functional limitations): Earliest follow‐up (time point closest to 3 months)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="5" valign=""> <p>The mean functional limitations outcome at follow‐up ranged across the other conservative treatment comparison groups from 8 to 60 points. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="5" valign=""> <p>The mean functional limitations in the exercise treatment groups was 4 points better than the other conservative treatment comparison groups at follow‐up (2 to 6 points better). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Participants = 6004; studies = 52; study groups = 69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>moderate<sup>c</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>due to risk of inconsistency</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <br/>  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p>*The anticipated absolute effects without exercise come from the range of outcomes at follow‐up in the other conservative treatment comparison groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup> For all comparisons and outcomes ‐ certainty may be raised one level given that further similar research is very unlikely to change our confidence in the estimate of effect. </p> <p><sup>b</sup> Eleven studies (14 groups; 835 participants) were judged to have high risk of bias (13% of participant data). Exclusion of these studies in sensitivity analysis did not change conclusions. Serious inconsistency (considerable heterogeneity I<sup>2</sup> = 81%, point estimates and confidence intervals varied considerably), partially explained by exploration of effect in specific comparison subgroups (I<sup>2</sup> &lt; 75% for five of eight comparisons). No concerns about indirectness or imprecision. Some evidence of potential publication bias (Egger's test, P = 0.001). </p> <p><sup>c</sup> Seven studies (9 groups; 571 participants) were judged to have high risk of bias (10% of participant data). Exclusion of these studies in sensitivity analysis did not change conclusions. Serious inconsistency (considerable heterogeneity I<sup>2</sup> = 82%, point estimates and confidence intervals varied considerably), partially explained by exploration of effect in specific comparison subgroups (I<sup>2</sup> &lt; 75% for five of eight comparisons). No concerns about indirectness or imprecision. No evidence of publication bias (Egger's test, P = 0.40). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: Exercise treatment compared with other conservative treatments for chronic low back pain</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009790-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study population and exercise treatment characteristic definitions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Characteristic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definitions</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Population LBP duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Acute</b> = Low back pain episode less than 6 weeks in duration<br/><b>Subacute</b> = Low back pain episode between 6 weeks and 3 months in duration<br/><b>Chronic</b> = Low back pain episode 3 months or more in duration </p> <p><b>Chronic recurrent</b> = Two episodes in a year, lasting more than 24 hours, with more than 30 days pain‐free between<br/><b>Mixed</b> = If population was mixed, we recorded the proportion of the population that had chronic low back pain </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Population source</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Healthcare</b> = Primary care, secondary/tertiary (referred), physiotherapy, occupational therapy, etc.<br/><b>Occupational</b> = Population selected by workplace, workers' compensation claims, etc.<br/><b>General</b> = Population selected to represent all residents living in a geographic area (non‐clinical)<br/><b>Mixed</b> = Two or more of the above categories </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise type</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Strengthening</b> = Strengthening exercises were those that were designed to increase an individual's ability to exert or resist force using load‐bearing or resistance exercises including weights, weight machines, or elastic cords. Strengthening exercises were categorised as whole‐body where they involved a broad set of exercises that were not specific only to the low back region (i.e. directed at muscles connecting to the lumbar spine and/or pelvis). </p> <p><b>Stretching</b> = Stretching exercises were those that intended to elongate soft tissues and poses held for varying periods of time. For the purpose of this review, stretching exercises were self‐administered (but could use aids). Depending on the location and types of stretches, stretches could be classified as whole‐body or back‐specific or both.<br/><b>Core strengthening</b> = Core strengthening exercises were those that were designed to improve the control, co‐ordination, and strength of the core, lumbar, and pelvic region muscles. These included motor control exercises, core stability or sling exercises, and Pilates, but excluded those that were generalised (whole‐body) stability exercises. We categorised core strengthening exercises as back‐specific.<br/><b>Flexibility/mobilising</b> = Neuromuscular techniques involved repeated movements within the patient’s range of motion and within the patient’s control. Typically, such exercises were geared toward improving the range of motion of joints related to low back pain and thereby were classified as low back‐specific.<br/><b>Aerobic</b> = Aerobic exercises were those that were designed to improve cardiorespiratory fitness and used large muscle groups, as such, we categorised it as a whole‐body exercise.<br/><b>Functional restoration</b> = Functional restoration treats chronic pain and is focussed on improving/maximizing patient function and activities through a multi‐pronged strategy of psychosocial support and physical activities. We categorised it as whole‐body. </p> <p><b>McKenzie</b> = McKenzie involves individualised assessment, specific loading exercises, and postural training and education including managing pain through self‐management. Because McKenzie was developed for and focusses on managing low back pain, we categorised it as low back‐specific.<br/><b>Yoga</b> = Yoga is a practice with many branches and styles, but which may involve physical poses designed for strengthening and stretching (asanas), controlled breathing (pranayama), and often medication (dhyana). Given the generalised physical nature of yoga practices, we categorised yoga as a whole‐body exercise. </p> <p><b>Mixed</b> (3 or more types) = Mixed exercises incorporated three or more types of exercise in which one did not clearly predominate/form most of the exercise intervention. Mixed exercises could be whole‐body, low back‐specific, or both, depending on the types and combination of exercises involved. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise specificity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Whole‐body</b> = Exercises involved many muscle groups from around the body, generally seeking to improve overall fitness.<br/><b>Back‐specific</b> = Exercises were concentrated around muscle groups that support the back (core, trunk, abdominal, back, pelvic, upper leg, etc.).<br/><b>Both</b> = Aspects of the intervention were focussed on both overall fitness and on the back specifically.<br/><b>Unclear</b> = Not enough description of the exercise(s) was provided to determine what part of the body it was working on.<br/><b>Other</b> = Exercises were not working on the body overall, nor focussed on the back, but a different specific part of the body. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Programme individualisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Individually designed</b> = Treating therapist completed a clinical history and physical examination and delivered an exercise treatment specifically designed for the individual participant.<br/><b>Partially individually designed</b> = Exercise treatment included the same type of exercises for all participants, but varied in intensity, duration or both.<br/><b>Standard design</b> = A fixed exercise treatment was delivered to all participants. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Delivery mode</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Independent</b> = Home exercises only, in which the participants met initially with therapists, then participated in the exercise treatment with no supervision or follow‐up<br/><b>Independent with follow‐up</b> = Supervised home exercises in which the participants met initially with therapists, participated in the exercise treatment, and had follow‐up with their therapist at least every six weeks<br/><b>Group</b> = Group supervision, in which participants attended exercise treatment sessions with two or more participants<br/><b>Individual</b> = Individual supervision, in which participants received one‐on‐one intervention or supervision </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐exercise comparisons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Usual care/no treatment</b> = Participants received no intervention and received the same standard medical care they would have without being recruited to the study or participants who received a placebo or sham treatment. </p> <p><b>Education</b> = Verbal or written guidance, online or in person, related to their back pain (a formal intervention – not just advice) </p> <p><b>Electrotherapy</b> = e.g. TENS, laser, ultrasound, PENS </p> <p><b>Manual therapy</b> = Manual therapist, physiotherapist, or other professional delivers manual therapy; these can be passive techniques, mobilisation. </p> <p><b>Physical therapy</b> = Mixed physical therapy interventions, including more than one non‐modality (e.g. heat + mobilisation; manual therapy + TENS + heat); does not include exercise as a main treatment component of intervention. </p> <p><b>Psychological therapy</b> = A psychological intervention, delivered by a healthcare professional, including Cognitive Behavioural Therapy (psychologist, psychological therapist, psychiatrist, counsellor, etc.) </p> <p><b>Back school</b> = A programme containing both educational and active training components, delivered by a therapist or other professional. Topics cover a range, including spinal anatomy, causes of LBP, ergonomic advice, exercises to deal with LBP, causes of LBP, posture, relaxation, LBP prevention. </p> <p><b>Anti‐inflammatory/analgesics</b> = Participants in this group were given analgesics or nonsteroidal anti‐inflammatory drugs to deal with LBP symptoms. </p> <p><b>Relaxation</b> = Relaxation programme/intervention delivered by a healthcare professional </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p><sup>LBP: low back pain</sup><br/><sup>PENS: Percutaneous electrical nerve stimulation</sup><br/><sup>TENS: Transcutaneous electrical nerve stimulation</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study population and exercise treatment characteristic definitions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009790-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sources of risk of bias</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Bias domain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Source of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Possible answers</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Was the method of randomisation adequate?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(2) Was the treatment allocation concealed?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(3) Was the patient blinded to the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(4) Was the care provider blinded to the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(5) Was the outcome assessor blinded to the intervention?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(6) Was there missing outcome data (dropout rate described and acceptable)?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(7) Were all randomised participants analysed in the group to which they were allocated?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(8) Are reports of the study free of suggestion of selective outcome reporting?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(9) Were the groups similar at baseline regarding the most important prognostic indicators?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other (adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(10) Were co‐interventions avoided or similar?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other (adherence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(11) Was the compliance acceptable in all groups?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(12) Was the timing of the outcome assessment similar in all groups?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(13) Are other sources of potential bias unlikely?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes/no/unsure</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>See <a href="./references#CD009790-bbs2-0518" title="FurlanAD , MalmivaaraA , ChouR , MaherCG , DeyoRA , SchoeneM , et al. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine2015;40(21):1660-73.">Furlan 2015</a> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sources of risk of bias</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009790-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Criteria for a judgement of ‘‘yes’’ for the sources of risk of bias</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A random (unpredictable) assignment sequence. Examples of adequate methods are coin toss (for studies with two groups), rolling a dice (for studies with two or more groups), drawing of balls of different colours, drawing of ballots with the study group labels from a dark bag, computer‐generated random sequence, pre‐ordered sealed envelopes, sequentially‐ordered vials, telephone call to a central office, and preordered list of treatment assignments. Examples of inadequate methods are: alternation, birth date, social insurance/security number, date in which they are invited to participate in the study, and hospital registration number. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assignment generated by an independent person not responsible for determining the eligibility of the patients. This person has no information about the persons included in the trial and has no influence on the assignment sequence or on the decision about eligibility of the patient. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Index and control groups are indistinguishable for the patients or if the success of blinding was tested among the patients and it was successful </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Index and control groups are indistinguishable for the care providers or if the success of blinding was tested among the care providers and it was successful </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adequacy of blinding should be assessed for each primary outcome separately. This item should be scored ‘‘yes’’ if the success of blinding was tested among the outcome assessors and it was successful or: </p> <p>‐ for patient‐reported outcomes in which the patient is the outcome assessor (e.g. pain, functional limitations): the blinding procedure is adequate for outcome assessors if participant blinding is scored ‘‘yes’’<br/>‐ for outcome criteria assessed during scheduled visit and that supposes a contact between participants and outcome assessors (e.g. clinical examination): the blinding procedure is adequate if patients are blinded, and the treatment or adverse effects of the treatment cannot be noticed during clinical examination<br/>‐ for outcome criteria that do not suppose a contact with participants (e.g. radiography, magnetic resonance imaging): the blinding procedure is adequate if the treatment or adverse effects of the treatment cannot be noticed when assessing the main outcome<br/>‐ for outcome criteria that are clinical or therapeutic events that will be determined by the interaction between patients and care providers (e.g. co‐interventions, hospitalisation length, treatment failure), in which the care provider is the outcome assessor: the blinding procedure is adequate for outcome assessors if item ‘‘4’’ (caregivers) is scored ‘‘yes’’<br/>‐ for outcome criteria that are assessed from data of the medical forms: the blinding procedure is adequate if the treatment or adverse effects of the treatment cannot be noticed from the extracted data </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The number of participants who were included in the study but did not complete the observation period or were not included in the analysis must be described and reasons given. If the percentage of withdrawals and dropouts does not exceed 20% for short‐term follow‐up and 30% for long‐term follow‐up and does not lead to substantial bias, a ‘‘yes’’ is scored. (N.B. these percentages are arbitrary, not supported by literature) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All randomised patients are reported/analysed in the group they were allocated to by randomisation for the most important moments of effect measurement (minus missing values) irrespective of noncompliance and co‐interventions. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All the results from all prespecified outcomes have been adequately reported in the published report of the trial. This information is either obtained by comparing the protocol and the report, or in the absence of the protocol, assessing that the published report includes enough information to make this judgement. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Groups have to be similar at baseline regarding demographic factors, duration and severity of complaints, percentage of patients with radicular symptoms, and value of main outcome measure(s). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>If there were no co‐interventions or they were similar between the index and control groups </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The reviewer determines if the compliance with the interventions is acceptable, based on the reported intensity, duration, number and frequency of sessions for both the index intervention and control intervention(s). For example, physiotherapy treatment is usually administered for several sessions; therefore it is necessary to assess how many sessions each patient attended. For single‐session interventions (e.g. surgery), this item is irrelevant. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timing of outcome assessment should be identical for all intervention groups and for all primary outcome measures. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other types of biases. For example:<br/>‐ When the outcome measures were not valid. There should be evidence from a previous or present scientific study that the primary outcome can be considered valid in the context of the present.<br/>‐ Industry‐sponsored trials. The conflict of interest (COI) statement should explicitly state that the researchers have had full possession of the trial process from planning to reporting without funders with potential COI having any possibility of interfering in the process. If, for example, the statistical analyses have been done by a funder with a potential COI, usually ‘‘unsure’’ is scored. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>See <a href="./references#CD009790-bbs2-0518" title="FurlanAD , MalmivaaraA , ChouR , MaherCG , DeyoRA , SchoeneM , et al. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group. Spine2015;40(21):1660-73.">Furlan 2015</a> </p> <p>COI: Conflict of interest</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Criteria for a judgement of ‘‘yes’’ for the sources of risk of bias</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/full#CD009790-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">PRIMARY ANALYSES</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Pain (/100): Earliest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.24 [‐13.82, ‐8.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Exercise vs. no treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2746</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.22 [‐18.26, ‐12.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Exercise vs. other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.10 [‐12.63, ‐5.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Pain (/100): Short‐term follow‐up (6‐12 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.42 [‐14.71, ‐8.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Exercise vs. no treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.36 [‐20.32, ‐12.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Exercise vs. other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.61 [‐13.08, ‐4.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Pain (/100): Medium‐term follow‐up (~6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5569</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.77 [‐12.03, ‐5.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Exercise vs. no treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1491</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.57 [‐15.03, ‐6.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Exercise vs. other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4078</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.11 [‐12.31, ‐3.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Pain (/100): Long‐term follow‐up (&gt; 12 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.22 [‐11.78, ‐0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Exercise vs. no treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>498</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.80 [‐21.98, ‐1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Exercise vs. other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.22 [‐11.27, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Function (/100): Earliest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Exercise vs. no treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2942</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.81 [‐8.32, ‐5.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Exercise vs. other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.11 [‐5.98, ‐2.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Function (/100): Short‐term follow‐up (6‐12 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Exercise vs. no treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.42 [‐9.24, ‐5.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Exercise vs. other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.95 [‐5.99, ‐1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Function (/100): Medium‐term follow‐up (~6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Exercise vs. no treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1831</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.55 [‐8.29, ‐4.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Exercise vs. other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3531</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.22 [‐4.53, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Function (/100): Long‐term follow‐up (&gt; 12 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.72 [‐2.80, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Exercise vs. no treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>550</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.40 [‐7.29, ‐1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Exercise vs. other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2816</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [‐2.16, 2.68]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">PRIMARY ANALYSES</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SUBGROUP ANALYSES (Population source)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Pain (/100); Earliest follow‐up; Exercise vs. no treatment or usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2716</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.40 [‐18.49, ‐12.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Healthcare populations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.94 [‐20.94, ‐12.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Occupational populations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐22.87 [‐39.68, ‐6.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 General populations or mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.20 [‐17.10, ‐7.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Pain (/100); Earliest follow‐up; Exercise vs. other conservative treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.03 [‐12.59, ‐5.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Healthcare populations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2602</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.02 [‐12.17, ‐3.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Occupational populations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.61 [‐28.41, ‐0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.3 General populations or mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2698</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.35 [‐12.76, ‐3.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Function (/100); Earliest follow‐up; Exercise vs. no treatment or usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2788</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.01 [‐8.67, ‐5.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Healthcare populations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1900</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.86 [‐10.03, ‐5.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Occupational populations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.35 [‐7.06, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.3 General populations or mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.65 [‐8.43, ‐2.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Function (/100); Earliest follow‐up; Exercise vs. other conservative treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5944</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.97 [‐5.85, ‐2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Healthcare populations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2488</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.25 [‐6.15, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Occupational populations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>583</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐6.97, 2.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.3 General populations or mixed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2873</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.41 [‐8.10, ‐2.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SUBGROUP ANALYSES (Population source)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SUBGROUP ANALYSES (Symptom duration)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Pain (/100): Earliest follow‐up; Exercise vs. no treatment or usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2746</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.20 [‐18.24, ‐12.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Moderate duration of symptoms (12 weeks ‐ 3 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.41 [‐22.55, ‐10.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Long duration of symptoms (&gt; 3 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.54 [‐11.05, ‐6.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.3 Duration of chronic symptoms not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>905</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐21.55 [‐26.57, ‐16.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Pain (/100): Earliest follow‐up; Exercise vs. other conservative treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.10 [‐12.63, ‐5.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Moderate duration of symptoms (12 weeks ‐ 3 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.57 [‐18.12, ‐3.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Long duration of symptoms (&gt; 3 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2094</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.75 [‐11.68, ‐1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 Duration of chronic symptoms not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2646</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.46 [‐14.22, ‐4.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Function (/100): Earliest follow‐up; Exercise vs. no treatment or usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2942</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.82 [‐8.32, ‐5.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Moderate duration of symptoms (12 weeks ‐ 3 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>543</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.74 [‐7.08, ‐2.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 Long duration of symptoms (&gt; 3 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.58 [‐7.41, ‐3.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.3 Duration of chronic symptoms not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.50 [‐11.44, ‐5.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Function (/100): Earliest follow‐up; Exercise vs. other conservative treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.11 [‐5.98, ‐2.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Moderate duration of symptoms (12 weeks ‐ 3 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.80 [‐7.78, ‐1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Long duration of symptoms (&gt;3 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2076</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.87 [‐8.52, ‐1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.3 Duration of chronic symptoms not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.00 [‐6.20, 0.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SUBGROUP ANALYSES (Symptom duration)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SUBGROUP ANALYSES (Radicular symptoms)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Pain (/100): Earliest follow‐up; Exercise vs. no treatment or usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2746</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.23 [‐18.26, ‐12.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Study populations excluded leg pain and/or neurologic symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>816</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.95 [‐22.61, ‐11.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Study populations included leg pain and/or neurologic symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.89 [‐20.85, ‐10.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.3 Leg pain and/or neurologic symptoms not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.23 [‐14.65, ‐7.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Pain (/100): Earliest follow‐up; Exercise vs. other conservative treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.10 [‐12.63, ‐5.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Study populations excluded leg pain and/or neurologic symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1657</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.51 [‐14.59, ‐4.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 Study populations included leg pain and/or neurologic symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2766</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.87 [‐9.09, ‐0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.3 Leg pain and/or neurologic symptoms not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1872</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.71 [‐20.03, ‐7.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Function (/100): Earliest follow‐up; Exercise vs. no treatment or usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2942</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.80 [‐8.30, ‐5.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 Study populations excluded leg pain and/or neurologic symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>983</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.01 [‐8.14, ‐3.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 Study populations included leg pain and/or neurologic symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.63 [‐8.37, ‐4.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.3 Leg pain and/or neurologic symptoms not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.34 [‐13.52, ‐1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Function (/100): Earliest follow‐up; Exercise vs. other conservative treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.11 [‐5.98, ‐2.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 Study populations excluded leg pain and/or neurologic symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2022</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.85 [‐8.85, ‐2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.2 Study populations included leg pain and/or neurologic symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐3.54, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.3 Leg pain and/or neurologic symptoms not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.73 [‐10.54, ‐2.92]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SUBGROUP ANALYSES (Radicular symptoms)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SUBGROUP ANALYSES (Conservative comparisons)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Pain (/100): Earliest follow‐up, Exercise vs. other conservative treatments <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.10 [‐12.63, ‐5.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Exercise vs. Education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2039</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.17 [‐19.38, ‐4.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Exercise vs. Manual therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [‐3.14, 5.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.3 Exercise vs. Electrotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.34 [‐23.86, 3.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.4 Exercise vs. Psychological therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐18.67 [‐30.75, ‐6.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.5 Exercise vs. Mixed physical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1869</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.42 [‐15.22, ‐5.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.6 Exercise vs. Back school</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.02 [‐22.68, ‐5.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.7 Exercise vs. Relaxation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.50 [‐13.11, 6.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.8 Exercise vs. Anti‐inflammatories</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.82 [‐24.44, ‐5.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Function (/100): Earliest follow‐up, Exercise vs. other conservative treatments <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.10 [‐5.97, ‐2.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Exercise vs. Education</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.03 [‐10.75, ‐5.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Exercise vs. Manual therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1637</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [‐1.47, 4.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.3 Exercise vs. Electrotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.81 [‐10.07, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.4 Exercise vs. Psychological therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.50 [‐25.37, 10.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.5 Exercise vs. Mixed physical therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1074</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.28 [‐9.00, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.6 Exercise vs. Back school</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.74 [‐6.34, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.7 Exercise vs. Relaxation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.59 [‐4.72, 13.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.8 Exercise vs. Anti‐inflammatories</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.78 [‐21.98, ‐5.57]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SUBGROUP ANALYSES (Conservative comparisons)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">SENSITIVITY ANALYSES (No assumptions about data)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Pain (/100): Earliest follow‐up, no imputation of SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.08 [‐15.49, ‐8.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Exercise vs. No treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.65 [‐20.81, ‐12.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 Exercise vs. Other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.85 [‐14.40, ‐5.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Function (/100): Earliest follow‐up, no imputation of SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 Exercise vs. No treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2076</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.38 [‐9.33, ‐5.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.2 Exercise vs. Other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4743</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.12 [‐6.28, ‐1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Function (/100): Earliest follow‐up, RMDQ measurement only <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.1 Exercise vs. No treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.83 [‐10.21, ‐5.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.2 Exercise vs. Other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4082</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.27 [‐8.05, ‐2.49]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">SENSITIVITY ANALYSES (No assumptions about data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SENSITIVITY ANALYSES (Low risk of bias)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Pain (/100): Earliest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.18 [‐14.11, ‐8.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 Exercise vs. No treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.34 [‐18.91, ‐11.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.2 Exercise vs. Other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5460</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.06 [‐12.99, ‐5.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Function (/100): Earliest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.1 Exercise vs. No treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.27 [‐9.04, ‐5.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.2 Exercise vs. Other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.39 [‐6.45, ‐2.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SENSITIVITY ANALYSES (Low risk of bias)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">SENSITIVITY ANALYSES (Excluding outlying means)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Pain (/100): Earliest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.68 [‐10.82, ‐6.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Exercise vs. No treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.49 [‐13.82, ‐9.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.2 Exercise vs. Other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.25 [‐10.15, ‐4.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Function (/100): Earliest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.1 Exercise vs. No treatment or usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2703</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.35 [‐6.47, ‐4.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.2 Exercise vs. Other conservative treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5727</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.61 [‐5.49, ‐1.73]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">SENSITIVITY ANALYSES (Excluding outlying means)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009790-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">SENSITIVITY ANALYSES (Placebo only comparisons)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Pain (/100): Earliest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 Exercise vs. Placebo treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.85 [‐15.12, ‐2.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Function (/100): Earliest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.1 Exercise vs. Placebo treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.60 [‐11.19, ‐0.01]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">SENSITIVITY ANALYSES (Placebo only comparisons)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009790.pub2/references#CD009790-tbl-0014">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009790.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009790-note-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009790-note-0018">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009790-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009790-note-0017">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD009790-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD009790-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD009790-note-0016">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD009790-note-0011">Português</a> </li> <li class="section-language"> <a class="" href="th#CD009790-note-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009790-note-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009790-note-0010">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009790\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009790\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009790\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009790\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009790\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009790.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009790.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009790.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009790.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009790.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727376227"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009790.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727376231"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009790.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eaa7a6e829377',t:'MTc0MDcyNzM3Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 